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1.1 Periodicity of Childhood Diseases. Time series (top to bot-
tom) of measles, chicken pox, and mumps in New York City, along
with measles in Baltimore. Each disease had a seasonal window
when epidemics occurred. Epidemics occurred either annually or at
multi-annual intervals [5]. Figure reproduced from Wayne P. Lon-
don, James A. Yorke, Recurrent Outbreaks of Measles, Chickenpox
and Mumps: I. Seasonal Variation in Contact Rates, American Jour-
nal of Epidemiology, 1973, volume 98, issue 6, 453–468, by permission
of Oxford University Press. . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 Seasonality of Human Births. Time series of births in Spain
showing consistent seasonality relating to a springtime peak in con-
ception. Societal events, such as wars, altered the amplitude of birth
seasonality and introduced irregularities; however, birth seasonality
persisted [6]. Reprinted from Current Biology, Vol 18 issue 17, Rus-
sell G. Foster, Till Roenneberg, Human Responses to the Geophys-
ical Daily, Annual and Lunar Cycles, Pages R784–R794, Copyright
(2008), with permission from Elsevier. . . . . . . . . . . . . . . . . . 4
1.3 Seasonal Gene Expression in the Human Immune System.
Over 5000 genes (∼ 23%) of the human immune system were iden-
tified as seasonal. Plot shows fitted cosine curves for seasonal genes.
Seasonal genes were binned into groups of summertime-expressed and
wintertime-expressed genes, with the exception of a single gene that
didn’t fall into either category. Figure reproduced from [14], licensed
under a Creative Commons Attribution 4.0 International License. . 7
vi
1.4 Summertime Polio Epidemics. The distribution of polio cases in
the US, Australia, and New Zealand. Polio epidemics peaked in the
summer: Feb–Mar in Australia and New Zealand, and Jun–Oct in the
US. US states displayed south-to-north variation in epidemic timing,
with southern states having the earliest epidemics, followed by in-
termediate latitude states. Northern states had the latest epidemics.
Figure reproduced from [19]. . . . . . . . . . . . . . . . . . . . . . . 10
2.1 Birth Data from the US. Temporal patterns of birth rates (per
1000 individuals per month) in the US organized by geographic re-
gion, separated into three eras: Pre-Baby Boom (1931–1945), Baby
Boom (1946–1965), and Modern Era (1965–2008). The time series
for Louisiana is plotted at the top as an example. . . . . . . . . . . 20
2.2 Latitudinal Gradients in US Births. Spatiotemporal patterns of
seasonal birth peak timing and amplitude in the US. (Top panels)
Pre-Baby Boom (1931–1945), (Middle panels) Baby Boom (1946–
1964), and (Bottom panels) Modern Era (1965–2008). Maps depict
the latitudinal gradient in the timing of the birth peak. Colors in-
dicate the mean timing of the birth peak for each state. Hatched
regions represent states in which a significant bi-annual peaks were
discernible and are color coded based on the timing of their primary
annual birth pulse (also see Figs S1 & S2). States shown in white did
not exhibit a significant periodicity. Regressions show the latitudinal
variation in seasonal amplitude, with the colors representing the peak
birth timing for the respective period. . . . . . . . . . . . . . . . . . 22
2.3 Northern Hemisphere Latitudinal Gradient in Birth Season-
ality. Northern Hemisphere patterns of seasonal birth pulses color
coded by region. Birth pulses occurred earlier in the year at northern
latitudes. Table S5 provides the details for each country, including
the time frame of the data which ranges from the 1960s to 2011. . . 24
vii
2.4 Impact of Birth Seasonality on Childhood Disease. (A) Epi-
demic and skip-year incidence varies with birth peak timing along
the x-axis. Solid curve shows the change in epidemic year incidence
when birth seasonality is added to the measles model. Dashed curve
shows the change in the skip-year. The phase relationship between
seasonal births and transmission determines whether birth season-
ality has an effect on incidence. The greatest increase in epidemic
year incidence is when the birth peak occurs after children return
from winter holiday (orange points). A decrease in epidemic year
incidence occurs when births peak prior to summer vacation (green
points). School terms are noted and vertical arrows mark the timing
of incidence peaks during the epidemic year. (Inset) Time series from
the constant birth model (black), and time series corresponding to
the color-matched points on the main graph. (B) Bifurcation dia-
gram showing the change in epidemic and skip-year peak incidence
with increasing birth amplitude. In the absence of birth seasonality,
epidemics are biennial. As birth amplitude increases, skip-year inci-
dence increases and epidemic year incidence decreases. When birth
amplitude reaches ∼40% epidemics become annual. Time series in
the inset correspond to the points in the main graph; blue time se-
ries are biennial, and golden are annual. Arrows denote the birth
amplitude observed in Switzerland, Cuba, Egypt, Nigeria, Guinea,
and Sierra Leone, left to right. Amplitudes for Nigeria, Guinea, and
Sierra Leone are from [49]. . . . . . . . . . . . . . . . . . . . . . . . 27
2.5 Bias in R0 estimates due to the exclusion of birth seasonality
in a SEIR model. Time series were generated using a SEIR model
with a birth peak day of 162 (turquoise), 295 (blue), or 351 (orange).
Each time series was fit to the SEIR model with a birth amplitude
of 0%. The actual R0 value is shown by the dashed line and the
likelihood profiles show that maximum likelihood estimate of R0 is
either over- or under-estimated when birth seasonality is excluded
from the model. 95% confidence intervals for MLE are indicated on
profiles. Note, in the published form of this manuscript, this is panel
C, and is combined with the two panels from the previous figure. . . 28
viii
2.6 Measles Cases in New York City. (A) Measles incidence (black)
and a stochastic realization using the MLE for each type of birth
covariate: seasonal births with a 3 month lag (blue), seasonal births
with a 6 month lag (green), seasonal births with a 9 month lag (yel-
low), and births with no seasonality (maroon). Legend applies to all
of Fig 5. (B) The shape of the likelihood surface with respect to R0.
The MLE R0s are indicated by points and the standard errors are
represented by horizontal lines. (C) MLE transmission splines for
each model. (D) Transmission splines estimated using TSIR [46, 47]
for each type of birth covariate. The MLEs differed with and without
birth seasonality, but the differences in the point estimates were over-
whelmed by uncertainty in parameter estimates (Figs 5B & 5C). No
difference in transmission parameters was observed using the TSIR
method. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.1 Rhythms and Temporal Niche. (A) The timing of host and para-
site activities falls in the intersection of environmental rhythms, host
life history, host immunity rhythms, and parasite rhythms. This in-
tersection is embedded within geophysical rhythms, diel and annual
cycles. (B) Biological and environmental rhythms can enter into epi-
demiological models in multiple ways. . . . . . . . . . . . . . . . . 46
3.2 Conceptual model for investigating host-parasite contribu-
tions to rhythms in infectious disease. (A) Host immune defense
is resource-driven and tracks the host’s environmental conditions (i.e.,
host resource availability). (B) Host immune defense has an inverse
relationship with environmental conditions; this could occur due to a
trade-off against investment into reproduction during high resource
availability. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.1 Spatiotemporal patterns in US polio incidence. (A) Total monthly
case reports, 1931–1954, color-coded by per-capita incidence. (B) Log-
transformed per-capita incidence by state, ranked top-to-bottom by popu-
lation size. (C) Disease fadeout frequency as a function of state population
size, during the pre-baby boom and the baby boom. The lines represent
fitted negative exponential curves, which tended toward zero. (D) Pair-
wise epidemic synchrony between states during the pre-baby boom and
the baby boom. Mean and 95% bootstrap confidence envelope shown. (E,
F) Relative timing of polio epidemic peaks during the (E) pre-baby boom
and (F) baby boom eras. Color indicates mean rank of each state across
years; lower rank indicates earlier epidemic peak. Below each map, rela-
tive timing is regressed on latitude. Lower latitude states had significantly
earlier epidemic peaks. . . . . . . . . . . . . . . . . . . . . . . . . . 95
ix
4.2 Model schematic and example likelihood profile. (A) Births en-
ter the first susceptible infant class, SB1 . Susceptible infants of age 0–6
months, SB1−6, are susceptible to infection, but are protected from symp-
tomatic disease by maternal antibodies. Susceptible individuals over 6
months of age are in the SO class. Infected infants and non-infant infec-
tions are in IB and IO, respectively. Infected individuals over 6 month
of age, IO, can have symptomatic illness and subsequently be reported
as a clinical case with mean probability ρt. ρt is a composite parameter
that represents the probability of symptoms and reporting. (B) Likelihood
profile for the report rate, ρt, of non-infant infections and the immigration
rate, ψ, for the state of Wisconsin. MLE indicated by green asterisk. The
report rate for Wisconsin was constant through time. . . . . . . . . . . 97
4.3 Fitted Model and Seasonality. (A) Observed data (black, shown for
Wisconsin) and three stochastic simulations from the MLE (blue/green)
highlight that both observed and simulated polio epidemics have a large
amount of interannual variation in size, but a narrow seasonal window.
Fitted and out-of-fit data regions are indicated by blue and green, respec-
tively. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.4 Epidemic Emergence and Source-Sink Dynamics. (A) Annual num-
ber of infected individuals in the US in contrast to the small number of
reported cases. Annual infections were reconstructed for the US using par-
ticle filtering means. The particle filtering mean is the expected value at
time t, given the data up to time t: E(Xt | casest). (B) Annual infections
in the US represented as the percent of the population. Reconstructed
infections show an increase in infection incidence that accompanies (C)
the increase in the birth rate. (D) Simulated WPV extinction probability.
The probability of extinction measured as the mean annual probability of
observing an extinction during the off-season (Dec–May). “sink” popula-
tions are those states with a high extinction probability. (E) Simulated
trough infections. Trough infections indicate the minimum number of in-
fections during off-seasons. For each state, the median was taken across
simulations and averaged across years. “source” populations are those
that maintain a high number of infections. Panels D–E were constructed
using the 500 stochastic simulations for each state. . . . . . . . . . . . 102
x
4.5 Source-Sink Population Predictors. (A) Linear regression of state
population size versus simulated trough infections, both on a log10 scale.
Trough infections are those shown in Fig 4.4E. (B) Residuals from the
regression of population size versus trough infections were used as the
dependent variable in the multiple regression model, where the predic-
tors were: the state’s seasonal minimum reproductive ratio, the immigra-
tion rate, and the seasonal amplitude of the reproductive ratio, measured
as half the peak-tough difference in the reproductive ratio. Plot shows
on the y-axis, the residuals, ri, from panel A, along with the prediction





2 + b3ψi, where R
i
t is the reproductive ratio, ψi is the im-
migration rate, and i indicates the state. Taken together, panels A and B
demonstrate that the predictors of a source versus sink are: the population
size, the minimum reproductive ratio, the amplitude of the reproductive
ratio, and the immigration rate. (C) Map of the seasonal minimum repro-
ductive ratio showing geographic clustering. (D) The residuals, ri, versus
the seasonal amplitude of the reproductive ratio (i.e., the transmission
amplitude), point size and color indicate the immigration rate, ψi. (E)
The residuals, ri, versus the seasonal minimum reproductive ratio, point
size and color indicate the immigration rate, ψi. . . . . . . . . . . . . 104
4.6 Persistence Mechanisms. (A) Example of simulated infections and
cases for Wisconsin. Months absent of reported cases are indicated in
green. During periods when the disease is absent, WPV infections are of-
ten silently transmitted in the population. In this simulation, there were
two instances (indicated by arrows) when the local chain of transmission
was broken and WPV went locally extinct, but quickly rebounded due to
reintroduction. This example illustrates the two polio persistence mecha-
nisms observed throughout the US, which are (i) local WPV persistence
via unbroken chains of transmission, and (ii) WPV extinction and rein-
troduction. (B) Distributions of mean monthly silent infections during
periods absent of reported disease. (C) Distributions of cumulative silent
infections during periods absent of disease. Distributions in B and C are
10–90% quantiles and the median based on 500 simulations per US state.
Silent infections are those that occur in the absence of reported cases,
and highlight the unobservable dynamics of polio. (D) Simulated cases
surrounding WPV extinction events. Distributions show 10–90% quan-
tiles and the median number of cases observed up to 6 months preceding
and 6 months following an extinction event. Generally, fewer than 5 cases
per month are reported two months to either side of an extinction event.
However, it is unclear whether 5 months with < 5 cases is a reliable signal
of extinction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
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5.1 MMWR and NOVS data. (a) MMWR data, polio cases per
100000 population in the contiguous US from January 1933–December
1969. (b) Births per 1000 population over the same time period. (c)
NOVS data, polio cases for which symptomatology was classified as
paralytic or non-paralytic; this is a subset of the cases in MMWR,
all others were unspecified. . . . . . . . . . . . . . . . . . . . . . . . 122
5.2 PSU Data. Cases reported to the Poliomyelitis Surveillance Unit
detailed by vaccine status and symptomatology. Individuals with
the full 3+ dose series of IPV or OPV are indicated by IPV3+ and
OPV3; unvaccinated and under-vaccinated individuals are indicated
as IPV3- or OPV3-; “ukn” indicates unknown vaccine status. Symp-
tomatology is divided into two categories: (a) paralytic or (b) non-
paralytic polio. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
5.3 Age structured population size and polio vaccine coverage
in the US. (a) Annual size of childhood age classes. (b) Percent
of children in each age group with 3+ doses of IPV. (c) Percent of
children with 3 doses of OPV. . . . . . . . . . . . . . . . . . . . . . 126
5.4 Distribution of IPV and OPV during the roll-out in the US.
(a) Cumulative distribution of IPV in the US. Data are quarterly from
1955–1961, after which they are annual. (b) Cumulative distribution
of OPV monovalent type I, II, and II, and trivalent OPV. . . . . . . 127
5.5 Polio cases in the USSR. Monthly polio cases reported in (a)
Lithuania, (b) Estonia, (c) RSFSR, and (d) Ukraine, along with the
percent of the population vaccinated with OPV (white points). OPV
was first introduced in Lithuania and Estonia, where vaccine coverage
reached > 60% in the second year of vaccination. As of December
1959, only 2.8% of population was vaccinated in the RSFSR and 5.6%
in Ukraine. However, by December 1960, the reported vaccination
coverage in the RSFSR was 36% and 33% in Ukraine. . . . . . . . . 128
5.6 Vaccine era polio transmission model. (a) Schematic model of
polio transmission and vaccination. The model has two vaccinated
categories, IPV and OPV, which include individuals with 3+ doses
of IPV and 3 doses of OPV, respectively. The model categorizes
infections by vaccine status and symptomatology (i.e., paralytic and
non-paralytic polio). (b) The timeline of polio in the US and USSR,
epidemic periods are indicated along with the roll-out of IPV and
OPV in each country. In the US, monovalent OPVs were licensed
and used for epidemic response before the switch from IPV to OPV
for immunization in April 1963 when trivalent OPV was licensed. . 129
xii
5.7 Polio observation models for the US and USSR. The obser-
vation models detail how symptomatic infections from the process
model (turquoise and orange ovals) were reported in the (a) US via
cases in the MMWR, NOVS, and PSU data sets, (b) Estonia and
Lithuania, and (c) the RSFSR and Ukraine. In the US, the process
model state variables that fed into the observation model were par-
alytic and non-paralytic infections broken down by vaccine status,
either on a monthly or annual basis. The full US observation model
is shown in (a); however, a nested version that includes only the
MMWR and NOVS data was used for fitting IPV efficacy parame-
ters. For Lithuania and Estonia, the observable state variables were
the monthly number of non-paralytic and paralytic infections broken
down by OPV status, assuming OPV protects from non-paralytic
polio. For the RSFSR and Ukraine, the observable state variables
were the monthly number of paralytic polio infections by OPV sta-
tus. Subscripts indicate individuals with IPV3+ or OPV3 doses, lack
of subscripts indicate unvaccinated/under-vaccinated individuals. . . 133
5.8 MLEs of the seasonal transmission rate. Rates for the (a) US,
(b) Lithuania and Estonia, and (c) RSFSR and Ukraine. The trans-
mission rate parameters were estimated using the pre-vaccine era
data. For the USSR, the transmission rate equates to the reproduc-
tive number. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
5.9 US pre-vaccine data and one-month-ahead predictions from
the MLE. (a) Monthly MMWR polio cases and model predictions.
(b) Annual NOVS polio cases that were classified as paralytic or
non-paralytic polio, along with model predictions. One-month-ahead
predictions are particle filtering prediction means. . . . . . . . . . . 137
5.10 USSR pre-vaccine data and one-month-ahead predictions
from the MLE. Monthly polio cases and one-month-ahead predic-
tions for (a) Lithuania and (b) Estonia. Paralytic polio cases and
one-month-ahead predictions for (c) the RSFSR and (d) Ukraine.
One-month-ahead predictions are particle filtering prediction means. 138
5.11 US MLE vaccine coverage. Vaccine coverage based on MLE vac-
cine uptake rates fit to the vaccine coverage data for the 1–14 year
old age group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
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5.12 IPV efficacy. (a) Tradeoff in IPV efficacy parameters observed dur-
ing the inference process. The parameters measured the susceptibility
to infection of IPV3+ individuals, relative to unvaccinated individu-
als, and the infectiousness of IPV3+ individuals, relative to unvacci-
nated infected individuals. The tradeoff is such that there is ridge in
the likelihood surface and the product of the IPV parameters is well
identified. (b) Due to the tradeoff between the IPV efficacy parame-
ters we fixed the susceptibility to infection of IPV3+ individuals to ∼
1 (meaning IPV does not reduce susceptibility) and estimated the in-
fectiousness of IPV3+ individuals. We used the MMWR and NOVS
data from the IPV era for profiling because it became computation-
ally infeasible to use the PSU data (see Appendix). We estimated
IPV infectiousness to be 0.31. Thus, IPV reduces transmission by
69% (95% CI 67–74%). In (a) we indicate the IPV efficacy ridge
tracing the MLE at 0.31 (turquoise dashed line). . . . . . . . . . . . 142
5.13 IPV efficacy, one year ahead predictions for the US. IPV efficacy
parameters were fit to the MMWR and NOVS data up to December 1962.
Using the MLE for IPV efficacy, a particle filter was run to December
of each year and use to simulate forward through the next year to pre-
dict epidemic trajectories. The December-to-December predictions were
done simultaneously for (a) MMWR data, (b) paralytic polio reported
to NOVS, and (c) non-paralytic polio reported to NOVS. December-to-
December predictions tested the ability of the model to predict the next
year’s epidemic. In general, the model under-predicted the number of
cases, suggesting that we are nearby, but have not yet reached the true
MLE. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.14 OPV efficacy 2D profiles. The RSFSR was used to estimate OPV
efficacy parameters. Two dimensional likelihood profiles of (top) the
reduction in infectiousness caused by the full 3 dose series of OPV, rel-
ative to unvaccinated individuals, and the reduction in the paralytic
probability. Top profile assumes that OPV does not reduce suscepti-
bility. (bottom) The reduction in susceptibility to infection and the
reduction in the paralytic probability. The bottom profile assumes
OPV does not reduce infectiousness. The relative infectiousness of
OPV individuals seems to be well identified in the top profile, but the
bottom profile is relatively flat, and low likelihood, suggesting that
we cannot assume OPV does not reduce infectiousness. . . . . . . . 146
xiv
5.15 OPV efficacy 3D profile. The RSFSR was used to estimate OPV
efficacy parameters. A three dimensional 50x50x50 likelihood profile
of the reduction in infectiousness caused OPV, the reduction in sus-
ceptibility, and the reduction in the paralytic probability was created.
Plotted in (a) the log likelihood of OPV efficacy across the profiled
range. We measured efficacy by taking the combined effect of OPV
on susceptibility and infectiousness. The MLE efficacy of 96% is indi-
cated in green. The OPV efficacy MLE was then validated using (b)
one-month-ahead predictions. The white line is the vaccine coverage
based on the MLE uptake rate. . . . . . . . . . . . . . . . . . . . . 147
5.16 Independent validation of OPV efficacy. The OPV efficacy
MLE from the RSFSR was used to predict out-of-fit, the cases in (a)
Lithuania, (b) Ukraine, and (c) Estonia. . . . . . . . . . . . . . . . 148
A.1 Bi-annual winter (November-April) birth peak timing by period. (a)
pre-baby boom (1931-1945), (b) baby boom (1946-1965), and (c)
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ABSTRACT
The Drivers of Acute Seasonal Infectious Diseases
by
Micaela Martinez-Bakker
Co-chairs: Pejman Rohani and Aaron A. King
Seasonality is a feature of all ecological systems. Earth’s terrestrial and pelagic life
has evolved in a highly seasonal abiotic environment with intra-annual variation in
photoperiod, temperature, and precipitation, among many other abiotic and biotic
factors. Seasonal aspects of mammals and birds include seasonally varying birth
rates, seasonal changes in endocrine hormones, and seasonal variation in immunity.
One area where seasonal biology is particularly salient is disease ecology. The mech-
anisms underlying the seasonality of communicable diseases are poorly understood.
I propose that much of the unexplained seasonality observed in infectious disease
dynamics could be attributed to seasonal biology, including (1) birth seasonality, (2)
seasonal variation in immunity, and (3) seasonal cycles in parasite traits and para-
site population parameters. In my dissertation, I present work on various aspects of
seasonality. In Chapter II, I explored the seasonality of births in human populations
and quantified the effects of birth seasonality on measles epidemics. In Chapter III,
I reviewed circadian and circannual rhythms in host and parasite populations, and
proposed both ecological and evolutionary models for integrating biological rhythms
into the study of infectious diseases. In Chapters IV–V, I presented my in-depth
xxiv
ecological studies of poliovirus, a notoriously seasonal summertime infection. I ex-
plored geographical variation in polio’s seasonality and tested whether human birth
seasonality or transmission seasonality drove epidemics of this disease. In addition
to studying polio seasonality, I revealed the connection between (i) polio’s emergence
and human demography, (ii) the geographical distribution of poliovirus and its per-
sistence, and (iii) polio symptomatology and silent chains of transmission. Lastly, I
highlighted the public health implications of seasonal transmission by measuring the





A unifying feature of infectious diseases is periodicity [1]. Periodicity is observed
in infectious disease dynamics at both the population and within-host level. As
illustrated by London and Yorke in Fig 1.1, at the population level, infectious dis-
ease incidence displays seasonal—and often multiannual—periodicities [2, 3]. At the
within-host level, periodicities occur at shorter time scales, such as daily cycles of
symptoms and/or parasite abundance [4]. In my dissertation I focused on identifying
the drivers of (a) seasonal disease incidence at the population-level, and (b) circa-
dian cycles of infections within-hosts. The systems I studied were polio, measles, and
other acute infections. My research on disease seasonality can be categorized into (1)
host phenology (i.e., seasonal cycles) and biological rhythms, (2) the ecological role of
transmission seasonality, and (3) the public-health implications of transmission sea-
sonality. Given widespread seasonal structuring of host-pathogen interactions, there
is much to be gained by exploring the influence of seasonal abiotic and biotic factors
on disease dynamics and measuring the relative importance of interconnected sea-
sonal ecological factors. Much attention has been given to seasonal drivers external
to host biology, such as temperature, rainfall, humidity, and host aggregation. How-
ever, I aimed to elucidate the role of seasonal fluctuations in host biology (i.e. human
phenology and biological rhythms) as a driver of disease periodicity.
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Figure 1.1: Periodicity of Childhood Diseases. Time series (top to bottom) of
measles, chicken pox, and mumps in New York City, along with measles
in Baltimore. Each disease had a seasonal window when epidemics oc-
curred. Epidemics occurred either annually or at multi-annual intervals
[5]. Figure reproduced from Wayne P. London, James A. Yorke, Recur-
rent Outbreaks of Measles, Chickenpox and Mumps: I. Seasonal Variation
in Contact Rates, American Journal of Epidemiology, 1973, volume 98,
issue 6, 453–468, by permission of Oxford University Press.
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1.1 Human Birth Seasonality & Disease
In order to understand the impact of human phenology on seasonal infectious
diseases, I studied the influence of human birth seasonality on measles epidemic dy-
namics. I hypothesized, since fully immunizing childhood diseases, such as measles,
rely on births for susceptible recruitment, birth seasonality plays an important role
in temporally structuring childhood disease epidemics. Using measles transmission
models, I found in Chapter II that high amplitude seasonal fluctuations in births are
capable of altering the magnitude and periodicity of measles epidemics. My models
predicted that birth seasonality is consequential for measles epidemics in populations
with high amplitude birth seasonality, such as populations in Africa. I also found that
the phase relationship between the birth pulse and the seasonal peak in transmission
is important for determining epidemic size.
Overall, birth seasonality has the effect of shifting the distribution of infections
between years. Therefore, birth seasonality does not simply make epidemics “bigger”
or “smaller”; rather, birth seasonality can redistribute infections, which has practical
implications for epidemic response. In particular, it would be beneficial if public
health officials could anticipate the between-year distribution of clinical cases. Models
that explicitly account for birth seasonality can facilitate such predictions. Due to
(a) the nuanced relationship between birth seasonality and seasonal transmission, and
(b) the large amount of regional variation in the timing of birth pulses around the
world, I concluded that birth seasonality should be considered for disease control at a
regional level. Ideally, birth seasonality would be used to plan vaccination campaigns
because birth seasonality is a reliable indicator of the susceptible pool growth rate.
Since vaccination initiatives manage the size of the susceptible pool, knowledge of
birth seasonality may prove invaluable.
Although my work demonstrated that birth seasonality is relevant for disease
dynamics, it is unknown why human births are seasonal. Seasonal reproduction “is
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Figure 1.2: Seasonality of Human Births. Time series of births in Spain show-
ing consistent seasonality relating to a springtime peak in conception.
Societal events, such as wars, altered the amplitude of birth seasonal-
ity and introduced irregularities; however, birth seasonality persisted [6].
Reprinted from Current Biology, Vol 18 issue 17, Russell G. Foster, Till
Roenneberg, Human Responses to the Geophysical Daily, Annual and
Lunar Cycles, Pages R784–R794, Copyright (2008), with permission from
Elsevier.
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the general rule for the majority of mammals” [7], so it is perhaps not surprising
that birth seasonality is a feature of all human populations, both historically and in
the modern day. The presence of birth seasonality in populations across geographic
regions, cultures, economic regimes, and time periods [8], suggests birth seasonality
is a life-history trait, rather than an artifact of culturally motivated human behavior.
The persistent seasonality of births is illustrated in Fig 1.2, which shows monthly
births in Spain spanning decades [6]. Patterns of birth seasonality are somewhat
complex, some populations have biannual cycles of births (i.e., two peaks per year)
[9], and as I will discuss in depth in Chapter II, there is a large amount of regional
variation in the amplitude and timing of birth seasonality. For instance, within a
country the seasonal characteristics of births can vary among populations and shift
over time [10].
Using data from the US, Canada, UK, Germany, Greece, Japan, New Zealand,
Sweden, South Africa, and Switzerland, Moos & Randall [11] found that each coun-
try had a temporally-stable annual conception minimum. The month of minimum-
conception had a strong correlation with latitude (correlation coefficient of r =
−0.7678). The latitudinal pattern of births is highly suggestive that environmen-
tal conditions play a role in determining the timing of the conception minimum and
the birth pulse. There are various highly debated and rarely agreed upon hypotheses
regarding the underlying mechanism of seasonal births in humans. The hypotheses
can be broadly summarized as attributing birth seasonality to either behavioral or
physiological factors linked to environmental conditions.
Environmental drivers of birth seasonality, proposed by demographers and phys-
iologists, often focus on the effects of temperature or photoperiod on the ability to
conceive. Temperature is hypothesized to have a direct effect on conception via its
impact on reproductive factors such as sperm count and motility [8]. Whereas, pho-
toperiod, is hypothesized to modulate endogenous physiological rhythms–specifically
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in ovarian and androgen activity—that are important for conception in other mam-
mals but are not well characterized in humans [10]. Since it is difficult, or perhaps
not plausible, to investigate the mechanisms of birth seasonality using laboratory ex-
periments, studies that have attempted to establish mechanism have been correlative
and inconclusive. Importantly, despite underlying mechanisms, the annual variation
in human reproduction has implications for susceptible recruitment in childhood dis-
ease systems. My work has provided some of the first indication of the public-health
importance of human birth seasonality, although the mechanisms of birth seasonality
remain nebulous.
1.2 Biological Rhythms & Infection
My research on birth seasonality in humans provided indication that seasonal life
history plays an important role in the dynamics of acute infections. I wanted to
expand on this and investigate host biological cycles in Chapter III, specifically en-
dogenous biological rhythms, and identify which biological cycles contribute to the
ecology of disease. I analyzed the ways in which circadian (i.e., daily) and circannual
(i.e., seasonal) rhythms could influence disease transmission and affect within-host
dynamics of infection and pathology. The literature on rhythms in the immune sys-
tem is rapidly expanding. Circadian rhythms have now been implicated in within-
host infection dynamics [12] and circannual rhythms in pathogen killing ability have
been documented in wild species [13]. Using a transmission model and data from
Siberian stonechats, a migratory bird with strong seasonal life history, I illustrated
that seasonality in reproduction, migration, and immunity can interact to generate
seasonality in acute infections. Interestingly, my model demonstrated that multiple
non-sinusoidal out-of-phase seasonal drivers that differ in their epidemiological link
to infection dynamics could result in “simple” patterns of seasonal disease incidence.
This led me to conclude that the complicated seasonal structure of host behavior and
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Figure 1.3: Seasonal Gene Expression in the Human Immune System. Over
5000 genes (∼ 23%) of the human immune system were identified as
seasonal. Plot shows fitted cosine curves for seasonal genes. Seasonal
genes were binned into groups of summertime-expressed and wintertime-
expressed genes, with the exception of a single gene that didn’t fall into
either category. Figure reproduced from [14], licensed under a Creative
Commons Attribution 4.0 International License.
life history can constrain parasite transmission to particular windows in the annual
cycle, which I refer to as the construction of a parasite temporal niche.
Wild species display seasonal life history and circadian clocks occur in all eu-
karyotes (including eukaryote parasites) and some prokaryotes [15, 16]. The ubiquity
of biological rhythms, and the unsolved mystery of rhythmicity in infections, makes
the study of biological rhythms an exciting area in disease ecology. In fact, coinci-
dent with the publication of my work on biological rhythms, it was discovered that
the human immune system displays functional seasonal variation in gene expression
[14]. I anticipate as circannual rhythms in humans and other animals continue to
be characterized, it will be discovered that biological rhythms are important drivers
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of infectious disease periodicity. S.F. Dowell first presented this hypothesis in 2001
[17], and the evidence that has accumulated over the past 14 years supports his idea.
In addition to the role of biological rhythms in disease ecology, biological clocks are
ancient in origin. In Chapter III, I propose ways in which host and parasite biological
rhythms could impose selective pressure upon one another and affect the evolutionary
trajectory of rhythms. In order to build scaffolding for future studies of rhythms and
infection, I have developed both evolutionary and ecological models addressing the
influence of biological rhythms on host-parasite interactions.
1.3 The Ecology of Polio
There are two avenues of inquiry for addressing seasonality in infectious disease
systems. First, if seasonal drivers are known, they can be incorporated into trans-
mission models or manipulated in the lab to quantify their effect on disease. Sec-
ond, if seasonal drivers are unknown, transmission models can be fit to disease data
to quantify seasonal epidemiological parameters, but the mechanism(s) will remain
unidentified. Quantification of seasonal epidemiological parameters can provide in-
sight into the ecology of infection and disease periodicity, even if seasonal mechanisms
are obscure. My work on birth seasonality and biological rhythms emerged from the
first avenue of inquiry. I identified birth seasonality and biological rhythms as having
the potential to drive disease seasonality. I then incorporated them into transmis-
sion models to test whether they were viable mechanisms. In contrast, I followed
the second avenue to study the transmission ecology of poliovirus. Polio has a long
list of potential seasonal drivers, I therefore investigated the implications of seasonal
transmission without knowledge of the mechanism.
Using extensive historical data, I confirmed earlier studies that described polio
as a summertime disease [18]. Polio epidemics occur during summer and autumn.
I demonstrated that, not only do polio epidemics occur in a fixed seasonal window,
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but there is also latitudinal variation in polio’s seasonal timing. As shown in Fig 1.4,
polio’s latitudinal variation was first documented in the 1932 [19], but it was unknown
until now whether the latitudinal gradient was a persistent feature of polio’s ecology,
which it was. The latitudinal gradient suggests that polio seasonality is driven by a
mechanism that also varies with latitude. Unfortunately, since many environmental
and host factors vary with latitude, I was unable to identify a seasonal driver. How-
ever, I characterized the underlying transmission seasonality of poliovirus and the
ecological implications of transmission seasonality.
I found that the polio transmission rate undergoes large seasonal shifts. In some
regions, seasonal variation in transmission was so extreme that it caused poliovirus
extinction during the wintertime low season. Importantly, despite local extinction,
due to regional variation in host demography and transmission seasonality, poliovirus
was able to persist via sources-sink dynamics. Transmission seasonality, which is a
determinant of the reproductive number, is a key parameter for designing vaccination
campaigns because it influences the vaccine coverage needed for pathogen extinction
[20]. Unfortunately, seasonal fluctuations in transmission are often ignored in cam-
paigns against polio and other vaccine-preventable diseases. Exceptions to this have
proven useful; for instance, poliovirus was eradicated in areas of Mexico with rela-
tively low, <82%, oral polio vaccine coverage by launching vaccination campaigns
during the low season [21]. Armed with the quantification of seasonal transmission,
eradication campaigns could drive pathogens to extinction with relatively low vaccine
coverage (low relative to the coverage needed to achieve the same result outside the
low season).
With new knowledge of polio transmission, I was able to study the practical im-
plications of transmission seasonality for polio eradication. I collected historical data
from the US and the USSR that represented the transitional period during which po-
liovirus went from being epidemic to rare, and eventually extinct. Using these data,
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Figure 1.4: Summertime Polio Epidemics. The distribution of polio cases in the
US, Australia, and New Zealand. Polio epidemics peaked in the summer:
Feb–Mar in Australia and New Zealand, and Jun–Oct in the US. US
states displayed south-to-north variation in epidemic timing, with south-
ern states having the earliest epidemics, followed by intermediate latitude
states. Northern states had the latest epidemics. Figure reproduced from
[19].
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I estimated the efficacy of the inactive polio vaccine (IPV) and the oral polio vaccine
(OPV). I confirmed that OPV is more effective than IPV at reducing poliovirus trans-
mission; a conclusion in line with clinical trials and the experience of the global polio
eradication initiative. My key finding was, although IPV is inferior to OPV, IPV ef-
fectively reduces poliovirus transmission. I estimated that IPV reduces infectiousness
by 69%. This result is a large step forward, not only for polio eradication, but also
for the evaluation of vaccines. Vaccine trials are able measure the extent to which
vaccines reduce susceptibility to infection. However, trials are logistically incapable
of measuring vaccine-induced reductions in infectiousness. For most diseases, it is im-
practical to trace all secondary infections arising from vaccinated and unvaccinated
individuals, which is required to measure realized relative infectiousness.
IPV’s 69% reduction in infectiousness is hopeful indication that the future with-
drawal of OPV and introduction of IPV is a practical eradication strategy. Although
IPV is effective at reducing transmission, my work suggests IPV can only be used
to eradicate polio in regions (and in seasons) when the reproductive number is ≤
3. This would require ≥ 96% IPV coverage for populations that do not have pre-
existing OPV- or naturally-derived immunity. Based on my work on polio in the US
and the USSR, polio’s reproductive number falls below 3 in many populations during
the low season. If this is the case for today’s endemic countries, IPV could be used
to eradicate polio.
As a collection, my work demonstrates that seasonal ecology is undeniably impor-
tant for the control and eradication of diseases, including polio. I have exclusively
focused on the seasonality of acute infectious diseases. The seasonal factors that
influence chronic infections largely overlap with those of acute infections, including
birth seasonality and environmental conditions [22]; however, the seasonality of some
chronic infections, such as nematode infections, is complicated by environmental life
stages of the parasites [23]. In future work, I hope to apply the knowledge gained
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in my dissertation to a broader class of infectious diseases and explicitly account for
rhythms in host immunity. This will require cross-disciplinary integration of data
and experiments from disease ecology, chronobiology (i.e., the study of biological
rhythms), immunology, and parasitology.
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My (Micaela Martinez-Bakker) contribution to the work was the integration of human
birth seasonality into the models of childhood disease. I also worked with my co-
authors to design the study and write the manuscript. Specifically, I conducted all
the analyses that went into Fig 2.4–2.6 and Appendix A Figures A.7 and A.8. The
collection, digitization, and analyses of human birth data were conducted by Kevin
M. Bakker (co-author).
Abstract. More than a century of ecological studies have demonstrated the impor-
tance of demography in shaping spatial and temporal variation in population dynam-
ics. Surprisingly, the impact of seasonal recruitment on infectious disease systems has
received much less attention. Here, we present data encompassing 78 years of monthly
natality in the United States, and reveal pronounced seasonality in birth rates, with
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geographic and temporal variation in both the peak birth timing and amplitude. The
timing of annual birth pulses followed a latitudinal gradient, with northern states
exhibiting spring/summer peaks and southern states exhibiting fall peaks, a pattern
we also observed throughout the northern hemisphere. Additionally, the amplitude of
US birth seasonality was more than two-fold greater in southern states versus those in
the north. Next, we examined the dynamical impact of birth seasonality on childhood
disease incidence using a mechanistic model of measles. Birth seasonality was found
to have the potential to alter the magnitude and periodicity of epidemics, with the
effect dependent on both birth peak timing and amplitude. In a simulation study,
we fitted an SEIR model to simulated data, and demonstrated that ignoring birth
seasonality can bias the estimation of critical epidemiological parameters. Finally,
we carried out statistical inference using historical measles incidence data from New
York City. Our analyses did not identify the predicted systematic biases in parame-
ter estimates. This may be due to the well-known frequency-locking between measles
epidemics and seasonal transmission rates or may arise from substantial uncertainty
in multiple model parameters and estimation stochasticity.
The ubiquity of seasonal variation in the incidence of infectious diseases has driven
much epidemiological research focused on understanding the responsible underlying
mechanisms [1, 2, 3, 4, 5]. Surprisingly, there remains much uncertainty regarding
the drivers of seasonal incidence for numerous infections including polio, pertussis,
scarlet fever, diphtheria, rotavirus, among others [5, 6, 7, 8]. Early work on diphtheria
and measles implicated elevated contact rates among children in school as the driver
of pulsed transmission [9, 1], leading to much emphasis on school-term forcing [2, 3,
5, 10, 11]. More recently, additional mechanisms of seasonal transmission have been
identified, including climatic drivers of pathogen survival [12], transmission [13, 14],
and vector activity [15, 16], seasonal host migration [17], and seasonal fluctuations
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in host immunity [18, 19]. Here, we propose that seasonality in host recruitment
rates may also shape epidemiology. This is a possiblity that has been appreciated
in studies of wildelife diseases [20, 21, 22, 11, 23]. For instance, studying cowpox
virus in voles, Begon et al. found that susceptible recruitment is seasonal, and higher
breeding-season birth rates delayed epidemic peaks [24]. However, despite evidence
demonstrating the importance of host demography in recurrent epidemics [25, 26, 27,
28], and the ubiquitous appreciation of seasonal reproduction in broader ecology and
evolution [29], we submit that a deep understanding of the dynamical impact of birth
seasonality on infectious diseases of humans is currently lacking.
To explore this phenomenon, we first characterize the landscape of birth seasonality
in modern human populations, and second determine if/how it can impact epidemic
dynamics, particularly for immunizing childhood infections. Some precedent has been
set in the field of demography, with seasonal variation in human births first docu-
mented in the early 1800s [30, 31] and currently recognized as a global characteristic
of humans [32, 33, 34, 35, 36]. Early studies of vital statistics in various US regions
established a national-level seasonal pattern of births with troughs in the spring and
peaks in autumn [35, 37]. Subsequent research has focused on either a few locations
over long time periods, or many locations over short time periods. Collectively, these
studies showed that northern and southern states have differences in their seasonal
birth amplitude [32, 33, 34, 38, 35, 37] and birth/conception minima [38, 39, 32, 40].
Studies of births in Africa and Asia have been sparse, but seasonal peak-trough dif-
ferences in conception ranging from 11–64% have been documented in Africa and
8–58% in Asia [36]. To date there has been no long term, large scale, spatiotemporal
analysis of births in either the US or worldwide.
We have compiled the most extensive spatiotemporal data set on human births to
date, and explored the effect of birth seasonality on childhood disease incidence using
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simulated and empirical data. Measles was chosen because it is the paradigmatic
example of a childhood disease, with two key features: (i) a low mean age of infection
during the pre-vaccine era, with infections occurring in the youngest age group, the
size of which is tightly linked to the birth rate, and (ii) seasonal transmission, which
is a feature of many childhood diseases. We focus on birth seasonality in the presence
of seasonal transmission to explore the interplay between these two forces. Our novel
demographic data set is comprised of birth records across the globe, consisting of 7.3
× 108 births. Specifically, these data consist of monthly births spanning a 78-year
period (1931–2008) for each state in the continental US along with over 200 additional
time series from countries spanning the Northern Hemisphere. We have analyzed
these data in combination with a transmission model and statistical inference tools
to examine the dynamic implications of birth seasonality on childhood infection.
Data
Monthly state-level time series of live births from 1931–2008 were downloaded from
US Vital Statistics [41] and digitized. Annual state-level population size data were
collected from the US Census Bureau [42] and used to construct monthly time series of
birth rates per 1000 individuals per month. Worldwide monthly births were retrieved
from the United Nations database [43] and filtered for countries containing at least 5
years of consecutive data.
The US data were split into three eras, to account for the baby boom: (i) Jan 1931–
Dec 1945, which we term the Pre-Baby Boom Era, (ii) Jan 1946–Dec 1964, the Baby
Boom Era, and (iii) Jan 1965–Dec 2008, the Modern Era. To test for periodicity, a
wavelet spectral analysis [44] was performed independently for each US state in each
era and for each country in the global data set. The significance of each period was

















































































































































Figure 2.1: Birth Data from the US. Temporal patterns of birth rates (per 1000 in-
dividuals per month) in the US organized by geographic region, separated
into three eras: Pre-Baby Boom (1931–1945), Baby Boom (1946–1965),
and Modern Era (1965–2008). The time series for Louisiana is plotted at
the top as an example.
lag–1 autocorrelation test. For each data series significant at a 1 year period, phase
angle time series were constructed to determine the timing of birth peaks occurring
at 11–13 month intervals. Independently, seasonal decomposition was run on all data
series to filter out noise, and the seasonal amplitude was calculated by taking one-half
the difference between the maxima and minima, measured as a percent of the annual
mean (refer to Equations in Appendix A). Inter-annual variation was examined by
analyzing the percent change in mean birth rates from one year to the next.
Measles models
We used a discrete-time SEIR model of measles adapted from Earn et al. [25],
with school-term forcing based on the England & Wales school year (Table S1; [11]).
20
We incorporated seasonality in births using a sine function with varying amplitude
and phase. The equations describing the model and parameter values are provided
in Appendix A.
We conducted statistical inference on both simulated and empirical measles in-
cidence data to test for the effect of birth seasonality on epidemic dynamics and
parameter estimation. This work aimed to answer the question: how does the omis-
sion of birth seasonality affect the precision and bias of estimated parameters? Using
a Markovian analogue of our SEIR model (Equations in Appendix A), three time
series were generated assuming the following parameterizations: a birth peak day
of either 162, 295, or 351 and a 28% birth amplitude (see Table S3 for parameter
values). For each simulated time series, our stochastic SEIR model was fit assuming
constant births (birth amplitude set to 0%) and an unknown mean transmission rate.
All other parameters were assumed known. Thus, the only free parameter was the
mean transmission rate, which is directly proportional to R0. The transmission rate
was profiled and the likelihood was calculated using a particle filter (Appendix A
Materials & Methods) [45].
In order to test for bias in parameter estimation using real world data, we utilized
historical measles case reports from New York City. These data are from the Baby
Boom Era, when the birth amplitude was low, approximately 7% for the state of New
York. To account for maternal antibodies, we fit models which lagged births 3, 6,
or 9 months (see Appendix A for methods). We used both maximum likelihood via
iterated filtering [45] and the TSIR methodology of Finkenstadt & Grenfell [46, 47]
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Figure 2.2: Latitudinal Gradients in US Births. Spatiotemporal patterns of sea-
sonal birth peak timing and amplitude in the US. (Top panels) Pre-Baby
Boom (1931–1945), (Middle panels) Baby Boom (1946–1964), and (Bot-
tom panels) Modern Era (1965–2008). Maps depict the latitudinal gradi-
ent in the timing of the birth peak. Colors indicate the mean timing of
the birth peak for each state. Hatched regions represent states in which
a significant bi-annual peaks were discernible and are color coded based
on the timing of their primary annual birth pulse (also see Figs S1 & S2).
States shown in white did not exhibit a significant periodicity. Regres-
sions show the latitudinal variation in seasonal amplitude, with the colors
representing the peak birth timing for the respective period.
The seasonal timing of births
Figs 1 and S3 provide an overview of birth rates in the US. Most states had sig-
nificant seasonal (1 year) birth pulses in the Pre-Baby Boom Era, while all states
showed significant birth seasonality in the Baby Boom and Modern Eras. Of the 210
time series analyzed outside the US, 132 (63%) had significant birth seasonality. Most
of the locations for which seasonality was not significant were short time series (5–7
years) or countries with less than 100 births per month.
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We observed a latitudinal gradient in the timing of the birth peak across the US;
this same gradient was observed throughout the Northern Hemisphere (Figs 2 & 3).
In general, the birth peak occurs earlier in the year in locations further from the
equator. For example, in the Pre-Baby Boom Era the birth peak occurred as early
as June in the northern states of Oregon and Maine, whereas the peak occurred as
late as November in Florida. The variation in birth peak timing was largest during
the Pre-Baby Boom Era, when the most out-of-phase states differed by more than 5
months.
During the Baby Boom Era, most states had birth peaks that occurred in August
or later. The only peaks which occurred prior to August were in seven northern
states and this pattern continued during the Modern Era. The earliest birth peaks
always occurred in northern states, followed by mid-latitude states, and the latest
peaks occurred in southern states. Across all eras, the latest peak was consistently
in Florida, where the peak timing ranged from early October in the Modern Era, to
early November in the Pre-Baby Boom Era.
The latitudinal gradient in peak birth timing seen in the US was reflective of a
worldwide pattern. The worldwide timing also followed a latitudinal gradient with
birth peaks occurring earlier at higher latitudes and later for countries closer to the
equator (Fig 3). However, at any given latitude there was a large amount of variation
in the timing of the birth peak. In the highest latitude countries (> 50◦ N), birth
peaks occurred between April and July. While there were two outlying mid-latitude
countries with birth peaks in March and April (Italy, 1970–1985 and Tajikstan, 1989–
1994), typical mid-latitude locations (20–50◦ N) had peaks between May and Novem-
ber. Countries in the vicinity of the equator (0–20◦ N) displayed the least amount of
variation in timing. The equatorial countries, such as those in the Caribbean, consis-
tently had birth peaks between September and November, with the latest birth peak
23

































































































Figure 2.3: Northern Hemisphere Latitudinal Gradient in Birth Seasonality.
Northern Hemisphere patterns of seasonal birth pulses color coded by
region. Birth pulses occurred earlier in the year at northern latitudes.
Table S5 provides the details for each country, including the time frame
of the data which ranges from the 1960s to 2011.
occurring in Saint Vincent and the Grenadines during the period 1992–2005.
In addition to the annual birth peaks, in the US a significant bi-annual (6 month)
birth pulse was detected in 24 states. In the Pre-Baby Boom Era, all states with
bi-annual periodicity were clustered in the lower midwest, deep south, and southeast
(Figs 2, S1, & S2). In the Baby Boom Era, only 13 states continued to exhibit a
bi-annual period. Arkansas is the only state where this bi-annual birth pulse persists
in the Modern Era.
The amplitude of seasonal births
Birth amplitude was measured for each time series, each year, as the one-half peak-
trough difference with noise removed. Amplitudes are represented as a percent of the
mean annual birth rate (Appendix A Materials & Methods). As with the seasonal
24
timing, in the US the amplitude of birth seasonality displays a latitudinal gradient.
Fig 2 depicts the negative relationship between birth amplitude and latitude. We
found that 29–53% of the variation in birth amplitude can be explained by latitude (p
< 4.6e-5). However, the amount of variation in birth amplitude explained by latitude
decreased through time, perhaps due to the decline in birth amplitude throughout
southern states during the Modern Era (Figs 2 & S4). We did not observe a latitudinal
gradient in birth amplitude outside of the US (Fig S5).
As expected, the mean combined amplitude across all states was found to be com-
parable to the national level amplitude reported in the literature [48] and was 9.0%,
9.8%, and 8.5% for the Pre-Baby Boom, Baby Boom, and Modern Eras, respectively.
Interestingly, due to the geographical variation in birth peak timing, state-level births
are out of phase. Thus, aggregated US birth data has a deceptively low amplitude
that is not reflective of individual states. Birth amplitudes > 15% were observed in
many southern states throughout the time series (Fig S4).
Prior work has shown that the levels of inter-annual variation in births observed
in the US can have a dynamical impact on disease incidence [25]. It would follow
logically that variability of this same magnitude over a shorter time period may also
be important. Thus, we sought to compare the magnitude of the seasonal variation
in births with inter-annual variation. Inter-annual variation was measured for each
state as the percent change in mean birth rate from one year to the next. We found
that in almost every instance, seasonal variation exceeded inter-annual variation, with
seasonal variation in the Modern Era being 2–3 times larger than the variation from
year to year (Fig S6).
25
The effects of birth seasonality on epidemic dynamics
We investigated the impact of birth seasonality on epidemics of childhood disease by
employing models of measles transmission. As shown in Fig 4A, birth seasonality can
have the effect of amplifying or dampening incidence during epidemic years. Crucially,
the impact of birth seasonality depends on the amplitude and phase relationship
between susceptible recruitment and transmission seasonality. In our simulation study
we did not account for maternal antibodies, thus the peak in susceptible recruitment
was equivalent to the birth peak. However, inclusion of maternal antibodies would
translate into a lag between the peak in births and the peak in susceptible recruitment.
We found that if the peak in susceptible recruitment occurs at the beginning of the
year, when children are in school and measles transmission is elevated, the epidemic is
amplified due to the availability of susceptibles. In contrast, if the peak in susceptible
recruitment occurs at the end of the school year, when children are entering summer
break, the epidemic is dampened (Fig 4A).
Independent of the timing of the birth peak, the effect of birth seasonality on
measles epidemics depends on the birth amplitude (Figs 4B & S7). The larger the
birth amplitude the greater the change in measles incidence. Not only does the am-
plitude affect incidence, but birth rates with high amplitude fluctuations (> 40%) can
alter incidence to such an extent that they can drive dynamical transitions (Fig 4B).
Statistical inference on simulated data led to small biases in the estimate of R0
for measles (Fig 4C). For the time series in which the birth peak occurred in mid-
December, day 351, a time at which susceptible recruitment increases epidemic year
incidence, omitting birth seasonality resulted in over-estimating R0 in order to capture
the elevated epidemic year incidence. In contrast, when the birth peak was set to
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Figure 2.4: Impact of Birth Seasonality on Childhood Disease. (A) Epidemic
and skip-year incidence varies with birth peak timing along the x-axis.
Solid curve shows the change in epidemic year incidence when birth sea-
sonality is added to the measles model. Dashed curve shows the change in
the skip-year. The phase relationship between seasonal births and trans-
mission determines whether birth seasonality has an effect on incidence.
The greatest increase in epidemic year incidence is when the birth peak
occurs after children return from winter holiday (orange points). A de-
crease in epidemic year incidence occurs when births peak prior to summer
vacation (green points). School terms are noted and vertical arrows mark
the timing of incidence peaks during the epidemic year. (Inset) Time se-
ries from the constant birth model (black), and time series corresponding
to the color-matched points on the main graph. (B) Bifurcation diagram
showing the change in epidemic and skip-year peak incidence with in-
creasing birth amplitude. In the absence of birth seasonality, epidemics
are biennial. As birth amplitude increases, skip-year incidence increases
and epidemic year incidence decreases. When birth amplitude reaches
∼40% epidemics become annual. Time series in the inset correspond to
the points in the main graph; blue time series are biennial, and golden
are annual. Arrows denote the birth amplitude observed in Switzerland,
Cuba, Egypt, Nigeria, Guinea, and Sierra Leone, left to right. Amplitudes
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basic reproductive ratio, R0
(birth amplitude = 28%)
Figure 2.5: Bias in R0 estimates due to the exclusion of birth seasonality
in a SEIR model. Time series were generated using a SEIR model
with a birth peak day of 162 (turquoise), 295 (blue), or 351 (orange).
Each time series was fit to the SEIR model with a birth amplitude of
0%. The actual R0 value is shown by the dashed line and the likelihood
profiles show that maximum likelihood estimate of R0 is either over- or
under-estimated when birth seasonality is excluded from the model. 95%
confidence intervals for MLE are indicated on profiles. Note, in the pub-
lished form of this manuscript, this is panel C, and is combined with the
two panels from the previous figure.
recruitment dampens epidemic year incidence and elevates skip-year incidence, we
under-estimated R0. However the bias in R0 was small, approximately ≤0.4–1.3%.
We found that models with seasonal births effectively capture measles dynamics in
New York City (Fig 5A). In contrast to our simulation study, however, when multiple
unknown parameters were estimated simultaneously, the small predicted bias in R0
was masked by uncertainty in parameters and Monte Carlo error (Fig 5). Hence, the
maximum likelihood parameter estimates (MLEs) for models with and without birth
seasonality were nearly identical. The MLEs of the basic reproductive number, R0,
ranged from 19.3–20.3. Thus, the incorporation of birth seasonality into the model
did not substantially change parameter estimates, and the dynamics of baby-boom






















































































































































































































































































Figure 2.6: Measles Cases in New York City. (A) Measles incidence (black) and
a stochastic realization using the MLE for each type of birth covariate:
seasonal births with a 3 month lag (blue), seasonal births with a 6 month
lag (green), seasonal births with a 9 month lag (yellow), and births with
no seasonality (maroon). Legend applies to all of Fig 5. (B) The shape
of the likelihood surface with respect to R0. The MLE R0s are indicated
by points and the standard errors are represented by horizontal lines.
(C) MLE transmission splines for each model. (D) Transmission splines
estimated using TSIR [46, 47] for each type of birth covariate. The MLEs
differed with and without birth seasonality, but the differences in the
point estimates were overwhelmed by uncertainty in parameter estimates
(Figs 5B & 5C). No difference in transmission parameters was observed
using the TSIR method.
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Discussion
Seasonal fluctuations in human births are observed throughout the world. The tim-
ing of the birth peak displayed a marked latitudinal gradient throughout the Northern
Hemisphere. The latitudinal gradient in peak birth timing was observed in the US
for the entirety of our data, and was reflective of a much broader geographic pat-
tern. National level birth data from Asia, Europe, the Americas, and the Caribbean
also exhibited this latitudinal gradient with birth peaks occurring months earlier at
locations further from the equator.
Contemporary seasonal birth amplitudes are substantial with a range of 7–12% in
the US and 6–35% in other Northern Hemispheric countries. Along with the latitudi-
nal gradient in peak birth timing, in the US we also observed a latitudinal gradient in
birth amplitude. States in the southern US have larger seasonal fluctuations in births
than northern states. This negative relationship between latitude and amplitude was
more pronounced in the Pre-Baby Boom and Baby Boom Eras, relative to the Mod-
ern Era. However, this pattern was not observed outside of the US, suggesting this
may either be a localized phenomenon or strongly correlated with social, economic,
and/or cultural factors in the US.
In addition to the striking geographical variation in timing and amplitude of the
annual birth peak, these data displayed additional complexity with the occurrence of
bi-annual peaks across the lower midwest, deep south, and southeastern US in the
Pre-Baby Boom Era. This bi-annual pulse was lost over time, with only Arkansas
exhibiting bi-annual periodicity in the Modern Era. Bi-annual fluctuations in births
have been documented in previous studies [38], but our data suggests that bi-annual
birth pulses in the US are a relic of the past, lost to societal changes [38, 39], yet may
still exist in other countries. Given the robustness of birth seasonality as a global
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phenomenon of contemporary human populations, it is surprising that mechanisms
driving these patterns remain poorly understood. Demographers have implicated a
host of social, environmental, and physiological factors that may interact to drive
birth seasonality. While a consensus has yet to be reached, and mechanisms vary
geographically, hypothesized drivers include income, culture, race, holidays, rainfall,
cold winters, and seasonally variable sperm quality[50, 51, 52, 53, 54, 38, 55, 56].
Although we focused on characterizing the variation in birth seasonality, rather than
the mechanisms underlying this variation, it is our hope that the latitudinal gradient
in peak birth timing and amplitude observed here will help elucidate the primary
drivers of birth seasonality.
Despite our high resolution birth data for the Northern Hemisphere, Southern
Hemispheric data proved difficult to obtain. Our analysis focused solely on the US
and countries where birth data were readily available. Unfortunately this leaves out
many South American and African countries where vaccine preventable childhood
diseases are most prevalent. Southern Hemispheric birth data may help us under-
stand the variation observed in the seasonality of childhood infections. For instance,
historical work in Africa has shown that measles incidence peaks in April in Uganda,
Kenya, and Tanzania, but earlier (November–January) in their southern neighbors
Zambia, Zimbabwe, and Malawi [57]. Knowing the seasonal birth peak timing and
amplitude in these locations may allow us to better understand this variation. We
anticipate the latitudinal gradient in peak birth timing will also be found in the
Southern Hemisphere.
The impacts of birth seasonality on epidemic dynamics were explored here in the
context of childhood diseases. Our theoretical predictions indicate birth seasonality
has the potential to influence the dynamics of fully immunizing infections of child-
hood – for which susceptible recruitment most heavily relies on births [25, 11]. We
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demonstrated that birth amplitude and the timing of the birth peak relative to peak
transmission determine whether, and to what extent, birth seasonality affects disease
incidence patterns. In our inference study using simulated data, we found that ig-
noring birth seasonality can bias parameter estimation. As a proof of concept study,
we tested for these biases using New York City measles data from the pre-vaccine
era. However, we did not detect any systematic biases. There may be a number
of reasons for this finding. First, during the time span of these data, the seasonal
birth amplitude was low in New York City. Second, the short infectious period of
measles is known to lead to pronounced frequency-locking with forcing in transmission
[7, 58, 11], which may swamp any dynamical impacts of weakly seasonal susceptible
recruitment. Finally, the combination of process- and measurement-noise in the data,
combined with uncertainty in parameter estimates and Monte Carlo error may have
made it impossible to detect the predicted estimation bias.
Our simulation studies demonstrated that high amplitude birth seasonality, cur-
rently observed in many African and Asian countries (Table S5 and [36, 49]), can affect
disease periodicity and epidemic magnitude. In these settings, our findings have the
potential to explain some of the spatial and temporal variation observed in the pe-
riodicity of diseases such as measles, rotavirus, and polio; and present a promising
avenue for future research. Indeed, a recent study of birth seasonality across devel-
oping countries found that the timing of the birth peak influences epidemic timing,
and a high birth rate magnifies the effect of birth seasonality on measles epidemics
[59]. Although our study—focused exclusively on measles epidemiology—suggests
that high amplitude birth seasonality is required to alter disease incidence, we pre-
dict that lower birth amplitudes may have a dynamical effect when coupled with a
higher mean birth rate or for childhood diseases with longer infectious periods that
may exhibit less frequency-locking with seasonal transmission [7]. Ultimately, our
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experience with these systems indicate that the impact of seasonal births on epidemi-
ology will likely be determined by multiple factors, including: the age-distribution
of infections, age-specific pattern of contacts, differences in R0, and the demographic
context.
Dynamical consequences of birth seasonality aside, we emphasize that the spatial
variation in birth seasonality documented here is pertinent when developing time-
specific vaccination campaigns. For example, the World Health Organization imple-
ments time-specific vaccination campaigns to supplement routine immunization for
the control of measles and polio in Africa, the Eastern Mediterranean, and South-East
Asia. Clearly, if these infant immunization campaigns occur prior to the birth pulse,
they will be inefficient. Thus, it is our hope that future studies aimed at mitigating
childhood diseases will utilize birth seasonality to reduce the burden of disease and
tackle some of the unanswered questions in disease ecology.
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The Influence of Biological Rhythms on
Host-Parasite Interactions
Preamble. This chapter is our published manuscript provided verbatim. Reprinted
from Publication Trends in Ecology & Evolution, Vol 30 issue 6, Micaela Martinez-
Bakker, Barbara Helm, The influence of biological rhythms on host-parasite interac-
tions, Pages 314–326, Copyright (2015), with permission from Elsevier.
Abstract. Biological rhythms—from circadian control of cellular processes to annual
cycles in life history—are a main structural element of biology. Biological rhythms are
considered adaptive because they allow organisms to partition activities to cope with,
and take advantage of, predictable fluctuations in environmental conditions. A flour-
ishing area of immunology is uncovering rhythms in the immune system of animals,
including humans. Given the temporal structure of immunity, and rhythms in parasite
activity and disease incidence, we propose that the intersection of Chronobiology, Dis-
ease Ecology and Evolutionary Biology holds the key to understanding host-parasite
interactions. We review host-parasite interactions while explicitly considering biolog-
ical rhythms, and propose that (1) rhythms influence within-host infection dynamics
and transmission between hosts, (2) rhythms might account for diel and annual pe-
riodicity in host-parasite systems, and (3) rhythms can lead to a host-parasite arms
race in the temporal domain.
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Biological Timekeeping
Environmental rhythms are a ubiquitous feature of our planet. Many rhythms
are caused by geophysical cycles, including diel, tidal, lunar, and annual rhythms.
These rhythms are highly predictable and have resulted in the evolution of biological
clocks throughout the tree of life [1]. Most biological activities have rhythmic time
structure, which scales from gene expression to life history events such as breeding
and hibernation. Rhythmic time structure allows organisms to partition and pri-
oritize life history activities—whether they are molecular or behavioral—relative to
predictable fluctuations in environmental conditions. For example, for cyanobacteria,
which are an ancient lineage, sunlight provides both energy and risk. Cyanobacteria
have adapted to this challenge by temporally partitioning photosynthesis from UV-
sensitive DNA replication [2]. Likewise, throughout the year, organisms must meet
survival needs, while seasonally requiring further resources for reproduction and other
activities. This leads to annual cycles of life history, when animals alternate between
reproductively active states and inactive states such as dormancy, hibernation, or
migration, a retreat to wintering grounds that buffer against resource scarcity [1].
Over evolutionary time, organisms have adapted to environmental fluctuations by
an internal representation of time—endogenous biological clocks—that perpetuate
biological rhythms even when environmental conditions are kept constant. These
rhythms are characteristically innate, evidenced by the observation that individuals
who have never experienced environmental fluctuations display rhythmicity [1]. En-
dogenous biological rhythms oscillate with period lengths that approximate those of
geophysical cycles, and are accordingly called circadian, circatidal, circalunar, and
circannual. Circadian rhythms, which are most heavily studied, are driven by cell-
specific transcription-translation feedback loops that are integrated across the organ-
ism. The evolutionary origin of internal clocks is ancient, with circadian clocks being
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a unifying feature of eukaryotes and cyanobacteria [3], and a new area of research
in other bacterial lineages [4]. The endogenous circannual clock underlying seasonal
rhythms is also thought to be evolutionarily conserved, since circannual clocks are
found in organisms ranging from dinoflagellates [5] to mammals and birds [6, 7].
An internal representation of time enables the anticipation of favorable environmen-
tal conditions, ensuring that activities are initiated in advance to match the opportune
time. For example, to rear offspring at the time of maximal food abundance, many
species activate their reproductive system and copulate far in advance, potentially un-
der harsh conditions. If individuals initiated breeding activities when food abundance
was maximal, offspring would be reared outside the optimal environmental window
[6]. Endogenous biological clocks function in concert with the geophysical cycles to
which they synchronize [8, 9]. Synchronizing cues (also called zeitgebers) include diel
and annual changes in light, temperature, and other factors. Jetlag, the overturning
of rhythms resulting from changing time zones, and the subsequent re-synchronization
of the circadian clock, is familiar to many of us. Species and even populations vary
greatly in the way their clocks interact with the environment. They assume differ-
ent phases, e.g., of activity or reproduction, relative to the environmental cycle, and
also differ in the use of synchronizing cues. To varying degrees, organisms retain the
ability to adjust their rhythms to respond to current, less predictable, conditions.
While some species’ rhythms show considerable phenotypic plasticity (e.g., the repro-
ductive rhythm of Great tits, Parus major), other species have rigid rhythms that
impose fitness costs under rapid environmental change (e.g., the seasonal phenology
of Snowshoe hare coat color, Lepus americanus) [10, 11, 8]. In addition to phenotypic
plasticity, evolutionary malleability of biological rhythms is supported by directional
evolution of time adjustments in multiple species, which include heritable shifts in the
seasonal timing of life history events such as reproduction, dormancy, and migration
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[12, 13].
Biological rhythms are observed across biological processes. In addition to substan-
tial diel and annual fluctuations in activity, reproduction, and metabolism, there is
also overwhelming evidence for temporal structuring of immunity. Importantly, such
fluctuations cannot be comprehensively characterized as changes in overall immu-
nity; rather, they are a selective re-organization of structural and functional aspects
of the immune system [14, 15, 16]. Differentiated temporal structuring of immune
defenses can arise from heterogeneous requirements and costs of specific defenses, in-
vestment in self-maintenance versus immunity, or the integration of immunity with
other aspects of physiology [17, 18]. In light of this, we review biological rhythms
pertinent to host-parasite interactions, and propose that rhythms of hosts, parasites,
and the environment impose temporal structure on epidemiological and evolutionary
dynamics.
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Figure 3.1: Rhythms and Temporal Niche. (A) The timing of host and parasite activities falls
in the intersection of environmental rhythms, host life history, host immunity rhythms, and parasite
rhythms. This intersection is embedded within geophysical rhythms, diel and annual cycles. (B)
Biological and environmental rhythms can enter into epidemiological models in multiple ways. The
schematic shows a Susceptible-Infected-Recovered model, SIR, with natural and disease-induced
deaths, D. The model distinguishes between infections, I, and the subset of infections that are
observed as symptomatic cases, C. The model is parameterized using the life history of Siberian
stonechats. Four seasonal rhythms enter into the model (births, temperature, immunity, and migra-
tion). Host births, Bt, are seasonal. The transmission rate, βt, is a function of (1) an environmental
rhythm (i.e., temperature) that influences parasite transmissibility, and (2) the seasonal immune sta-
tus of hosts. We assume seasonal immunity also influences the recovery rate, γt, and the probability
of symptoms, ρt. We also assume infected individuals suffer disease-induced mortality, κt, associated
with the autumn migration (i.e., migratory culling), which multiplies the (here constant) rate of nat-
ural mortality δ. (C) Annual fluctuations in temperature and birth seasonality in Siberian stonechats
[95]. (D) Annual host immunity is based on bacterial killing activity [53], elevated mortality during
autumn migration is inferred from natural migratory timing. (E) Incidence of symptomatic cases
assuming: temperature has a positive correlation with transmission, bacterial killing activity reduces
transmission, reduces the probability of symptoms, and increases the recovery rate. The four seasonal
rhythms act collectively to determine the parasite’s temporal niche, the time of year when the parasite
is abundant and disease outbreaks occur.
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Timekeeping in the Host-Parasite Context
Interactions between hosts and parasites (i.e., microparasites and macroparasites)
are embedded within environmental rhythms (Figure 1A). In addition to the environ-
ment, host immunity imposes selective pressure on parasites, whilst parasite-driven
morbidity and mortality reduces host fitness. These multiple selective forces make
optimal timing of allocation of limited resources to survival and reproduction par-
ticularly tricky. For hosts, massive investment into parasite resistance, for instance,
might only be energetically feasible during a resource pulse (i.e., opportunity) also fa-
vorable for reproduction, resulting in an optimization problem for resource allocation
to survival versus reproduction [19]. Yet hosts also undoubtedly face the challenge of
mitigating the deleterious effects of parasites when resources are scarce, a situation
that might favor investment into parasite tolerance versus resistance. For parasites,
not only does the host immune response impose risk, additional risks can be in-
troduced by environmental regimes during transmission [20] or environmental life
stages [21]; which has led to parasite risk avoidance strategies such as climate-driven
arrested development [22]. For both hosts and parasites, therefore, external environ-
mental conditions impose selective pressure by providing fluctuating opportunity for
reproduction and risk of mortality. These exogenous factors need not be identical
for hosts and parasites, although they co-occur in the same physical environment.
For example, we need not expect that rhythms in parasite reproduction, host repro-
duction, and host immune investment be synchronized. An empirical case of this is
the seasonal influence of temperature and humidity on development of the free-living
nematode parasite (Trichostrongylus) of rabbits, which results in an autumn peak in
the force of infection; whereas, the rhythm in host immunocompetence has a peak in
the springtime [23].
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The temporal structure of host immunity and parasite success suggests that con-
straints (1) preclude hosts from maintaining high levels of parasite resistance, and (2)
prevent parasites from sustaining high reproductive output (fitness). Such constraints
would result in trade-offs between investments in opportunity versus risk avoidance
[24, 19]. Consequently, we hypothesize that both hosts and parasites time their bio-
logical processes with reference to both the external environment and each other, and
that therefore in many cases periodic incidence of infectious disease is a consequence
of biological rhythms, as has been suggested elsewhere (e.g., [25]). Below, we first lay
out empirical evidence for the role of rhythms in host-parasite interactions. In order
to inspire quantitative study of biological rhythms in host-parasite systems, we uti-
lize a transmission model to illustrate the epidemiological consequences of rhythms.
We then formulate a conceptual evolutionary model for understanding host-parasite
dynamics embedded within the rhythmic context in which they are evolving.
Biological Rhythms in Host and Parasite Traits
The incidence of many infectious diseases displays substantial seasonality [26, 27,
28]. Seasonally structured disease incidence can be discussed from the viewpoint of
hosts or parasites. From a host’s perspective, parasite exposure can be influenced by
host behavior, such as seasonal aggregation; a contemporary example being epidemic
seasonality of mycoplasmal conjunctivitis in house finches [29]. However, physiologi-
cal factors influencing host susceptibility to infection and symptomatic disease, such
as seasonal changes in immunity, can also drive disease seasonality [28, 23, 30]. Table
1 summarizes some known diel and annual rhythms in host immunity and parasite
traits (see [31, 32, 33, 16, 34] for extensive reviews). Although rhythms in immunity
are observed across a broad array of taxa, including plants [35, 36] and animals, we
focus on mammalian and avian hosts to enhance the link to human health. A very
active area of biomedical research is characterizing temporal structure in both innate
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and adaptive immunity, and correspondingly, in disease susceptibility [33, 32]. For
now, biomedical studies use model organisms; but in the future should include non-
model organisms [37], which are either directly relevant for understanding natural
host-parasite systems, or enable a broader understanding of within-host dynamics of
infection. Longitudinal studies of wild or captive animals compare immune parame-
ters during active versus resting phases and are typically combined with experimental
approaches. In the wild these may include repeated immune challenges [38, 39, 40],
and in captivity may involve constant conditions, shifted environmental rhythmic-
ity, or biological clock disruption. Studies of rhythms in immunity under natural
conditions—wild immunology—are important for understanding how non-model or-
ganisms deal with exposure to multiple co-occurring parasites [41]. Studies of wild
systems allow us to test, for instance, how seasonal allocation into defense against one
parasite can result in enhanced susceptibility to another [42], and whether temporal
variation in immune status covaries with other physiological traits and is influenced
by nutritional status and parasite exposure [43, 18, 44]. Laboratory studies, in turn,
are necessary for distinguishing between endogenous rhythms in immunity versus
variation that occurs as a result of patterns of infection or other biotic factors.
By profiling the response to infection across time, much progress has been made
in characterizing biological rhythms in immunity. For example, in mice, the circa-
dian rhythmicity of a receptor that recognizes pathogens substantially influences the
inflammatory response and survival prospects (for details, see Box 1). The health im-
plications of circadian rhythms in immunity have also been demonstrated using hosts
entrained to different light-dark cycles, and mice with genetically modified circadian
clocks. Such recent studies have revealed that the immune system is fundamentally
circadian in nature [33, 45, 46, 47, 48, 49], which is highlighted by the local circadian
clock of macrophages [46], and the feedback between immunity and molecular, cel-
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lular, and behavioral rhythms. The emerging picture is that the immune system is
an active component of integrated whole-body circadian rhythms in animals [50] and
plants [35, 36], lending support to the idea that sophisticated mechanisms of immune
defense were also present in their common ancestor [51].
Annual cycles in immunity are not as well characterized as circadian cycles because
of the time scale of experimentation [31, 16] but are epidemiologically relevant [28].
Longitudinal studies under controlled captive conditions have revealed substantial
annual changes in immune parameters (Table 1). These included a down-regulation
of key aspects of immunity during the time of reproductive activation, induced solely
by photoperiodic simulation [52, 34, 14, 16]. Such rhythms might have evolved from a
trade-off between immune defense and demanding life-cycle stages, and can underlie
annual patterns of disease incidence, as suggested, for example, by rhythms of bac-
tericidal capacity of whole blood (Box 1; Figure 1D [53]). It is important to note,
however, based on the existing evidence for both circadian and annual immunomodu-
lation, that temporal patterns can differ between innate and adaptive immunity and
among traits even within the same immune cell subset [16, 33].
In addition to immunomodulation, several other aspects of host rhythmicity can
have population-scale consequences for host-parasite dynamics. Relevant host annual
cycles include aggregation [29, 54, 55], sexual contacts (with regard to STDs), habitat
use, migration [56, 57, 58], and birth pulses that (1) act to replenish the pool of
susceptible individuals, (2) can influence the critical community size required for
parasite persistence, and (3) can determine the geographic synchrony of outbreaks
[59, 60, 61, 62, 63]. The sweeping effects of annual cycles in host physiology on disease
incidence are exemplified by White-Nose Syndrome (WNS), which is drawing many
North American bat species near extinction. A new longitudinal study indicated
that neither birth pulses nor social behavior affected transmission and intensity of
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WNS. Instead, WNS is associated with hibernation [30], which in mammals that
have been studied in captivity, is a programmed circannual rhythm [6]. We speculate
the link between WNS and hibernation is mediated by hibernation-associated changes
in immunity. Evidence thus far suggests that there are large adjustments in immunity
in hibernating mammals, including a 90% decrease in circulating white blood cells
[64], down-regulation of the acute-phase response to LPS [65], and modifications of
intestinal immunity [66, 64].
Migration is another host rhythmicity receiving attention in infectious disease ecol-
ogy. In monarch butterflies, the protozoan parasite Ophryocystis elektroscirrha dis-
plays a seasonal pattern of prevalence and a spatial gradient along the monarchs’
migratory flyway. Parasite prevalence declines as monarchs migrate, which is likely
due to migratory culling [57]. In migratory culling, the coupled energetic demands of
migration and fighting infection result in increased mortality of infected individuals
during fall and spring migrations. The uninfected are most likely to survive the jour-
ney to the breeding or wintering grounds, allowing the destination to be relatively
parasite-free. Thus, migratory culling is a direct intersection of host seasonal rhythms
and disease prevalence [56], and anthropogenically-driven disruption of this rhythm
results in elevated disease burden [58].
Taking the parasite’s perspective, rhythmic patterns in parasite dissemination can
be influenced by fluctuating abiotic and biotic conditions that affect parasite survival
and transmission. Clear examples of abiotic influences are (1) the role of temperature
and humidity in transmission of influenza [67], which might be responsible for lati-
tudinal clines observed in influenza incidence [68, 69], and (2) the UV sensitivity of
sporulation in Isospora, which might have driven the remarkably robust diel pattern
of oocyst outputs [21]. In addition to abiotic effects, biotic influences can stem from
rhythms of vectors [70] and other parasites [71]. Effects of vector circadian rhyth-
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micity have been studied in the malaria vector Anopheles gambiae, whose rhythmic
gene expression persists under constant conditions. Rhythmically expressed genes
include those implicated in the melanization immune response, which encapsulates
the Plasmodium parasites, and can thereby affect mosquito to human transmission.
Vectors can also temporally structure parasite transmission via their diel patterns of
feeding [72] and their phenology [73]. Interspecific influence of parasites on one an-
other’s rhythm, to our knowledge, has only been described for Drosophila parasitoids,
which gain a fitness advantage by temporally segregating circadian rhythms in egg
oviposition [71], hypothesized to alleviate competition.
Perhaps then unsurprisingly, parasites—faced with rhythms in their abiotic envi-
ronment, hosts, and vectors—display what seem to be biological rhythms. Docu-
mentation of parasite rhythms dates back over 100 years, long before the discovery
of biological clocks. In fact, the early observation that both malaria parasites and
microfilariae are abundant in the blood of hosts at night was instrumental to the
discovery of mosquitoes as the malaria vector [74]. Experimental studies of parasites
report diel and annual rhythms, as measured by fluctuations in parasite burden and
infectivity (Table 1), but disentangling the contributions of host and parasite to these
rhythms is difficult [75]. To our knowledge, the only described example of a parasite
life history event that depends on a host rhythm is reproduction in the ectoparasitic
rabbit flea, a vector of myxoma virus. To reproduce, rabbit fleas must undergo mat-
uration on a pregnant or newborn nestling host, and flea maturation is controlled by
host hormone cues associated with pregnancy and parturition, thereby synchronizing
parasite and host life cycles [76, 77, 78]. There is solid evidence for adjustment of
diel parasite rhythms to those of the host, for example from trematodes like Schisto-
soma mansoni—an agent of schistosomiasis in humans—whose emergence from snail
hosts is initiated by light [79, 80]. These parasites display diel cycles that shift to
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match perturbations in their hosts’ circadian rhythm [81]. Similar results were found
in rodent-infecting Trypanosomes. Rats infected with T. lewisi and housed under
a normal light-dark cycle (LD 12:12 h) experienced a peak in circulating T. lewisi
during the early part of night and a trough in the early morning. However, when
the host photoperiod was inverted, the parasite rhythm was also reversed [82]. In
Isospora, the characteristic diel pattern of oocyst output persisted under continuous
light in the high Arctic, although feeding and activity rhythmicity of their avian hosts
was greatly diminished, suggesting synchronization to subtle host rhythms or possibly
self-sustained parasite rhythms [21].
Experimental studies give clear evidence that synchronization to host rhythms im-
pacts parasite fitness. For example, murine host rhythms were experimentally mis-
matched to that of their malaria parasite (Plasmodium chabaudi). This mismatch
resulted in a 50 per cent reduction in both parasite replication and production of
transmissible life-stages [83]. Follow up experiments have now revealed additional
complexities, with the effect of mismatch manifesting differently between parasite
life stages, and downstream effects on host disease severity. Mismatch can confer a
substantial cost to the parasite, and this cost is experienced at the onset of infec-
tion, rather than acquired throughout infection [84, 85]. This suggests there can be
intense selective pressure on parasites to maintain a specific phase position relative
to their host rhythms, or to vector rhythms, since parasite ability to infect vectors
is also time-of-day dependent [72]. Fortunately, the amassing knowledge of biological
clocks might help identify host cues used for entrainment of parasite rhythms. For
example, the nocturnally-peaking hormone melatonin is a core circadian feature of
many vertebrates, and applying this knowledge produced indication that parasites
might be using melatonin to synchronize their circadian cell cycle [86, 21].
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While we still lack unambiguous evidence for endogenous circadian or circannual
rhythms of parasites, recent research suggests the intriguing possibility that parasites
can actively manipulate host and vector rhythms to their advantage. For exam-
ple, various parasites interrupt host diel activity at specific times of day to enhance
transmission [87, 88]. The diel timing and synchrony of host behavioral manipula-
tion, along with candidate molecular mechanisms of manipulation, strongly implicate
circadian clock pathways [87, 89]. By integrating chronobiology with infectious dis-
ease ecology, we might be able to identify, for example, the mechanism by which
the trematode Dicrocoelium manipulates diel host behavior, inducing suicide, and
facilitating trophic transmission [90], and how the notoriously manipulative fungus
(Ophiocordyceps unilateralis s.l.) seemingly breaks the host circadian clock to per-
petuate transmission [87]. Transkingdom cross-regulation between prokaryotic and
eukaryotic rhythms is plausible because it has already been documented for other
systems (e.g., in bioluminescent squid light organ symbionts and in mammalian gut
microbiota) [4, 91].
Despite our knowledge of (1) rhythmic host immunity and physiology, (2) rhythms
in parasite reproduction and transmission, and (3) enticing evidence that host rhythms
can impact parasite fitness and be exploited by parasites, the effects of biological
rhythms on host-parasite dynamical processes remain poorly understood. We sur-
mise that careful consideration of biological rhythms in infectious disease ecology and
evolution will provide a better understanding of (1) daily and annual patterns of
diseases, (2) within-host parasite dynamics, and (3) parasite transmission.
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Models for Investigating Host-Parasite Contributions to Rhythms
in Infectious Disease
In order to determine how biological rhythms impose temporal structure on host-
parasite dynamical processes, we can integrate empirical data on host and/or parasite
rhythms into epidemiological and evolutionary models. Biological rhythms research
has great potential for feedback between laboratory studies, field ecology, and dynam-
ical systems modeling. First, rhythms in immunity characterized under laboratory
or field conditions can be used in transmission models to make predictions about
the epidemiological consequences of those rhythms in nature. Second, observations
of diel and annual cycles in infection—characterized via disease incidence, parasite
abundance, or host serological markers of infection history—can be used to make
predictions regarding rhythms generating such patterns. A new study of the first
type [92] explores the effect of annual and biannual rhythms in births (in bats) on
the persistence of filoviruses (i.e., Marburgvirus and Ebolavirus). Transmission mod-
els predict that filoviruses can persist in species with biannual birth pulses—making
them potential reservoirs of infection—and this prediction is supported by serology
data showing that species with biannual birth pulses are more likely to be seropositive
for filoviruses; demonstrating that explicit consideration of host rhythms can inform
targeted surveillance and control of emerging zoonotic diseases. A study of the second
type is that of [23], in which long-term field data on nematode infections in Euro-
pean rabbits were used to discriminate among multiple potential seasonal rhythms
in the host-parasite system. This led to identification of epidemiologically relevant
seasonality in host immunity; the endogenous nature of which can be tested in the
lab.
Building upon the examples above, as well as other transmission models that in-
corporate reproductive rhythms [93, 94, 59, 60, 61], here we provide a Susceptible-
55
Infected-Recovered (SIR) model of a directly transmitted hypothetical bacterial in-
fection in the Siberian stonechat to illustrate the numerous entry points for biological
rhythms into epidemiological processes (Figure 1B). We narrate our model with sea-
sonal rhythms in mind; however, this can be extended to circadian rhythms. The
model incorporates ambient temperature as a covariate influencing parasite transmis-
sion as well as empirical data on host circannual cycles in reproduction, immunity
and migration (Figure 1CD; cf. Box 1) [95, 53]. For migration, the timing is de-
fined empirically, while the model assumes migratory culling of infected individuals
only during the autumn migration, when host bacterial killing activity is lowest [53].
Importantly, we propose that circannual cycles in host immunity can influence (1)
the transmission rate, (2) the recovery rate, and (3) the pathological consequences
of infection, which manifests as symptomatology and enters the model as the report
rate. The multiple rhythms: temperature, births, bacterial killing activity, and mi-
gratory culling act collectively to shape the observed incidence of disease, which is
the model output shown in Figure 1E. We define the resulting seasonal window of ele-
vated disease incidence as the parasite’s temporal niche. The seasonal incidence that
arises from this model matches the expectations from the underlying data. How-
ever, in contrast to most models of seasonal infectious diseases, which only place
sinusoidal seasonality in the transmission rate, it contains multiple axes of seasonal
forcing. Thus, we provide this model to encourage the inclusion of empirically char-
acterized rhythms into models as covariates. Such models can be used to explore the
epidemiological consequences of host and parasite rhythms, although for simplicity
the parasite is not explicitly modeled here. Host-parasite systems where modeling
parasite rhythms is particularly compelling include nematodes with seasonal arrested
development [96, 22], microfilariae which display both circadian and seasonal cycles
[97], and Plasmodium within-host circadian cycles [75]. Major challenges of incor-
porating biological rhythms into epidemiological or within-host models, will be (1)
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recognizing which host and/or parasite rhythms are epidemiologically relevant, and
(2) identifying the functional relationships between rhythms and epidemiological pa-
rameters, including: transmission, recovery, and symptomatology.
In addition to the epidemiological consequences of rhythms, we can benefit from un-
derstanding the feedback between host and parasite rhythms and the multiple axes
that shape their temporal structure. Thus, we provide a conceptual evolutionary
model for understanding how hosts and parasites time their biological processes with
reference to each other while being embedded in environments with temporally struc-
tured risk and opportunity. We pose this model in evolutionary terms, but depending
on the varying degrees of plasticity of biological rhythms, individuals may also adjust
their rhythms during their life.
Our evolutionary model illustrates three idealized scenarios of how host immune
defense varies seasonally, relative to fluctuating environmental conditions (Figure 2A–
C). These scenarios are motivated by life history theory and by empirical observations
of seasonal immunity in mammals and birds (Table 1). The scenarios assume that
immune defense, specifically, parasite resistance, either parallels the availability of
resources (A, “resource-driven”), or is reduced when resources are used for reproduc-
tion (B, “traded-off”). The third is an extension of the “resource-driven” scenario
with modulation related to life history events that can lead to complicated, but po-
tentially important, annual patterns. In our example of migration (C) we assume
down-regulation of immune defense during migration (see Figure 1; this could also
occur during other vulnerable times such as molting or hibernation [65]), and a shal-
low trough under favorable conditions in the wintering grounds. We then (D) switch
to the parasite’s perspective and illustrate how parasites are subject to two axes of
seasonal fluctuations: (i) seasonal environmental conditions outside the host and, (ii)
seasonal immune defense of the host. We propose that together the two seasonal
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axes shape parasite transmission (i.e., parasite fitness; which is captured by the basic
reproductive number).
The last and crucial component of our model is the evolutionary feedback between
host and parasite rhythms. We propose that due to parasite-induced host morbidity
and mortality, selection can drive changes in host seasonal immune defense. Subse-
quently, since host immune defense is one of the seasonal axes influencing parasites,
selection will favor changes in the parasite rhythm. This interplay can continue, driv-
ing hosts and parasites to sequentially alter their seasonal rhythms while working
within the constraints of environmental conditions. Figure 2E shows these steps.
We suggest that under certain conditions this can escalate into an evolutionary
arms race. In this framework, the prerequisite for an arms race is that parasite fit-
ness is sufficiently impacted by the temporal structure of the host immune response,
and that the host immune response is predictably rhythmic. To be clear, when con-
sidering the temporal structure of immune defense, reference to “low” host immune
defense pertains to the parasite in question. However, it must be appreciated that
a time of diminished resistance to one parasite (e.g., a helminth) can be a time of
high investment into fighting another (e.g., a virus). Furthermore, infection with one
parasite can seasonally elevate host susceptibility to another, as is exemplified by
concomitant infections of myxoma virus and nematodes [98] and increased suscepti-
bility to bovine TB resulting from helminth coinfection [18]. The arms race itself has
two requirements. First, hosts must be able to shift their immune defense to counter
exploitation by parasites (host changes in Figure 2E). Changes in host rhythms then
translate into a new landscape of time-structured risk and opportunity for parasites.
Upon experiencing a new temporal landscape, a dynamic host-parasite arms race can
arise only if the second requirement is met: parasites shift their rhythm by changing




















































































































Figure 3.2: Conceptual model for investigating host-parasite contributions
to rhythms in infectious disease. (A) Host immune defense is resource-driven and
tracks the host’s environmental conditions (i.e., host resource availability). (B) Host immune defense
has an inverse relationship with environmental conditions; this could occur due to a trade-off against
investment into reproduction during high resource availability. (C) Resource-driven immune defense
in a migrating species that has reduced immune defense during migration. Migrations (indicated
by black points) result in shallower environmental troughs since individuals migrate to regions with
higher resource availability. For all scenarios, we consider immune defense to be resistance to the
parasite in question, although we acknowledge that this simplifies the complexity of the immune
system (e.g., independent immunomodulation of innate or adaptive immune parameters). For the
resource-driven host immune defense strategy, in (D) we show seasonal parasite fitness shaped by
both environmental conditions and seasonal host immune defense. Although host and parasite co-
occur in the same physical environment, the environmental rhythms pertinent to the parasite need
not be identical to the environmental rhythms pertinent to the host, which is why we distinguish host
versus parasite environmental rhythms. (E) Arms race between host and parasite. For illustrative
purposes, the arms race is initiated with resource-driven host immune defense and parasite seasonality.
The host changes the seasonal timing of peak immune defense to coincide with peak parasite fitness.
We then switch to the parasite perspective to consider the parasite’s environment. In response to
the new host seasonality, the parasite changes its timing of peak reproductive output. These cycles
can continue, with both host and parasite seasonality shifting within the bounds of their respective
environmental constraints.
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with other host-parasite arms races, an arms race in the temporal domain is subject to
tradeoffs for both the host and the parasite that might constrain the extent to which
their rhythms can be altered. Host tradeoffs can include an immunity-reproduction
tradeoff [99]; whereas, tradeoffs for the parasite can include a transmission-virulence
or transmission-recovery tradeoff [100, 99, 101]. Also, due to the rapid generation
time of parasites, relative to hosts, evolution of host rhythm shifts might be slow
relative to the evolution of parasite rhythms, but this would not preclude an arms
race from occurring.
Conclusion
There is enticing evidence that biological rhythms are structuring elements of host-
parasite interactions, both in within-host processes and in epidemiological dynamics.
Host circadian rhythms in the immune system influence the progression of infec-
tion and parasite burden, and annual rhythms might have similar effects [23, 30].
The existing evidence leads us to conclude that the effects of biological rhythms on
the perpetuation of parasites, and on host reactions during infection, can generate
population-level rhythms in infectious disease incidence [25], which we here define as
the parasite’s temporal niche. To formalize temporal niches across parasite taxa and
life history strategies, we will need novel integration of epidemiological, immunologi-
cal, and life history data of both hosts and parasites.
Importantly, circadian rhythms in immunity have direct implications for trans-
mission, and practical application for (i) timing of antibiotic, antiviral, and an-
thelmintic treatment, and (ii) managing immunopathology, such as cytokine storms.
The rhythms of parasites themselves can drive patterns of exposure and illness, as
is evident in malaria and filarial infections. Similarly, rhythms in parasitemia and
parasite release from hosts can impose temporal structure on transmission, which can
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be leveraged for interventions such as deworming campaigns.
We believe that a multi-disciplinary approach at the intersection of Chronobiology,
Disease Ecology and Evolutionary Biology holds the key to understanding how bio-
logical rhythms influence host-parasite interactions. We have outlined open questions
that will bring us closer to understanding the underlying biological interactions in the
temporal domain (refer to Outstanding Questions Box). We hope that this Opinion
will generate discussion on how to leverage rhythms for translational medicine, for
instance to counter the evolution of resistance; and we hope the insights provided
here inspire new avenues for interrogating transmission models with host-parasite
data from the laboratory and the field, ultimately, to better understand the forces
structuring disease incidence and the immunology of non-model organisms.
Finally, although it is beyond the scope of this Opinion, the importance of account-
ing for biological rhythms is accentuated by the accumulating data on anthropogenically-
driven disruptions and mismatches of biological rhythms that are occurring across
taxa. Circadian disruption due to light-at-night [102] and altered environmental sea-
sonality due to climate change [13] are challenging the plasticity of rhythms and
modifying the fitness advantages of their endogenous basis. For example, the ad-
verse effects of circadian disruption have already been seen in human health and gut
microbiota [91]. Given the pervasiveness of rhythms in host immunity, vectors and
parasites, we might soon be faced with palpable effects of rhythm disruptions on
infectious diseases [103, 104, 73].
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Table 3.1: Rhythms in Hosts and Parasites. Diel (circadian) and annual (cir-
cannual/seasonal) rhythms in host immunity, parasite reproduction, and par-
asite release.





Immunity Diel Macrophages (detection and restric-
tion of parasite invasion)
Mice 8% of transcripts are circadian; au-
tonomous macrophage circadian clock
controls rhythm
[46]
Immunity Diel Natural Killer Cells (early defense
against viruses and intracellular bac-
teria)
Humans Circadian trafficking between the
blood and organ compartments;
inverse trafficking compared to T-
lymphocytes
[105]
Immunity Diel Toll-like receptor 9 (evolutionarily con-
served receptor that recognizes bacte-
ria and viruses)
Mice Expression and function controlled by
circadian clock
[47]
Immunity Diel T-lymphocytes (surveillance for in-
fected cells)
Humans Cytokine production [106, 107]
Immunity Diel Leukocytes Humans Abundance in the blood follows a cir-
cadian rhythm for neutrophils, lym-
phocytes, monocytes, and eosinophils
[108]
Immunity Diel Whole blood response to LPS stimula-
tion
Humans Cytokine and chemokine production is
circadian in an environment free of
time cues
[109]
Immunity Diel Salmonella colonization and host cy-
tokine response to infection
Mice Mice have a different immunological
response to infection depending on
whether infection challenge occurs at
day or night; infection during the day
results in more inflammation; this ef-
fect is due to clock-controlled gene ex-
pression
[49]
Immunity Diel Clock genes and pro-inflammatory cy-




mRNA of cytokines and clock genes
are rhythmic under LD cycles and
constant conditions; inflammation is
rhythmic under LD cycles
[110]




PHA response and antibody produc-
tion depend on time of challenge, but
their peaks are phase-inversed
[17]
Continued on next page
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Lower bactericidal activity during mi-
gration, especially in autumn (birds);
Higher bactericidal activity during
breeding season (turtles); Higher bac-




Immunity Annual Leukocytes Birds
(captive)
Annual cycles in several immune traits,
no effect of Coccidia on annual cycle of
immune measures
[114]
Immunity Annual Lysis Birds (wild) Lower ability of plasma to lyse foreign
cells during migration and winter
[38]




Repression of sickness behavior dur-
ing reproduction in summer (birds);
repression of sickness behavior during
winter (hamsters)
[39, 115]
Immunity Annual Acquired Immunity Rabbits
(wild)
Resistance against nematodes [23]
Immunity Annual Spleen size (spleen is important for
both innate and adaptive immunity)
Birds
(wild)
Regression of spleen during migration [116]





Seasonal differences in pro- and
anti-inflammatory cytokine pro-
duction (humans); Summertime
photoperiod increases production of
pro-inflammatory cytokine TNF-α and
extends (rats) or elevates (hamsters)
disease symptoms
[117, 118, 119]
Immunity Annual Vaccine response Humans Seasonal variation in symptoms follow-
ing live influenza vaccine
[120]
Immunity Annual Intestinal immunity Ground
squirrels
(captive)
Increase in intestinal leukocytes, pro-
and anti-inflammatory cytokines dur-
ing hibernation
[66]
Continued on next page
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Susceptibility Diel Bacterial burden, pathogenesis,
and/or virulence of infection
Mice Timing of infection can affect: (a) bac-
terial burden due to circadian variation
in monocyte trafficking and/or gene
expression at site of infection, (b) dis-
ease severity from sepsis due to circa-
dian TLR9 expression, and (c) viru-
lence
[45, 49, 47, 121,
122]
Susceptibility Annual Susceptibility to fungal growth Bats (wild) Hibernating bats have temperatures
that match that of hibernacula, allow-











Parasite cohorts of millions of indi-
viduals synchronously burst from red





Annual Microfilariae (heartworm) Dogs Strong seasonal rhythm in microfilaria




Annual Nematodes (parasitic roundworms) Domestic
mammals
Parasites engage in seasonal hypobio-
sis, arrested development within hosts
that allows for persistence when envi-
ronmental conditions are unfavorable




Diel Coccidia Birds (wild
and captive)
Oocyte release is strictly circadian; al-
though parasites are vulnerable to sun
exposure the rhythmic pattern persists













The release of Echinostoma eggs by
hosts occurs during night when mice
are active. Human pinworms migrate
out of anus during the night to lay
eggs. In contrast, Schistosoma eggs




Annual Nematodes (roundworms) Dall’s Sheep
(wild)
Seasonal variation in intensity of para-
site larvae shed in feces
[125]
Continued on next page
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Diel Dicrocoelium trematode Ants
(intermediate
host)
In the evening infected ants affix them-
selves to the top of blades of grass and
enter torpor until the next morning,







Diel Manipulating fungus Ophiocordyceps Ants Ophiocordyceps manipulates host be-
havior and causes host death at char-
acteristic times of day
[87]
Box 1. Circadian and Seasonal (circannual) Modulation of
Host Immune Defense.
Circadian Immune Cycles. In order for hosts to mount an immune response
against an infecting pathogen, the immune system must first detect the presence of
the pathogen. One way that animals detect pathogens is by immune surveillance for
pathogen-associated molecular patterns (PAMPs), which are shared across groups of
pathogens. Host cells express pattern recognition receptors (PRRs) that recognize
PAMPs. Toll-Like Receptor 9 (TLR9) is an important PRR that can recognize both
viruses and bacteria, and is highly evolutionarily conserved. In 2012 Silver et al. dis-
covered that the expression of TLR9 by macrophages and B cells follows a circadian
rhythm. Importantly, the circadian rhythm of TLR9 has a significant effect on the
immune response and disease severity because the rhythm of TLR9 also produces
a rhythm in inflammatory cytokines. The implications were experimentally demon-
strated by inducing sepsis. Sepsis can occur during bacterial infections when a severe
inflammatory immune response causes damage to the host. Bacterial infection was
induced in laboratory mice using a puncture that allowed commensal bacteria to enter
65
the body cavity from the intestine. Mice were entrained to a light-dark cycle (LD
12:12 h), and infection was induced either at the midpoint of the light period or of
the dark period. Mice that were infected during the night, when the TLR9 inflamma-
tory response was elevated, had higher bacterial burdens, earlier mortality, and worse
disease scores, hypothermia, and tissue damage than mice that were infected during
the day. This study demonstrated that the functional response of the immune sys-
tem varies according to a circadian rhythm, and this variation is biologically relevant
because it can have a significant effect on the dynamics of infection [47].
Annual Immune Cycles. Faced with stark annual fluctuations in environmental
conditions and resources, many avian and mammalian species partition life history
events such as reproduction, growth, and hibernation into distinct times of year, and
their immune system also undergoes seasonal changes. Versteegh et al. 2014 set out
to investigate whether annual variation in immunity is due to seasonal adjustments
directly driven by environmental or physiological conditions, or originates from a
genetically-based circannual rhythm that allows organisms to prepare for changes in
the environment. They looked at 5 different immune measures, including bactericidal
competence of whole blood as a proxy for functional implications.
To determine whether seasonal immunity is a genetically encoded circannual rhythm,
genetically distinct subgroups of a widespread songbird, the stonechat (Saxicola
torquata), were bred and raised in a common garden experiment. The subgroups
chosen for this experiment differ in their seasonal life history and traits. They in-
cluded a (i) long-distance migrant, (ii) short-distance migrant, and (iii) a non-migrant,
along with hybrids. The prediction was that if seasonal immunity is a direct response
to seasonal environmental conditions and energy demands, then by raising birds in an
environment where (a) they have ample food, (b) they are not allowed to migrate or
breed, and (c) the only fluctuation to which they are exposed is changing day length,
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their annual rhythms in immunity would be lost.
The authors found that not only did the annual rhythm in immunity persist un-
der these controlled conditions but also that the subgroups and hybrids of the birds
showed specific patterns. The long-distance migrants displayed seasonality in 4 im-
munity parameters, which included bacterial killing ability (Figure 1D). The short-
distance migrants displayed seasonality in only 3 immunity parameters, and the non-
migrants displayed seasonality in only 2 parameters. Furthermore, the amplitude of
the annual fluctuation was greatest in the long-distance migrants. The inheritance
of the rhythm in hemolysis (the ability of antibodies and their compliment system to
lyse foreign cells) was also quite striking. Both the long- and short-distance migrants
showed reduced hemolysis during the time of the natural autumn migration. The
reduction in hemolysis in the long-distance migrants was much more extreme than
that of the short-distance migrant, and intermediate in F1- hybrids. Together, this
work demonstrates that an inherited, biological clock controls seasonal immunity in
stonechats, and these rhythms vary across groups that differ in their seasonal life
history [53]. Related avian studies generally confirm annual cycles in immune param-
eters, and although species differ, there is a common tendency for greater seasonal
immunomodulation with increasing migratory lifestyle.
Outstanding Questions.
1. Are rhythms in the immune system adaptive for fighting infection?
2. Are parasite rhythms adaptive for dealing with host rhythms or environmental
conditions?
3. Are observed parasite rhythms truly endogenous?
4. If parasite rhythms are endogenous, are they entrained by host rhythms?
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5. Are host circannual rhythms in immunity an adaptive response to (a) seasonal
parasite exposure or (b) resource limitations and life history trade-offs?
Glossary.
Adaptive immune system - cells of the adaptive immune system include B cells
and T cells. The initiation of the adaptive immune response occurs after the
initiation of the innate immune response. Receptors of adaptive immune cells
require genetic recombination and alteration to generate, resulting in antigen
specificity and immunological memory [126, 127].
Annual cycle - cycle with a length of approximately 1 year, with phases occurring
consistently at a particular time every year, on an annual/seasonal basis
Circadian - cycle that occurs with an approximate 24-hour period, used in reference
to endogenous rhythms
Circannual - cycle that occurs with a period of approximately 1 year, used in ref-
erence to endogenous rhythms
Diel cycle - cycle with a length of approximately 1 day, with phases occurring con-
sistently at a particular time during the day-night cycle
Immune defense - immune defense includes (1) resistance against the establish-
ment of infection and the reproduction of parasites, and (2) parasite tolerance,
in which the host mitigates the pathological consequences of infection, but tol-
erates infection
Innate immune system - cells of the innate immune system include macrophages
and neutrophils. Innate immune cells are immediate responders to infection.
A fundamental distinction between innate and adaptive immune cells is that
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innate immune cell receptors responsible for immune recognition are encoded
in the germline; whereas, receptors of adaptive immune cells require genetic
recombination and alteration to be generated. It was previously thought that
the innate immune response is not parasite-specific and lacks memory, but that
characterization is now considered incorrect [127].
LD-cycle - cycle in which light and darkness alternate, and each last for a given
duration, for example in LD 12:12 h, light and darkness both last for 12 hours
LPS - Lipopolysaccharide is a component of the outer membrane of Gram-negative
bacteria that is used in experiments to elicit an anti-bacterial immune response
Macroparasites - parasites that are large and typically metazoans (e.g., helminths)
Microparasites - parasites that are small and often unicellular (e.g., pathogenic
viruses, bacteria, and fungi)
Macrophage - phagocytes, often referred to as “big eaters” because they engulf
invading bacteria and are responsible for clearance of dead (apoptotic) cells.
Macrophages are one of the cells responsible for detection and restriction of
parasite invasion.
Parasite Resistance - The ability of the host’s immune response to prevent infec-
tion from establishing or limit parasite replication. Parasite resistance has a
negative impact on parasite fitness [128].
Parasite Tolerance - The ability of the host to mitigate the pathological conse-
quences of infection, rather than mitigate infection itself. Parasite tolerance
does not necessarily have a negative impact on parasite fitness [128].
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Abstract. Sustained and coordinated vaccination efforts have brought polio eradi-
cation within reach. Anticipating the eradication of wild poliovirus (WPV), and the
subsequent challenges in preventing its re-emergence, we look to the past to identify
why polio rose to epidemic levels in the mid-20th century and how WPV persisted
over large geographic scales. We analyzed an extensive epidemiological dataset, span-
ning the 1930s to the 1950s and spatially replicated across each US state, to glean
insights into the drivers of polio’s historical expansion and the ecological mode of
its persistence prior to vaccine introduction. We document a latitudinal gradient in
polio’s seasonality. Additionally, we fitted and validated mechanistic transmission
models to data from each state independently. The fitted models revealed that: (1)
polio persistence was the product of a dynamic mosaic of source and sink popula-
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tions; (2) geographic heterogeneity of seasonal transmission conditions account for
the latitudinal structure of polio epidemics; (3) contrary to the prevailing “disease of
development” hypothesis, our analyses demonstrate that polio’s historical expansion
was straightforwardly explained by demographic trends rather than improvements
in sanitation and hygiene; and (4) the absence of clinical disease is not a reliable
indicator of polio transmission because widespread polio transmission was likely in
the multi-year absence of clinical disease. As the world edges closer to global polio
eradication and continues the strategic withdrawal of the Oral Polio Vaccine (OPV),
the regular identification of, and rapid response to, these silent chains of transmission
is of the utmost importance.
Introduction
Poliovirus, like other members of Picornaviridae, usually generates mildly symp-
tomatic infection. However, the clinical manifestation of polio, Acute Flaccid Paral-
ysis (AFP), can result when the virus invades the central nervous system [1]. WPV
is transmitted fecal-orally, and in the Northern Hemisphere exhibits seasonal epi-
demics in late summer and autumn [1, 2, 3]. Polio outbreaks continue today within
this narrow seasonal window in Pakistan and Afghanistan [4, 5], but the seasonal
transmission structure of polio remains unexplored.
Propelled by public support, the race for the polio vaccine during the post-World
War II era led to the development of the Inactive Polio Vaccine (IPV) and the Oral
Polio Vaccine (OPV) which reduced the global incidence to less than 0.1% of pre-
vaccine levels [6]. Missing the 2014 goal of globally stopping WPV transmission has
left eradication elusive, primarily due to political and social obstacles for effective
vaccine distribution, including vaccine hesitancy and mistrust. In light of this—and
the call for innovative solutions [7]—an understanding of polio’s ecology can help
guide alternative strategies. Looking toward eradication and beyond, a polio-free
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world requires an understanding of the mode by which polio originally emerged and
historically persisted. We contend that a retrospective study of the ecology of WPV
in the absence of vaccine interventions can inform future planning, and may pinpoint
vulnerabilities in WPV’s epidemiology that could be leveraged for eradication.
Ironically, because of the success of polio vaccination, critical features of WPV
transmission remain obscure. The low global incidence of polio (due to high vaccine
coverage), in combination with the relative rarity of symptomatic infections, limits the
amount of epidemiological data with which to study transmission. Furthermore, data
limitations regarding vaccine coverage in developing countries confound transmission
studies, making it difficult to disentangle the effects of the vaccines, demography, and
transmission. Therefore, we took advantage of a dataset of unprecedented size and
resolution in both space and time to gain insights into the drivers of polio’s historical
expansion and the ecological mode of its persistence in the pre-vaccine period.
We present analyses of spatially-replicated incidence reports from the pre-vaccine
era in the US, and built mechanistic transmission models which incorporate these
data to reconstruct the unobservable infection dynamics. Our analyses allow us to
dissect three axes of polio epidemiology: (i) geographical and seasonal variation in
transmission, (ii) the role of demography in determining incidence, and (iii) the mode
by which polio persists.
Methods
Data.
We examined monthly polio case reports (January 1931–December 1954) from
the US Public Health Service Morbidity and Mortality Weekly Reports as compiled
by [8] and the CDC for each of the 48 contiguous US states and the District of
Columbia (Fig 4.1A–B). Prior to 1945, paralytic polio cases were primarily reported
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in the US [3, 1]; however, during the later period of this study, non-paralytic cases
comprised ≥ 40% of reported cases in populous cities such as New York, Detroit,
Kansas City, and Sacramento [9]. In addition to polio case data, we obtained state-
level births from 1931 onward from US Vital Statistics, and state population sizes
from the Population Distribution Branch of the US Census Bureau. Data from US
Vital Statistics are housed in the CDC online repository: National Center for Health
Statistics, Products, Vital Statistics. The US Census Bureau data were obtained
from their Population Estimates Repository, historical data Pre-1980. The polio
data set—with cases detailed weekly—has now been independently digitized and is
freely available and maintained online through the University of Pittsburgh Project
TYCHO. Birth data were not available for Texas and South Dakota beginning in 1931,
but began in 1932 and 1933, respectively. For exploratory analyses, we quantified the
relationship between disease fadeouts and population size. A threshold of 3 months
without a reported infection was chosen to define a fadeout [10]. The portion of
fadeout months was taken as the ratio of fadeout months to total months in Fig 4.1C.
To estimate spatial synchrony, we used the nonparametric spatial correlation function
[11, 12]. To measure the relative timing of polio epidemic peaks for each state and
each year, the 1 yr wavelet band phase angle was computed [13] and used to rank
states earliest to latest based on their epidemic peak timing.
Models.
We constructed a dynamic stochastic model with components incorporating polio
transmission, immunity, seasonality, and symptomatology along with empirical pop-
ulation sizes and birth rates. Birth rates displayed prominent seasonal, secular, and
geographical trends (Appendix B)[14]. We utilized Partially Observed Markov Pro-
cess (POMP) models which are suited for dealing with epidemiological data where
the state variables (susceptible, infected, and recovered individuals) were not observed
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in the data; rather the infected individuals were partially observed through clinical
case reports. For our process models, we used seasonally-forced stochastic monthly
discrete-time SIR models where transitions followed a Poisson process. The infectious
period was fixed at 1 month, because multiple studies have found the duration of shed-
ding to be 3–4 weeks [15]. Infection-derived immunity was assumed to be life-long
[16, 17]. The models contained 6 classes of infants susceptible (SBi ) to infection. These
infant classes contained 0–1 month olds, 1–2 month olds, etc. up to 6 month olds.
Models had a single infected class for infants (IB). The older age class which con-
tained individuals > 6 months of age, had its own susceptible (SO) and infected class
(IO). The onset of polio symptoms ranges from 5–35 days post-exposure, with a mean
of 12 days [18]; therefore, we assumed reporting of symptomatic infections occurred
within the 1 month infectious period. We modeled polio reporting explicitly and
consistent with clinical evidence, assumed that maternal antibodies protected from
severe disease and resulted in unreported infant infections[19, 20, 21, 22, 23]. Thus,
we assumed that infections in individuals under 6 months of age were asymptomatic,
and only individuals over 6 months of age could be symptomatic and reported as a

















, represents transmission that occurred
locally by individuals infected in the state at time t. Whereas, the second term,
ψ, encompasses WPV that arose in the population from external sources that were
divorced from the local infection dynamics. ψ placed a lower bound on the force of
infection, allowing WPV to rebound in the face of local extinction. We interpret ψ
as indicating virus imported from other geographic regions; however, it could also
be interpreted as representing a small number of individuals in the population that
shed WPV for an extended period, or environmental sources helping WPV persist
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over the winter. The transmission parameter, βt, was parameterized using a B-spline,
providing it the flexibility to have a constant or seasonal transmission rate. There





Here, each ξit is a periodic B-spline basis with a 1 year period. The process noise,
εt, was gamma distributed with mean 1 and variance that scaled to account for both
environmental and demographic stochasticity; refer to Appendix B for further details).
We assumed cases were drawn from a rounded, left censored normal distribution with
a mean report rate of ρt, and dispersion parameter τ ,
casest = round(xt), xt ∼ normal(ρtIOt , τIOt ). (4.3)
For calculating the likelihood, we used a binned-normal probability density. Full
model details are found in Appendix.
We fitted SIR models (one for each US state) to data independently using Maxi-
mization by Iterated particle Filtering (MIF) in the R package pomp [24, 25, 26]. For
each US state, we estimated 14–15 parameters. The parameters estimated were: 6
seasonal transmission parameters (βi), 3 parameters accounting for process and mea-
surement noise, 3 initial conditions for the older age class, the external contribution
to the force of infection (ψ), and 1–2 report rates (ρt). MIF is a simulation-based
likelihood method for parameter estimation. The basis of MIF is particle filtering,
which integrates state variables of a stochastic system and estimates the likelihood for
fixed parameters. Instead of fixing parameters, MIF varies them throughout the fil-
tering process and selectively propagates particles (i.e., parameter sets) that have the
highest likelihoods. By initializing MIF throughout parameter space we estimated
the shape of the likelihood surface for each US state and identified the Maximum
91
Likelihood parameter Estimates (MLEs). MIF was initialized from 1 million param-
eter sets for a global search, followed by additional phases of increasingly localized
searches, which included profiling. In total, for each US state, MIF was initialized
from > 10000 locations in parameter space to estimate the shape of the likelihood
surface and identify the MLEs.
Prior to 1945, non-paralytic polio cases were rarely included in our data, but the
reporting of non-paralytic polio became increasingly common [3, 1]. Thus, we tested
an optional parameter to account for increased representation of non-paralytic polio
in clinical cases data. We estimated two report rates, one for the pre-baby boom
era and another for the baby boom era, and discriminated between models with and
without time-varying reporting using Akaike Information Criterion (AIC). Profiles
were constructed for the two versions of the model, one in which the report rate was
constant through the entire time-period, and one in which the report rate increased
during the baby boom era. For each state AIC was used to discriminate between
constant and time-varying reporting, and the maximum likelihood estimates (MLEs)
were drawn from the appropriate two dimensional profile. Inference was performed
using the data from May 1932 to January 1953, with the exception of South Dakota
and Texas, whose inference began in May 1933 and 1934, respectively. Inference was
initiated in May of the year following the first full year of available data to allow us to
construct the infant initial conditions directly from birth data. For model validation,
the last two epidemic years were set aside for forecasting. Full details are provided in
Appendix B. Likelihood profiles were constructed for each state (example in Fig 4.2B,
all others in Appendix B).
To quantify model-data agreement, we evaluated the accuracy of one-step-ahead
predictions for all 49 states, both for data used in model parameterization (Fig 4.3B)
and for out-of-fit data (Fig 4.3C). Because of correlations between states (which vary
significantly in size) and mean incidence, simple linear regression is not appropriate
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for accessing model-data agreement; therefore, generalized R2 was calculated to quan-
tify the proportion of the variance explained by the model relative to that explained
by state alone. We calculated the generalized R2 for the one-step-ahead predictions
and out-of-fit predictions (See Appendix B for details). For Fig 4.4A–B, infections
were reconstructed using particle filtering means, and the reconstruction was limited
to data beginning in Jan 1935, because 1935 is the first full year for which we have
the models parameterized for all US states. Following model validation and infection
reconstruction, the fitted models were used as simulation tools to explore polio in-
fection dynamics. In Fig 4.4D–E, we used 500 simulations for each state from 1935
through 1954. In Fig 4.4D, we present the state-specific probability of extinction by
examining 500 realizations of the fitted models. Specifically, we calculated the an-
nual probability of polio extirpation during the off-season (Dec-May), and averaged
across years. Similarly, in Fig 4.4E the minimum number of infections during each
off-season was based on 500 simulations. For each simulation, the annual minimum
number of infections was identified, the median was taken across the 500 simulations,
and averaged across years. In order to identify the covariates and epidemiological
parameters that influenced the the number of trough infections—a measure of WPV
persistence—we regressed trough infections with various covariates and parameters;
results shown in Fig 4.5. In Fig 4.6B–D, distributions were generated by characteriz-
ing observations across 500 simulations per state. All simulations and data used for
producing the figures in this manuscript are available in Appendix B.
Results
Polio’s Seasonality & Latitudinal Gradient.
In the mid-20th century, polio outbreaks in the US were strongly seasonal. Epi-
demic peaks typically occurred between August–October (Appendix B); but the mag-
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nitude was highly variable among states. In the transition from the pre-baby boom era
(1931–1945) to the baby boom (1946–1954), epidemics increased in size and became
more regular (Fig 4.1A–B). Winter troughs were frequently marked by consecutive
months without reported cases. During the baby boom, the frequency of these lo-
cal fadeouts diminished (Fig 4.1C) while epidemics became more tightly synchronized
(Fig 4.1D). There was a striking latitudinal gradient in the timing of epidemics across
the entire US (Fig 4.1E–F, Appendix B). Two broad classes of mechanisms can give
rise to such a pattern. Seasonal movement of pathogen from southern populations
can generate a traveling wave, which has previously been observed in measles [27],
dengue [28], influenza [29, 30], and pertussis [31]. Alternatively, the pattern may
indicate latitudinal gradients in demographic (e.g., birth rates [14, 32]) and/or envi-
ronmental factors associated with transmission.
Model fit.
Our extensive search of parameter space resulted in the MLEs for each param-
eter. To quantify the shape of likelihood surface along two parameter dimensions
we identified as important (i.e., the report rate, ρt, and the external contribution to
the force of infection, ψ), we constructed two dimensional likelihood profiles for each
state. Two-dimensional profiles by definition have fixed parameter values along two
dimensions of parameter space, while the likelihood is maximized along all other pa-
rameter dimensions. There were 12 states that had constant reporting (i.e., the same
report rate during the pre-baby boom and baby boom era). Fig 4.3A illustrates that
the fitted models generate epidemic trajectories that display (1) the seasonal charac-
teristics of polio, and (2) the large amount of interannual variation in epidemic size.
Importantly, the fitted models faithfully reproduce observed dynamics. In particular,
the seasonality, epidemic shape, interannual variability in epidemic magnitude, and
the increase in incidence during the baby boom are captured by the models. Model
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Figure 4.1: Spatiotemporal patterns in US polio incidence. (A) Total monthly case
reports, 1931–1954, color-coded by per-capita incidence. (B) Log-transformed
per-capita incidence by state, ranked top-to-bottom by population size. (C)
Disease fadeout frequency as a function of state population size, during the pre-
baby boom and the baby boom. The lines represent fitted negative exponential
curves, which tended toward zero. (D) Pairwise epidemic synchrony between
states during the pre-baby boom and the baby boom. Mean and 95% bootstrap
confidence envelope shown. (E, F) Relative timing of polio epidemic peaks
during the (E) pre-baby boom and (F) baby boom eras. Color indicates mean
rank of each state across years; lower rank indicates earlier epidemic peak.
Below each map, relative timing is regressed on latitude. Lower latitude states
had significantly earlier epidemic peaks.
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fit was formally validated using one-step-ahead predictions for all 49 states (Fig 4.3B)
and out-of-fit predictions (Fig 4.3C), which indicate good agreement between models
and data. Furthermore, geographical structure in the timing of observed epidemics is
captured by the fitted models (Fig 4.3D). State-specific examples of one-step-ahead
predictions and out-of-fit predictions are shown in Fig S2–S3.
Explaining the Latitudinal Gradient.
We hypothesized that the latitudinal gradient in epidemic timing was driven by
either: (1) geographic variation in transmission due to environmental factors that
modulated transmission, (2) the geographic trend in birth seasonality in the US (de-
tailed in [14]), or (3) the movement of pathogen from south to north.
In support of hypothesis 1 (i.e., environmental factors), we identified a spatial
pattern in the phase of seasonal transmission (Fig 4.3E–G, Appendix B). States with
earlier epidemics had an earlier peak in the seasonal transmission rate in the fitted
models. Interestingly, due to polio’s long infectious period, peaks in transmission
preceded incidence peaks by 1–2 months. States not only varied geographically in
the timing of the transmission peak, but also in the wintertime transmission trough
depth and trough duration (Fig 4.3G).
Epidemiological theory indicates that birth seasonality can have important dy-
namical consequences for childhood diseases [33, 14, 34]. To test hypothesis 2 (i.e.,
birth seasonality), we carried out a comparison of the fitted models with and with-
out birth seasonality. Simulations of both models expressed the latitudinal gradient
(Fig S5). Therefore, birth seasonality is not necessary to explain the polio gradient
because geographic variation in transmission is sufficient. We attribute the negligible
effect of birth seasonality on polio incidence to the low amplitude of birth seasonality,
which was ∼ 10% in the US at this time.
We suggest that hypothesis 3 (i.e., pathogen movement) is an unlikely explanation
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Figure 4.2: Model schematic and example likelihood profile. (A) Births enter the
first susceptible infant class, SB1 . Susceptible infants of age 0–6 months, S
B
1−6,
are susceptible to infection, but are protected from symptomatic disease by
maternal antibodies. Susceptible individuals over 6 months of age are in the SO
class. Infected infants and non-infant infections are in IB and IO, respectively.
Infected individuals over 6 month of age, IO, can have symptomatic illness
and subsequently be reported as a clinical case with mean probability ρt. ρt
is a composite parameter that represents the probability of symptoms and
reporting. (B) Likelihood profile for the report rate, ρt, of non-infant infections
and the immigration rate, ψ, for the state of Wisconsin. MLE indicated by
green asterisk. The report rate for Wisconsin was constant through time.
of the latitudinal gradient. If the latitudinal gradient were a wave of pathogen move-
ment, it would require a high wave speed, which we see as incompatible with transport
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Figure 4.3: Fitted Model and Seasonality. (A) Observed data (black, shown for Wisconsin) and three stochas-
tic simulations from the MLE (blue/green) highlight that both observed and simulated polio epidemics
have a large amount of interannual variation in size, but a narrow seasonal window. Fitted and out-of-
fit data regions are indicated by blue and green, respectively. (B) Model validation showing observed
log10(cases) versus expected log10(cases) for fitted data and (C) out-out-fit predictions for all 49
states. Expected cases are one-step-ahead predictions from the fitted models. Insets show observed
cases (black) and expected cases (blue/green) for Wisconsin. Fitted data include May 1932–Jan 1953
for all states except South Dakota and Texas, whose covariate data limited our inference to begin
in May 1933 and 1934, respectively; out-of-fit data spanned Jan 1953–Dec 1954. The generalized
R2 = 0.76 for the fitted data and R2 = 0.61 for out-of-fit data, calculated on the natural scale,
while data are plotted on a log-scale for visualization. (D) Observed vs. simulated mean rank of
epidemic timing based on 10 realizations of the fitted models. Inset shows the latitudinal gradient
from one simulation; colors match Fig 4.1E–F. (E) Monthly polio cases in Texas and Wisconsin, and
(F) the MLE transmission rates. Epidemics occured earlier in southern states than northern states
because the seasonal peak in transmission occured earlier at lower latitudes. (G) MLEs of the sea-
sonal transmission rate for each state organized by geographic region; in our models this represents
the reproductive ratio. The reproductive ratio varies both seasonally and geographically, with some
states having a reproductive ratio < 1 during the wintertime off-season.
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of pathogen across the landscape. The pattern in Fig 4.1E–F corresponds to a wave
traveling approximately 1200 km/mo. For comparison, waves in pertussis have been
estimated to travel 110–320 km/mo [31]; waves in dengue appear to move 150 km/mo
[28]; and the measles wave-speed in the UK was estimated at 20 km/mo [27]. A polio
wave that is 10-fold faster than pertussis in the US is difficult to justify, and unnec-
essary because our fitted models support hypothesis 1. Thus, we have identified that
polio’s latitudinal gradient is driven by geographic variation in transmission, and we
are left with an unidentified seasonal driver that modulates transmission.
While geographical variation in birth seasonality was insufficient to explain the
latitudinal gradient seen in epidemic timing, birth seasonality had a small but observ-
able effect on the simulated incidence of infant infections. To quantify the influence
of birth seasonality on infant infections, we compared simulations of the fitted models
to simulations for which seasonal fluctuations in births were removed. In the presence
of birth seasonality, infant infection incidence was often higher (Fig S6); however, this
did not affect the incidence of disease directly, and no indirect effect was observed.
Symptomatology.
It is well known that AFP incidence represents a small fraction of true WPV
prevalence [35, 36]. Reassuringly, our independent estimates from the incidence data
agree: our MLEs indicate that typically < 1% of polio infections were reported.
We assumed that infected infants under 6 months of age were asymptomatic, due
to protection by polio-specific maternal antibodies. The report rate for individuals
not maternally-protected was 0.75% (averaged across states) in the pre-baby boom
era, and rose to 1.4% in the baby-boom era, with considerable variation across states
(Appendix B). Overall, we estimate that there were often 1+ million annual infections
in the US; though only 2000–57000 cases were reported every year (Fig 4.4A). Our
results are in line with a 1948 serology-based study in North Carolina, which estimated
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62–175 subclinical polio infections per paralytic case [37].
Spatiotemporal Heterogeneity in the Reproductive Ratio.
The fitted models revealed vast seasonal and spatial heterogeneity in WPV’s re-
productive ratio. Fig 4.3G shows large seasonal fluctuations in the reproductive ratio
within each US state. Several states maintained a reproductive ratio > 1 throughout
the year. In contrast, 28 states had reproductive ratios that fell < 1 for 4–5 months
from Dec–Apr.
States in the Northeast and Midwest had extreme seasonal variation in their re-
productive ratio. Deep winter troughs in transmission in the Northeast and Midwest
often had several consecutive months with a reproductive ratio < 1. In contrast, at
the peak of transmission in June and July, these same states had a reproductive ratio
> 20. Interestingly, each geographic region other than the Midwest, had at least one
state that maintained a reproductive number > 1 throughout the year. Southern
states typically maintained an intermediate transmission rate throughout the year.
Epidemic Emergence.
Our analyses provide a new perspective on polio’s historical emergence. Com-
monly described as a “disease of development”, polio’s emergence has been ascribed
to improved hygiene that reduced transmission and pushed the burden of infection
onto children more susceptible to paralytic polio. This explanation requires that re-
duced transmission raised the mean age of infection and therefore the risk of AFP
[1]. Our results suggest the marked increase in polio incidence from the 1930s to
the 1950s was a straightforward consequence of increased birth rates (Fig 4.4B–C)
and that hygiene effects on transmission are not required to explain polio’s rise to
epidemic levels. Since polio’s epidemic emergence was captured in the models due
to the changing birth rate, we did not explicitly test reductions in the transmission
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rate as an additional contributor to epidemic size and we cannot completely rule out
trends in transmission as a contributing factor. While the disease-of-development
explanation has also been questioned on other grounds [22], changes in hygiene and
sanitation could have contributed to the initial emergence of polio, which occurred
from the late 1800s to the early 20th century.
WPV Persistence.
Polio cases were consistently observed throughout the US during the period of
this study. We hypothesized: (a) WPV persisted locally in each state, or alterna-
tively, (b) WPV regularly went locally extinct and re-invaded from elsewhere. Due
to polio’s high asymptomatic infection ratio, distinguishing between these two mech-
anisms of persistence cannot be done using reported cases alone, since WPV may
be present during the off-season even in the absence of clinical cases. In order to
determine which of these two persistence mechanisms was the likely explanation of
continued infection, we simulated the fitted models and characterized the dynamics
of the process models (i.e., the unobserved infection dynamics rather than the ob-
servable disease dynamics). We focused on determining whether infections persisted
during the wintertime off-season, or if extinction and re-invasion occurred. In par-
ticular, we assessed (i) the average annual probability of an extinction event in each
state, which results from diminished local transmission and (ii) the annual minimum
number of infections. Fig 4.4D–E depicts the geographic variation in these quantities.
Some states experienced frequent local extinction during the off-season, followed by
re-colonization: we consider these “sink” populations. In contrast to sink states, a
few states maintained infections year-round: these we define as “source” populations.
The majority of states, however, were neither consistently sources nor sinks, because
even sink states had frequent overwintering of WPV. The fitted models suggest that
WPV underwent extinction and re-colonization in the classic metapopulation sense.
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Figure 4.4: Epidemic Emergence and Source-Sink Dynamics. (A) Annual number
of infected individuals in the US in contrast to the small number of reported
cases. Annual infections were reconstructed for the US using particle filtering
means. The particle filtering mean is the expected value at time t, given the
data up to time t: E(Xt | casest). (B) Annual infections in the US represented
as the percent of the population. Reconstructed infections show an increase
in infection incidence that accompanies (C) the increase in the birth rate. (D)
Simulated WPV extinction probability. The probability of extinction measured
as the mean annual probability of observing an extinction during the off-season
(Dec–May). “sink” populations are those states with a high extinction prob-
ability. (E) Simulated trough infections. Trough infections indicate the mini-
mum number of infections during off-seasons. For each state, the median was
taken across simulations and averaged across years. “source” populations are
those that maintain a high number of infections. Panels D–E were constructed
using the 500 stochastic simulations for each state.
Source-Sink Population Predictors.
We explored characteristics that contributed to states having been WPV sources
versus sinks. We used simulated trough infections, shown in Fig 4.4E, as the indi-
cator of a source versus a sink. States that maintained a high number of trough
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infections enabled WPV to persist through the off-season; whereas, states with a low
number of trough infections were likely to have experienced regular WPV extinction.
State population size accounted for 65% of the variation in the number of trough
infections, Fig 4.5A. We used multiple regression models to determine whether the
(i) mean birth rate, (ii) amplitude of birth seasonality, (iii) immigration rate, (iv)
seasonal minimum reproductive ratio, and/or (v) seasonal amplitude of the repro-
ductive ratio explained the residual variation in trough infections, after controlling
for population size. The mean birth rate and amplitude of birth seasonality had a
negligible impact on the residual variation in trough infections; therefore, they were
removed from the multiple regression model. A multiple regression model with the
immigration rate, seasonal minimum reproductive ratio, and the seasonal amplitude
of the reproductive ratio explained 56% of the residual variation in trough infections,
Fig 4.5B. Interestingly, even though there were no clear geographic patters of source-
versus-sink localization, Fig 4.4D–E, there was strong geographic clustering in the
minimum reproductive ratio, Fig 4.5C, demonstrating that even though source-sink
predictors display geographic clustering, the combination of predictors can generate
a source-sink mosaic. We found that after accounting for population size, states with
a higher immigration rate had more trough infections, Fig 4.5D–E. States with a
higher transmission amplitude, however, had fewer trough infections; we interpret
this as being due to susceptible depletion followed by deep infection troughs in states
with a high transmission amplitude, Fig 4.5D. The minimum reproductive ratio had
a positive relationship with tough infections; states that maintained a reproductive
ratio > 1 during the off-season tended to have more trough infections during the
off-season, Fig 4.5E.
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Figure 4.5: Source-Sink Population Predictors. (A) Linear regression of state popu-
lation size versus simulated trough infections, both on a log10 scale. Trough
infections are those shown in Fig 4.4E. (B) Residuals from the regression of
population size versus trough infections were used as the dependent variable in
the multiple regression model, where the predictors were: the state’s seasonal
minimum reproductive ratio, the immigration rate, and the seasonal ampli-
tude of the reproductive ratio, measured as half the peak-tough difference in
the reproductive ratio. Plot shows on the y-axis, the residuals, ri, from panel
A, along with the prediction of the residuals based on the multiple regression




2 + b3ψi, where R
i
t is the reproductive
ratio, ψi is the immigration rate, and i indicates the state. Taken together,
panels A and B demonstrate that the predictors of a source versus sink are:
the population size, the minimum reproductive ratio, the amplitude of the
reproductive ratio, and the immigration rate. (C) Map of the seasonal mini-
mum reproductive ratio showing geographic clustering. (D) The residuals, ri,
versus the seasonal amplitude of the reproductive ratio (i.e., the transmission
amplitude), point size and color indicate the immigration rate, ψi. (E) The
residuals, ri, versus the seasonal minimum reproductive ratio, point size and
color indicate the immigration rate, ψi.
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Silent Infections.
Disease eradication programs face the significant challenge of verifying success
in the presence of asymptomatic infections. Typically, a criterion for success is the
absence of disease for an extended period; however, the utility of this criterion is ques-
tioned when the symptomatic cases reported are only the tip of the iceberg in terms of
infection. Using our fitted models, we explored the reliability of absence-of-disease as
an indicator of WPV extinction. Due to widespread subclinical infections, there was
a stark contrast between the simulated number of polio infections and clinical cases
(Fig 4.4A). This contrast (i.e., the disconnect between infections and clinical cases),
can lead to epidemiological scenarios where absence-of-disease is uninformative. In
our models, WPV persistence was achieved by one of two mechanisms (1) local unbro-
ken chains of transmission, or (2) local extinction followed by rapid reintroduction.
For each of these two mechanisms, we found that clinical case data can be misleading,
as outlined in Table 4.1. For instance, if WPV circulated at low levels of infection,
extended absence of clinical cases could lead to the conclusion that WPV was locally
eradicated. Similarly, if local extinction of WPV occurred, and was quickly followed
by reintroduction and clinical cases, local extinction could go unrecognized, poten-
tially misdirecting targets for control (e.g., to focus on sink populations rather than
source populations).
By simulating our fitted models we identified extended periods absent of disease
and used these periods to quantify the number of silent infections (Fig 4.6B–C). We
observed that if infections were maintained at relatively low numbers (i.e., under 100
infections per month), then WPV could circulate silently for > 30 months (Fig 4.6B).
The silent circulation of WPV can result in thousands of infections before a single re-
ported case is observed (Fig 4.6C). Our models assumed homogeneous mixing within
each state, and it is important to recognize that different mixing patterns could in-
crease or decrease the duration of silent infections. Due to the silent circulation of
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polio, it is difficult—and perhaps indefensible—to use clinical case data (i.e., with-
out fitted models) to evaluate WPV persistence. We simulated the fitted models
to quantify the distribution of cases observed during periods with WPV extinction
(Fig 4.6D). The distribution of cases surrounding WPV extinctions is fairly symmet-
ric due to the reintroduction of WPV following extinction. Therefore, we conclude
that, in the face of rapid reintroduction following WPV extinction, case data cannot
be used to identify extinction events. Though it is desirable to use fitted models to
identify signals of extinction, and apply this knowledge to case data, it would require
extensive evaluation of silent circulation.





Disease data are uninformative,
and potentially misleading, be-
cause WPV is circulating silently
via subclinical infections
Disease data reflect that WPV




Disease data reflect that WPV
persists and transmission is on-
going
Disease data are uninformative
because they mask that WPV
goes extinct and is reintroduced
Table 4.1: Four scenarios for the relationship between WPV infections and clin-
ical disease. Local persistence of polio—within a state, region, or country—
occurs when WPV overwinters during the off-season and the transmission chain
is unbroken year-round. In contrast, local extinction and reintroduction occurs
when WPV goes extinct during the off-season, breaking the chain of transmis-
sion; a new transmission chain begins when WPV is reintroduced from else-
where. Discriminating among these scenarios is necessary for planning eradica-
tion strategies in endemic regions.
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Figure 4.6: Persistence Mechanisms. (A) Example of simulated infections and cases
for Wisconsin. Months absent of reported cases are indicated in green. During
periods when the disease is absent, WPV infections are often silently transmit-
ted in the population. In this simulation, there were two instances (indicated
by arrows) when the local chain of transmission was broken and WPV went
locally extinct, but quickly rebounded due to reintroduction. This example
illustrates the two polio persistence mechanisms observed throughout the US,
which are (i) local WPV persistence via unbroken chains of transmission, and
(ii) WPV extinction and reintroduction. (B) Distributions of mean monthly
silent infections during periods absent of reported disease. (C) Distributions
of cumulative silent infections during periods absent of disease. Distributions
in B and C are 10–90% quantiles and the median based on 500 simulations
per US state. Silent infections are those that occur in the absence of reported
cases, and highlight the unobservable dynamics of polio. (D) Simulated cases
surrounding WPV extinction events. Distributions show 10–90% quantiles and
the median number of cases observed up to 6 months preceding and 6 months
following an extinction event. Generally, fewer than 5 cases per month are re-
ported two months to either side of an extinction event. However, it is unclear
whether 5 months with < 5 cases is a reliable signal of extinction.
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Discussion
This work sheds light on the fundamental ecology of WPV. Latitudinal gradients
have been identified in several acute viral infections: including influenza, RSV, ro-
tavirus, and now polio [39, 40]. Our results indicate that the observed latitudinal
gradient in the timing of polio epidemics is driven by a latitudinal gradient in de-
mographic and/or environmental factors associated with transmission. Determining
which mechanism is responsible has implications for control and surveillance efforts.
Specifically, knowledge of the seasonal driver could allow for regionally-timed national
immunization campaigns or the ability to forecast changes in epidemic seasonality.
Our identification of birth rate as a driver of polio’s epidemic emergence during
the baby boom of the 1940s and 1950s, is yet another demonstration [41, 42] of the
need for full integration of demography into the study of childhood infectious disease
epidemiology. The rate of susceptible recruitment has long been known to control the
magnitude and frequency of epidemics of fully-immunizing childhood diseases [41, 43].
Today, in an era of human population expansion and emerging infectious diseases, we
are reminded of the importance of characterizing changes in host population ecology.
Due to limits of our demographic data, we were unable to address the early emergence
phase of polio from the late 1800s through the 1920s. Rather, we focused on the later
phase of emergence in the US, as the disease transitioned from small epidemics in the
1930s and early 1940s to large epidemics during the baby boom era. Though there
were increases in the report rate, which contributed to the trend in observed cases,
we also discovered an increase in the incidence of infection. Importantly, the increase
in infection incidence closely tracked birth rates in the mid-1900s.
To the extent that our results bear on contemporary polio ecology, the identifi-
cation of source-sink dynamics in the US suggests that successful local elimination
of polio in a sink population is inconsequential in the presence of a source pop-
ulation. This prediction has unfortunately been repeatedly borne out in current
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epidemics. Regional elimination of polio has been followed by reintroduction from
endemic countries, such as the 2013 outbreak in Somalia, Ethiopia, and Kenya with
WPV introduced from Nigeria, and repeat reinfection of Afghanistan from Pakistan
[38]. Moreover, the metapopulation structure of WPV demonstrates that preventing
emigration of WPV from source populations—which may be highly localized—is a
requirement for efficient control.
We estimate that > 99% of infections were subclinical, with the reporting of to-
tal infections regularly below 1%. Importantly, subclinical infections are likely more
common today than in our fitted models. This is because, first, both non-paralytic
and AFP cases were reported in the US, whilst only AFP cases are currently reported.
Second, our models were fit to data during the vaccine-free period of polio endemic-
ity; therefore, infection incidence was elevated each summer, allowing the number
of infections to grow sufficiently large to result in a high probability of clinical in-
fections. In contrast, today, as polio’s reproductive number approaches Rt = 1 in
highly vaccinated endemic countries, WPV can circulate at levels below that needed
for likely clinical observation. The recovery of environmental WPV isolates in Israel
in the complete absence of AFP cases supports this expectation [38]. Furthermore,
Fig 4.6B demonstrates that polio may circulate silently for extended periods (i.e., > 3
years) if the number of infections remains below the threshold for likely detection.
Two years of silent WPV circulation has been confirmed. The outbreak in Central
Africa detected in October 2013 was traced back to WPV circulation in Chad during
2011 [44]. Populations expected to have a small number of monthly infections in the
presence of WPV—due to their demography or because they are highly vaccinated—
would therefore be desirable targets for intense environmental surveillance. In terms
of information gained, environmental surveillance is a powerful tool for identifying
silent transmission in locations where polio would otherwise go undetected. In Pak-
istan the level of environmental surveillance has increased since 2011, and WPV has
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consistently been detected, even in the absence of AFP cases [45].
In the absence of validated transmission models, case data are relied upon to
determine whether a pathogen has gone locally extinct and estimate the critical com-
munity size required for pathogen persistence. In light of polio’s propensity for silent
circulation, we conclude that AFP data can be misleading; this conclusion extends to
any communicable disease in which clinical cases represent a small fraction of infec-
tions. Extended periods absent of reported cases can mask infections circulating at
levels below the threshold for likely reporting. We therefore advocate fitting trans-
mission models to contemporary data to draw inference regarding extinction. Since
infection can persist even in the extended absence of reported cases, knowledge of the
local infection dynamics could reveal invaluable epidemiological information. Trans-
mission models fit to endemic countries (i.e., Pakistan, Afghanistan, and Nigeria)
could be used to identify how demographic and environmental factors interact with
vaccine coverage to determine regional WPV persistence. In addition to coupling case
data with transmission models for endemic countries, another useful extension would
be to combine genetic data from WPV isolates with transmission models to further
distinguish between sustained local transmission and imported infection. Genetic
studies have found reductions in WPV genetic diversity in Afghanistan, suggesting
local extinction of some WPV strains [6].
Vaccination campaigns might take further advantage of the seasonality and geo-
graphic clustering of WPV’s reproductive ratio. Low transmission season vaccination
campaigns have been utilized by the GPEI [6]. We found that the “low season” repro-
ductive ratio can have geographic clusters where the reproductive ratio is > 1, which,
if identified in the contemporary setting, might be useful targets for intense low season
vaccination campaigns. Additionally, if the (1) seasonal reproductive ratio, (2) birth
seasonality, and (3) vaccine coverage are quantified for endemic countries, vaccination
campaigns could use this information to determine the regionally-optimal timing for
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national vaccination days. These three quantities could be used to estimate the sea-
sonal effective reproductive number, and evaluate alternative vaccination strategies.
For instance, one strategy might be to extend the duration of the wintertime trough
(i.e., by generating or extending the window during which the effective reproductive
number is < 1), which may push WPV to extinction. Alternative strategies might be
to vaccinate in the months prior to the seasonal peak in transmission or six months
following the peak in births. In the past, mass OPV campaigns held during the
low transmission season were deemed “most effective” [46], but it is unclear to what
extent this strategy is used today.
Historical data, particularly in pre-vaccine periods, offer a unique glimpse into the
ecology of infection, in the relative absence of human intervention. Historical data
offer several advantages. First, reporting rates from historical eras are informative
because they are reflective of (a) the symptomatology of infection, and (b) clinical
diagnosis of symptomatic infection. Second, it can be difficult to infer unobserved
infection dynamics using data for diseases that are near their eradication or elimi-
nation threshold. This is because the parameterization of transmission models with
data containing few cases—and lacking recurrent epidemics—can result in ambiguous
parameter estimates. The recurrent nature of historical epidemics gives us the unique
opportunity to unravel disease-specific transmission ecology. Once the baseline trans-
mission ecology is known, it can be coupled with data from contemporary periods to
test hypotheses regarding modern-day epidemics and their geographic coupling.
Our analyses demonstrate the power of an approach focused on coupling mecha-
nistic transmission models with long-term, spatially replicated longitudinal incidence
data. Specifically, we document intriguing continental-scale gradients in polio sea-
sonality, which we suggest are explained by latitudinal gradients in local transmission
rates. We also show that the historical emergence of epidemic polio was largely a
consequence of demographic trends rather than improvements in hygiene. Impor-
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tantly, we demonstrate that historical polio persistence in the US was driven by an
ever changing arrangement of source-sink populations. Finally, we found that even
protracted AFP-free periods do not reliably indicate WPV extinction. Because of
the difficulty in establishing fundamental aspects of WPV transmission in heavily
vaccinated populations, it is our hope that these insights will act as a baseline for
understanding modern polio transmission and disentangling vaccine effects from the
natural ecology of the disease.
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CHAPTER V
Both Salk and Sabin Vaccines Effectively Reduce
Polio Transmission in Epidemic Settings
Abstract. Wild poliovirus (WPV) is on the brink of eradication worldwide. There
are two vaccines against polio, the Salk Inactive Polio vaccine (IPV) and the Sabin live
Oral Polio vaccine (OPV). OPV is the primary weapon of the Global Polio Eradication
Initiative (GPEI) and is employed throughout the developing world. Unfortunately,
OPV has a serious drawback: reversion of the live attenuated virus to a pathological
form that can result in circulating vaccine derived poliovirus [1, 2]. In this way, OPV
acts as a source of poliovirus, and although OPV has been able to push WPV near
the eradication threshold, it cannot be used for complete eradication. For this reason,
OPV will be withdrawn and IPV re-introduced. The GPEI is now faced with deciding
where and when to withdraw OPV and introduce IPV. However, this decision is being
made in the face of great uncertainty regarding the efficacy of IPV at reducing polio
transmission [3, 1]. If IPV fails to induce herd immunity in endemic countries, the
premature withdrawal of OPV could lead to the resurgence of polio. Here, we use
the initial launch of IPV and OPV in the US and the USSR to measure the extent
that IPV and OPV reduce WPV transmission. We conclude, relative to unvaccinated
individuals, infected OPV and IPV vaccinated individuals transmit WPV 96% and
69% less, respectively; suggesting that IPV could be used to eradicate polio in regions
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with an off-season WPV reproductive number ≤ 3.
Polio from Past to Present
WPV is enigmatic for causing paralytic polio in a small fraction of infected indi-
viduals. Due to intense global vaccination efforts, WPV is on the brink of eradication
worldwide with only three remaining endemic countries (Pakistan, Afghanistan, and
Nigeria). There are two polio vaccines that were licensed in the 1950s and 1960s,
IPV and OPV, also known as the Salk and Sabin Vaccines, respectively. Most coun-
tries have eradicated polio using OPV, with the exception of Scandinavia and the
Netherlands, which used IPV [4]. OPV is the primary eradication tool for several
reasons: (1) OPV stimulates intestinal immunity by mimicking a natural infection
and generating a secretory IgA response that reduces viral shedding, (2) OPV con-
tains attenuated live virus that replicates in vaccinated individuals who then shed
attenuated virus and indirectly vaccinate others, and (3) OPV is inexpensive and
easily administered as oral drops or candy [3, 5]. IPV, on the other hand, is an in-
jectable vaccine that contains inactive virus killed using formalin [6]. The killed virus
in IPV does not establish infection within vaccinated individuals. A recent trial of
OPV vaccination followed by an IPV dose demonstrated that IPV can boost mucosal
immunity [5]; however, it is unknown whether IPV alone can stimulate enteric mu-
cosal immunity and reduce transmission, or if it merely stimulates humoral immunity
and protects from paralytic polio [3, 5]. It is widely recognized that OPV provides
superior protection from WPV infection and reduces transmission; however, OPV has
a serious drawback. The attenuated virus in OPV can undergo recombination with
other enteroviruses or can acquire point mutations and revert back to a pathologi-
cal form, known as vaccine-derived poliovirus [7, 8]. Estimates of the frequency of
vaccine-derived poliovirus vary. Generally, it is estimated that 1–2 cases of paralytic
polio arise per million primary OPV immunizations administered [2]. In these rare
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cases, the vaccinated individual acquires a paralytic vaccine-derived poliovirus infec-
tion that can be transmitted [1]. In this way, OPV acts as a source of poliovirus, and
although OPV has been able to push WPV near the global eradication threshold,
it cannot be used for complete eradication. For this reason, the 2013–2018 GPEI
action plan calls for the complete withdrawal of trivalent OPV, and subsequently, a
gradual withdrawal of bivalent OPV and introduction of IPV [9]. The GPEI is faced
with deciding where and when to withdraw OPV and introduce IPV while WPV
continues to circulate. It is unknown whether IPV has the ability to push WPV to
extinction in endemic regions because there is a lack of information on the extent to
which IPV reduces WPV transmission. Here, we utilize extensive longitudinal data
on poliomyelitis incidence and vaccination status of the population of the US and the
USSR in the 1950s and 1960s to estimate the population-level impact of IPV and
OPV on transmission of WPV.
Early in the 1900s polio became an epidemic disease in industrialized nations.
In the US, the incidence of polio increased steadily throughout the 1900s until the
sequential development of IPV and OPV. In the US alone, the unprecedented magni-
tude of polio epidemics in the 1950s resulted in > 10000 clinical cases and millions of
subclinical infections annually [10]. The majority of clinical cases were concentrated
in school-aged children [2]. Due to this age-structure, when the polio vaccines were
introduced, which first occurred in the US (for IPV) and USSR (for OPV), preference
was given to school-aged children and individuals under 20 years old [11, 12, 13]. In
order to gauge the safety and success of the massive polio immunization campaigns in
the US and USSR, the US launched the Poliomyelitis Surveillance Unit (PSU) at the
Centers for Disease Control and Prevention (CDC) [14]; at the same time, the USSR
Poliomyelitis Research Laboratory tracked the USSR’s intense OPV vaccination cam-
paigns and clinical cases. Detailed data from these surveillance units provided the

































































































Figure 5.1: MMWR and NOVS data. (a) MMWR data, polio cases per 100000
population in the contiguous US from January 1933–December 1969. (b)
Births per 1000 population over the same time period. (c) NOVS data,
polio cases for which symptomatology was classified as paralytic or non-
paralytic; this is a subset of the cases in MMWR, all others were unspec-
ified.
demic polio. Here for the first time, we curated data detailing the roll-out of IPV
and OPV in the US and USSR, combined it with clinical case data and mathematical
transmission models, and measured the efficacy of IPV and OPV at the population
level.
The race to develop a polio vaccine resulted in the development of IPV by Jonas
Salk and OPV by Albert Sabin. Placebo-controlled IPV trials were run by the Univer-
sity of Michigan and included the vaccination of over 700000 children [15], resulting
in IPV licensing in April 1955. Once licensed, IPV was quickly launched throughout
the US. Initially IPV was given to 2nd grade children but the program was rapidly
expanded to include all children and young-adults [16, 17]. OPV followed at the
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heels of IPV. The vaccine trials for OPV were held in the USSR. In September 1958
Albert Sabin provided the USSR with virus seeds for the three attenuated poliovirus
serotypes. The USSR used these seeds to culture the viruses in monolayer monkey
kidney cells. The USSR immediately cultured enough of each serotype to vaccinated
10 million people. The first cycles of immunization were conducted January–March
1959. The USSR held the first mass immunization campaigns with OPV in Estonia
and Lithuania. On December 16, 1959 the USSR approved widespread vaccination
with OPV, and vaccinated individuals 2 month olds to 20 years old. This involved
vaccinating 35% of total population, 77 million people, between January and June
1960. OPV was administered via Pomadka-Candy, which allowed for easy dissem-
ination [11, 12]. The US sequentially licensed each monovalent OPV and licensed
trivalent OPV in 1963. After the World Health Organization reviewed the details
and design of the USSR’s OPV trials and confirmed their success, OPV became the
vaccine of choice in the 1960s [18]. By 1969 OPV was more widely used in the US
than IPV. In order to estimate IPV and OPV efficacy, we focused on data detailing
the introduction of IPV in the US and the introduction of OPV in three regions of
the USSR: Estonia, Lithuania, Ukraine, and the Russian Soviet Federative Socialist
Data
Since the early 1900s, polio cases were regularly recorded in the US Weekly Public
Health Reports and the CDC Morbidity and Mortality Weekly Reports. We obtained
monthly reported polio cases in the US from January 1933–December 1969 from the
US CDC. We refer the reader to [10] for our baseline analyses of polio transmission
ecology in the US. We will refer to the US monthly polio data as the “MMWR
data” (Fig 5.1a). Beginning in 1951, the National Office of Vital Statistics (NOVS),
which collected the MMWR data, allowed symptomatology to be classified in case
reports. Cases could be reported as paralytic or non-paralytic polio, but many cases
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were unspecified. We obtained the subset of cases for which symptomatology was
provided, which we will refer to as the “NOVS data” (Fig 5.1c). The NOVS data are
annual from 1951–1965.
In addition to the MMWR and NOVS data, we digitized independent polio case
data collected by the CDC PSU and housed at the CDC library. The PSU was a
task force commissioned to gather detailed data on polio cases following the launch
of IPV in 1955 [14]. PSU data were collected independent of the MMWR and NOVS
data; because of this, not all cases represented in MMWR were included in PSU
data, and vice versa. The PSU data are annual from 1958–1965 and detail polio cases
by age, vaccine status, and symptomatology (Fig 5.2). The NOVS and PSU data
both classify cases as either paralytic or non-paralytic. The interpretation of non-
paralytic polio cases has always been problematic due to the lack of a consistency
in the clinical definition. There are two broad clinical definitions that have been
used to classify non-paralytic polio. Some authors define non-paralytic polio as a
symptomatic infection that lacks signs of central nervous system (CNS) involvement;
others define non-paralytic polio as an infection with CNS involvement that does not
result in paralysis. Those that use the latter definition generally place symptomatic
infections lacking CNS involvement into another category known as abortive polio
[19]. Inconsistency in the definition of non-paralytic polio requires acknowledgement
when interpreting polio case reports. We acknowledge that although paralytic polio
is a well-defined clinical manifestation of infection, non-paralytic polio is more of a
“catch-all” category for clinical WPV infections that do not manifest as acute flaccid
paralysis (AFP). All together, we have obtained three polio data sets from the US
(i.e., monthly MMWR data, annual NOVS data, and annual PSU data), which we
couple with complementary vaccination and demography data.
The PSU not only collected polio case data, but—along with the newly formed
National Immunization Survey—also collected data on the distribution of polio vac-
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Figure 5.2: PSU Data. Cases reported to the Poliomyelitis Surveillance Unit de-
tailed by vaccine status and symptomatology. Individuals with the full
3+ dose series of IPV or OPV are indicated by IPV3+ and OPV3; un-
vaccinated and under-vaccinated individuals are indicated as IPV3- or
OPV3-; “ukn” indicates unknown vaccine status. Symptomatology is di-
vided into two categories: (a) paralytic or (b) non-paralytic polio.
cines and age-structured vaccine coverage with IPV and OPV. We digitized PSU
vaccine data which included quarterly shipments of IPV in the US, annual shipments
of monovalent and trivalent OPVs, and the annual percent of individuals in five-year
age groups that have 0, 1, 2, 3, or 4+ doses of IPV, OPV, or combined IPV and
OPV (Figs 5.3 & 5.4). In addition to the disease and vaccine data, we also gathered
demography data for the US that included monthly births (Fig 5.1b), which were an
important determinant of polio incidence [10], and annual population size estimates
from the US Census Bureau.
For the USSR, we digitized monthly polio cases reported in Lithuania and Esto-
nia from January 1955–December 1960. The data were digitized from the Institute
for Poliomyelitis Research, Academy of Medical Sciences, Moscow, USSR. Data re-
ported in the Bulletin of the World Health Organization 1961, vol 25, pp 79–91 [13].
Mass immunization with OPV in Lithuania and Estonia occurred in the early part of
1959 and was repeated in the second quarter of 1960. The population sizes were ∼
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Figure 5.3: Age structured population size and polio vaccine coverage in the
US. (a) Annual size of childhood age classes. (b) Percent of children in
each age group with 3+ doses of IPV. (c) Percent of children with 3 doses
of OPV.
2700000 for Lithuania, and ∼ 1200000 for Estonia. By December 1959, the estimated
number of persons vaccinated in Lithuania and Estonia was 547000 (20% of popu-
lation) and 695000 (58%), respectively. By December 1960, the estimated number
of persons vaccinated in Lithuania was 1760000 (65%), and Estonia 827240 (69%).
Monthly paralytic polio cases reported in the RSFSR and Ukraine were obtained
from a shorter time period, January 1957–December 1960. The data were originally
reported as incidence per 100000. The population size was ∼ 119603000 for the RS-
FSR, and ∼ 42606000 for Ukraine. By December 1959, only 3310000 people (2.8% of
the population) were vaccinated in the RSFSR and 2378000 (5.6%) in Ukraine. How-
ever, by December 1960, the estimated number of persons vaccinated in RSFSR was










































































































































Figure 5.4: Distribution of IPV and OPV during the roll-out in the US.
(a) Cumulative distribution of IPV in the US. Data are quarterly from
1955–1961, after which they are annual. (b) Cumulative distribution of
OPV monovalent type I, II, and II, and trivalent OPV.
were given three times in 1960 and subsequently trivalent OPV was used for revacci-
nation. In some regions of Ukraine, trivalent vaccine was administered twice; and in
the remaining regions of Ukraine, monovalent vaccines were administered separately
and trivalent was used for revaccination.
Transmission Model
We constructed a stochastic discrete-time Susceptible-Infected-Recovered polio
transmission model that explicitly accounted for vaccine status. A pre-vaccine version
of this transmission model was previously validated for studying polio transmission
[10]. The model includes classes to track individuals with 3+ doses of IPV and/or
3 doses of OPV. In the PSU data we observed polio cases in vaccinated individuals
(Fig 5.2); therefore, we allowed for infection of, and transmission by, vaccinated indi-
viduals. For vaccinated individuals, we estimated their (i) susceptibility to infection
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Figure 5.5: Polio cases in the USSR. Monthly polio cases reported in (a) Lithua-
nia, (b) Estonia, (c) RSFSR, and (d) Ukraine, along with the percent of
the population vaccinated with OPV (white points). OPV was first intro-
duced in Lithuania and Estonia, where vaccine coverage reached > 60%
in the second year of vaccination. As of December 1959, only 2.8% of
population was vaccinated in the RSFSR and 5.6% in Ukraine. However,
by December 1960, the reported vaccination coverage in the RSFSR was
36% and 33% in Ukraine.
(a measure of vaccine leakiness), and (ii) infectiousness, relative to unvaccinated in-
dividuals. The model was constructed in order to infer (a) the mode of vaccine action
(i.e., whether each vaccine reduces susceptibility to infection, reduces infectiousness,
and/or protects against pathology), and (b) vaccine efficacy (i.e., the total amount
that each vaccine reduces transmission). Fig 5.6 shows the structure of the transmis-
128
Figure 5.6: Vaccine era polio transmission model. (a) Schematic model of polio
transmission and vaccination. The model has two vaccinated categories,
IPV and OPV, which include individuals with 3+ doses of IPV and 3 doses
of OPV, respectively. The model categorizes infections by vaccine status
and symptomatology (i.e., paralytic and non-paralytic polio). (b) The
timeline of polio in the US and USSR, epidemic periods are indicated
along with the roll-out of IPV and OPV in each country. In the US,
monovalent OPVs were licensed and used for epidemic response before the
switch from IPV to OPV for immunization in April 1963 when trivalent
OPV was licensed.
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sion model. In the absence of IPV and/or OPV in a country or region, the IPV and
OPV classes and their downstream classes are empty. In addition to the epidemiolog-
ical process model, we also included a parallel model to track the vaccine coverage in
the US and each of the four regions in the USSR. This was necessary because ∼ 99%
of polio infections are subclinical [10]; therefore, individuals vaccinated may already
have naturally-derived immunity, making it tenuous to directly use the susceptible
class from the epidemiological model to infer vaccine uptake rates from the vaccine
coverage data. The vaccine tracker model for the US tracked entry and exit from the
under 15 age group via births, deaths, and aging, and it is in this pure demography
model that we account for IPV and OPV vaccination. By fitting the vaccine tracker
model to the IPV and OPV coverage data, we obtained per capita vaccination rates
for the under 15 year age group, which we then applied to our susceptible class in
the epidemiological process model. We used a similar vaccine tracker model for each
region of the USSR, but in the USSR we tracked OPV coverage for all age groups.
All statistical inference was done using maximum likelihood by iterated particle
filtering (mif) in the R package pomp [20]. Our statistical inference pipeline is dis-
cussed in detail in the Appendix. For the US and each region in the USSR, we fit
the data independently and sequentially in the following order: we (1) fit polio trans-
mission parameters and report rates to the pre-vaccine era case data, (2) fit the per
capita vaccine uptake rates to the vaccine coverage data, and (3) fixed the maximum
likelihood estimate (MLE) transmission parameters, report rates, and vaccine uptake
rates in the model and fit the vaccine efficacy parameters to the vaccine era data.
The NOVS data from the US allowed us to estimate the probability of paralytic
and non-paralytic polio pathology. We estimated the probability of unvaccinated
individuals having paralytic or non-paralytic polio upon infection, and we assumed
these parameters are determined by host-pathogen biology and hold in both the US
and USSR. For each region in the USSR (i.e., Estonia, Lithuania, Ukraine, and the
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RSFSR), transmission parameters were fit to the USSR pre-vaccine era data, the
paralytic and non-paralytic probabilities were taken from our US estimates, but the
report rates of symptomatic polio infections were estimated for each region in the
USSR.
We fit IPV efficacy parameters by simultaneously fitting the model to the US
MMWR data and the NOVS data from January 1955–December 1962, the end of
the IPV era in the US. One difficulty of studying vaccine efficacy in the US is that
by the time OPV was fully rolled-out in the US in 1963, the incidence of polio was
already low because IPV had been in use for 8 years. Additionally, as the vaccine era
progressed in the US, the breakdown of reported cases in the PSU data signaled a
reduction in reporting of non-paralytic polio, reducing the reported cases even further.
The small number of reported cases during the OPV era in the US, and uncertainty
regarding the stationarity of reporting, left us with little data with which to estimate
OPV parameters; therefore, we took advantage of the OPV roll-out in the USSR to
study OPV efficacy.
We fit OPV efficacy parameters to the paralytic polio data from the RSFSR.
The RSFSR was specifically chosen because it reported only paralytic polio cases.
The PSU data from the US reported paralytic polio in OPV vaccinated individuals,
but never reported a non-paralytic case in an OPV vaccinated individual; we do not
know if this is because OPV protects from the non-paralytic polio or if this is due to
reporting bias. With no way of knowing whether the former or the latter was the case,
we left non-paralytic infections in OPV-vaccinated individuals out of the model and
used only paralytic polio cases when fitting OPV efficacy parameters. The observation
model for each country/region is schematically depicted in Fig 5.7. The process
model state variables that fed into the observation models included paralytic and
non-paralytic polio infections in (1) unvaccinated or under-vaccinated individuals, (2)
individuals fully vaccinated with 3+ doses of IPV, and (3) individuals fully vaccinated
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with 3 doses of monovalent OPVs or trivalent OPV. The observation models linked
observable state variables with the data from each country/region. In the US, the
full observation model allowed for observations in the MMWR, NOVS, and PSU data
as depicted in Fig 5.7. However, due to computational limits on calculating joint
likelihoods for 3+ time series simultaneously, a nested observation model for the US
that only included the MMWR and NOVS data was used for fitting IPV efficacy.
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Figure 5.7: Polio observation models for the US and USSR. The observa-
tion models detail how symptomatic infections from the process model
(turquoise and orange ovals) were reported in the (a) US via cases in the
MMWR, NOVS, and PSU data sets, (b) Estonia and Lithuania, and (c)
the RSFSR and Ukraine. In the US, the process model state variables
that fed into the observation model were paralytic and non-paralytic in-
fections broken down by vaccine status, either on a monthly or annual
basis. The full US observation model is shown in (a); however, a nested
version that includes only the MMWR and NOVS data was used for fit-
ting IPV efficacy parameters. For Lithuania and Estonia, the observable
state variables were the monthly number of non-paralytic and paralytic
infections broken down by OPV status, assuming OPV protects from
non-paralytic polio. For the RSFSR and Ukraine, the observable state
variables were the monthly number of paralytic polio infections by OPV
status. Subscripts indicate individuals with IPV3+ or OPV3 doses, lack
of subscripts indicate unvaccinated/under-vaccinated individuals.
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Results
Patterns in the US
The incidence of polio in the US displayed strong seasonality, with epidemics
occurring in the late summer and autumn (Fig 5.1). The transmission rate MLEs
for the US were 1.1 during the seasonal trough and 7.5 during the peak (Fig 5.8).
There is a great deal of geographic variation in transmission seasonality in the US
[10]; thus, the MLEs from the national data represent an aggregate estimate. The
seasonality persisted during the IPV era, but dissipated after the introduction of OPV
(Fig 5.1). Figures 5.1 & 5.2 show the dramatic decline in polio incidence following the
introduction of IPV and OPV. In the 8 years preceding the introduction of IPV, April
1947–March 1955, there were 274719 reported polio cases in the MMWR, as compared
to the 69608 reported cases during the 8 year IPV era, April 1955–March 1963.
Although the incidence of polio had already declined substantially when trivalent
OPV was introduced in April 1963, during the first 5 years of the OPV era, the
number of reported cases was 645, which was 3.3% of the number reported in the
previous 5 years, and 0.3% of those reported the last 5 years of the pre-vaccine
period. The NOVS data demonstrate that paralytic polio comprised more of the
reported cases than non-paralytic polio, this is likely due to the high report rate of
paralytic polio, which other studies estimated to be 60–80% in the US at this time
[21]. The breakdown of reported cases by vaccine status in the PSU data revealed
that paralytic polio was regularly reported in individuals with 3+ doses of IPV, but
unvaccinated and under-vaccinated individuals (i.e., IPV3- and OPV3-) represented
the largest number of paralytic polio cases.
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Patterns in the USSR
The USSR displayed epidemic seasonality similar to that in the US. Epidemics
occurred in the summer and autumn (Fig 5.5). However, with the exception of
Estonia, one noticeable difference between the epidemics in the US and those of the
USSR is that the off-season trough in cases is shallow in the USSR relative to the US
cases. This suggests the USSR maintained WPV infections at a higher level during
the wintertime off-season. This is supported by the estimates of the transmission
seasonality in the USSR (Fig 5.8). The seasonal minimum reproductive number was
estimated to be 21, 3, 3, and 2 for Lithuania, Estonia, the RSFSF, and Ukraine,
respectively. The seasonal maximum reproductive numbers were 63, 53, 8, and 7.
The seasonal peak reproductive numbers for Lithuania and Estonia > 50 are on
the level of that observed in the US Midwest, where explosive epidemic dynamics
occurred. However, the shallow trough in Lithuania, with a reproductive number of
21 is far above that estimated in any other location to date [10]. Interestingly, the
transmission rates for Ukraine and the RSFSR are similar to US estimates, with the
exception that the RSFSR and Ukraine both had a shoulder in the transmission rate
at the turn of the year.
Vaccine-induced reduction in polio incidence was observed across the USSR. Fig 5.5
shows monthly cases of polio in the USSR before and after the introduction of OPV.
Vaccine coverage in Lithuania and Estonia was >60% within the first two years of
OPV introduction. Seasonal epidemics were observed in both Lithuania and Estonia
prior to OPV introduction, and these epidemics were lost immediately following the
introduction of OPV. In the RSFSR and Ukraine, the widespread introduction of
OPV was delayed a year after its roll-out in Estonia and Lithuania. Because OPV
was introduced later, vaccine coverage in the RSFSR and Ukraine was lower as of
December 1960, 36% and 33%, respectively. Based on the data obtained from the
RSFSR and Ukraine, the incidence of paralytic polio declined during the first 2 years
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Figure 5.8: MLEs of the seasonal transmission rate. Rates for the (a) US, (b)
Lithuania and Estonia, and (c) RSFSR and Ukraine. The transmission
rate parameters were estimated using the pre-vaccine era data. For the
USSR, the transmission rate equates to the reproductive number.
We used one-month-ahead predictions to validate our MLEs of polio transmission
parameters. Fig 5.9 shows one-month-ahead predictions for the US, and Fig 5.10
shows the predictions for each region of the USSR. We used data from the pre-
vaccine era for fitting and validating transmission parameters. In the US, the com-
bined MMWR and NOVS data were used to estimate the probability of paralytic and
non-paralytic polio in unvaccinated infected individuals, as opposed to subclinical
symptoms or silent infection. Under the assumption that the report rate of paralytic
polio was between 60–80% [21], we estimated that the probability that an unvacci-
nated infected individual was paralyzed by poliovirus was 0.008 and the probability
of non-paralytic polio was 0.05. Taken together with the ambiguity in the clinical
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definition of non-paralytic polio, these estimates suggest that ≤ 5.7% of individuals
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Figure 5.9: US pre-vaccine data and one-month-ahead predictions from the
MLE. (a) Monthly MMWR polio cases and model predictions. (b) An-
nual NOVS polio cases that were classified as paralytic or non-paralytic
polio, along with model predictions. One-month-ahead predictions are
particle filtering prediction means.
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Figure 5.10: USSR pre-vaccine data and one-month-ahead predictions from
the MLE. Monthly polio cases and one-month-ahead predictions for
(a) Lithuania and (b) Estonia. Paralytic polio cases and one-month-
ahead predictions for (c) the RSFSR and (d) Ukraine. One-month-ahead
predictions are particle filtering prediction means.
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IPV Mode of Action & Efficacy
In order to fit IPV efficacy parameters, we first estimated monthly per capita
vaccine uptake rates for the US population under 15 years of age. Fig 5.11 shows
the MLE vaccine coverage fit simultaneously to four time series of vaccine coverage:
IPV3+ coverage, OPV3 coverage, dual IPV3+ and OPV3 coverage, and the percent
of the under 15 age group with less than 3 doses of each vaccine. In accordance with
the cumulative vaccine distribution data in Fig 5.4, we assumed a linear increase
in IPV coverage from 1955–1958, years for which we lacked vaccine coverage data.
We expected trends in cumulative vaccine distribution to be a good proxy for trends
in vaccine coverage, because vaccine coverage is the cumulative percent of children
vaccinated. Using the IPV era data from April 1955–December 1962, the MLE vaccine
uptake rates, and the MLE transmission parameters, we estimated the mode of action
and efficacy of IPV.
The IPV modes of action we tested were reductions in (1) susceptibility to WPV
infection, (2) transmission by infected vaccinated individuals (i.e., infectiousness),
(3) the probability of paralytic polio, and (4) the probability of non-paralytic po-
lio. Modes 1 and 2 act by reducing WPV transmission in the population and could
generate herd immunity. In contrast, modes 3 and 4 are effects on the pathological
consequences of infection, which would protect the individual vaccinated, and reduce
the observation of polio as a disease, but would not reduce transmission of WPV.
The efficacy of IPV was taken as the overall reduction in WPV transmission by IPV,
which we measured as the product of IPV’s effect on susceptibility and infectiousness.
All IPV parameters were estimated using the IPV era data from the US.
Our results indicate that IPV reduces polio transmission at the population-level
by reducing susceptibility and infectiousness, either alone or in combination. Due to
tradeoffs between parameter estimates for susceptibility and infectiousness (Fig 5.12a),
































































































Figure 5.11: US MLE vaccine coverage. Vaccine coverage based on MLE vaccine
uptake rates fit to the vaccine coverage data for the 1–14 year old age
group.
(i.e., by preventing the establishment of infection) or by reducing infectiousness (i.e.,
by reducing the duration or amount of viral shedding). To deal with this tradeoff,
we assumed that IPV effectively acts by reducing infectiousness, rather than suscep-
tibility. This assumption is supported by clinical data which suggest IPV does not
reduce the odds of the establishment of infection upon poliovirus challenge, but IPV
can reduce the quantity of virus shed and the duration of shedding [3]. Under this
assumption, we profiled IPV efficacy and estimated that IPV efficacy is 69% (95%
CI 67–74%), meaning that IPV reduces transmission to 31% of the natural level
(Fig 5.12b). We also estimated that IPV reduces the probability of paralytic polio
by 75% and reduces the probability of non-paralytic polio by 99%. However, we have
not measured the level of uncertainty in the latter two parameters. Taken together,
these results suggest that IPV acts via multiple modes to reduce both transmission
and pathology.
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We used hindcasting to validate our estimate of IPV efficacy. Specifically, we
used the fitted model to conduct December-to-December predictions of the MMWR
and NOVS data. The December-to-December predictions tested the power of the
model to predict “the next year’s epidemic”. The December-to-December predictions
(Fig 5.13) demonstrated that the model predicts the decline in polio cases driven by
the roll-out of IPV. However, the predictions usually underestimate the number of
cases in both the MMWR and NOVS data, suggesting that our estimates are nearby,
but are not, the true MLEs. We speculate that the under-predictions are due to
overestimating the reduction in the paralytic and non-paralytic probabilities. If this
is the case, profiling the reduction in the paralytic and non-paralytic probability will
improve model fit.
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Figure 5.12: IPV efficacy. (a) Tradeoff in IPV efficacy parameters observed dur-
ing the inference process. The parameters measured the susceptibility
to infection of IPV3+ individuals, relative to unvaccinated individuals,
and the infectiousness of IPV3+ individuals, relative to unvaccinated
infected individuals. The tradeoff is such that there is ridge in the like-
lihood surface and the product of the IPV parameters is well identified.
(b) Due to the tradeoff between the IPV efficacy parameters we fixed
the susceptibility to infection of IPV3+ individuals to ∼ 1 (meaning
IPV does not reduce susceptibility) and estimated the infectiousness of
IPV3+ individuals. We used the MMWR and NOVS data from the IPV
era for profiling because it became computationally infeasible to use the
PSU data (see Appendix). We estimated IPV infectiousness to be 0.31.
Thus, IPV reduces transmission by 69% (95% CI 67–74%). In (a) we in-
dicate the IPV efficacy ridge tracing the MLE at 0.31 (turquoise dashed
line).
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Figure 5.13: IPV efficacy, one year ahead predictions for the US. IPV efficacy pa-
rameters were fit to the MMWR and NOVS data up to December 1962. Using
the MLE for IPV efficacy, a particle filter was run to December of each year
and use to simulate forward through the next year to predict epidemic tra-
jectories. The December-to-December predictions were done simultaneously
for (a) MMWR data, (b) paralytic polio reported to NOVS, and (c) non-
paralytic polio reported to NOVS. December-to-December predictions tested
the ability of the model to predict the next year’s epidemic. In general, the
model under-predicted the number of cases, suggesting that we are nearby,
but have not yet reached the true MLE.
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OPV Mode of Action & Efficacy
The modes of action tested for OPV were reduction in (1) susceptibility to WPV
infection, (2) transmission by infected OPV vaccinated individuals, and (3) the prob-
ability of paralytic polio. All OPV parameters were inferred using paralytic polio data
from the RSFSR and then were independently validated by predicting the reduction
in polio cases in Lithuania, Estonia, and Ukraine following the introduction of OPV.
Since we anticipated a tradeoff in estimates of OPV efficacy parameters, as was the
case for IPV, we first profiled relative susceptibility, assuming full infectiousness, and
vice versa. We then profiled along all three modes of action.
In the RSFSR, we created a two-dimensional likelihood profile of OPV3 rela-
tive infectiousness and OPV3 relative paralytic probability (Fig 5.14 top), and a
two-dimensional likelihood profile of OPV3 relative susceptibility and OPV3 rela-
tive paralytic probability (Fig 5.14 bottom). For both profiles we let mif estimate
the OPV vaccine uptake rate. Using the MLE vaccine uptake rate from the two-
dimensional profiles, we then produced a 50x50x50 three-dimensional profile of OPV
relative susceptibility, infectiousness, and paralytic probability, by calculating likeli-
hoods at all 125000 profile points. We identified the MLE OPV efficacy from the
three-dimensional profile (Fig 5.15a). The MLE OPV efficacy was 0.04, indicating
that OPV reduces polio transmission by 96%. Interestingly, the MLE for OPV rel-
ative susceptibility was 1, and infectiousness was 0.04, indicating that OPV acts by
reducing infectiousness, rather than susceptibility. The OPV relative paralytic prob-
ability was 0.67, suggesting that OPV does reduce the probability of paralysis. We
used one-step-ahead predictions in the RSFSR to validate OPV efficacy (Fig 5.15b).
The one-step-ahead predictions captured the reduction in paralytic polio following
the introduction of OPV; however, the model tended to overestimate the number
of cases. We anticipate that higher resolution profiling will result in a MLE with a
reduced OPV paralytic probability and a better fit to the vaccine era data.
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We conducted independent validation of OPV efficacy by deploying the OPV
efficacy MLE in the models for Lithuania, Estonia, and Ukraine. The independent
validation was able to predict the decline in polio incidence in Lithuania, Estonia,
and Ukraine (Fig 5.16). Once again the model often over-predicted the number of
polio cases in the presence of OPV. We believe this discrepancy can be overcome with
higher resolution profiling of OPV efficacy and the reduction in paralytic probability.
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Figure 5.14: OPV efficacy 2D profiles. The RSFSR was used to estimate OPV
efficacy parameters. Two dimensional likelihood profiles of (top) the re-
duction in infectiousness caused by the full 3 dose series of OPV, relative
to unvaccinated individuals, and the reduction in the paralytic proba-
bility. Top profile assumes that OPV does not reduce susceptibility.
(bottom) The reduction in susceptibility to infection and the reduction
in the paralytic probability. The bottom profile assumes OPV does not
reduce infectiousness. The relative infectiousness of OPV individuals
seems to be well identified in the top profile, but the bottom profile
is relatively flat, and low likelihood, suggesting that we cannot assume
OPV does not reduce infectiousness.
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Figure 5.15: OPV efficacy 3D profile. The RSFSR was used to estimate OPV
efficacy parameters. A three dimensional 50x50x50 likelihood profile of
the reduction in infectiousness caused OPV, the reduction in susceptibil-
ity, and the reduction in the paralytic probability was created. Plotted
in (a) the log likelihood of OPV efficacy across the profiled range. We
measured efficacy by taking the combined effect of OPV on susceptibil-
ity and infectiousness. The MLE efficacy of 96% is indicated in green.
The OPV efficacy MLE was then validated using (b) one-month-ahead
predictions. The white line is the vaccine coverage based on the MLE
uptake rate.
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Figure 5.16: Independent validation of OPV efficacy. The OPV efficacy MLE
from the RSFSR was used to predict out-of-fit, the cases in (a) Lithuania,
(b) Ukraine, and (c) Estonia.
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Discussion
Using detailed data on polio incidence and the roll-out of IPV and OPV in the
US and USSR, we estimated the efficacy of IPV and OPV. In line with clinical trial
data and the eradication experience [3, 4], we found that OPV is superior to IPV in
reducing polio transmission. Our fitted models indicate the full 3+ dose series of IPV
reduces WPV transmission by 69%, relative to unvaccinated individuals. OPV, on
the other hand, reduces transmission by 96%. We found that IPV reduces transmis-
sion by either reducing susceptibility to infection or by reducing the infectiousness
of vaccinated individuals. Due to uncertainty regarding IPV’s mode of action, we
assumed IPV reduces infectiousness, rather than susceptibility. The basis for this
assumption is that multiple clinical studies have found that IPV does not reduce the
odds of infection and shedding, but reduces the quantity of virus shed in stool by
63–91%. Our estimated 69% reduction in transmission suggests that viral shedding
is an indicator of infectiousness. Clinical data also indicate that IPV decreases the
infectious period; however, due to the monthly structure of our model we were unable
to test shorter infectious periods.
The infectiousness of OPV vaccinated individuals was 0.04, relative to unvac-
cinated individuals. Importantly, the 96% reduction in transmission we estimated
matches clinical trials that found that the odds of OPV individuals shedding virus
after infection challenge was 0.13 [3]. The consistency between our IPV and OPV
efficacy estimates and the clinical trial data suggests that the individual-level efficacy
trials directly translated to reductions in transmission measured at the population-
level. In addition to effects on transmission, we also have an indication that IPV
reduces the probability of paralytic polio by 75% and the probability of non-paralytic
polio by 99%. Given the lack of reported non-paralytic polio in OPV3 individuals, we
assumed the full series of OPV offers complete protection from non-paralytic polio,
an assumption that requires further testing. As for paralytic polio, our MLE indi-
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cates that OPV reduces the probability of paralysis in infected individuals by 33%.
However, this is likely to change with refinement of the MLEs.
An important consideration for vaccine evaluation is how efficacy changes through
time. Mucosal immunity provided by OPV is known to wane over time [22]. Since our
inference was done using data from the initial roll-out of IPV and OPV, we did not
have the longer-term data necessary to evaluate waning vaccine-derived immunity.
However, if eradication is the goal, the waning of immunity over the course of several
years would be inconsequential if mass immunization raised “recent” vaccine coverage
high enough to hit the eradication target, and waning occurred post-eradication. In
other words, in the face of imperfect vaccines, globally-synchronized mass immuniza-
tion can be used to boost age groups, creating a honeymoon period with high levels
of immunity that could drive WPV to extinction.
Our profiles of IPV and OPV efficacy indicated that the reduction in transmission
provided by each vaccine was well identified. As previously mentioned, for IPV we
were unable to distinguish whether the mode of action was reduction in susceptibility
to infection, reduction in infectiousness, or both. The next step would be to fix the
infectiousness and estimate the susceptibility of vaccinated individuals. Due to the
strict tradeoff observed between IPV susceptibility and infectiousness in Fig 5.12, we
predict that the MLE for IPV efficacy will be ∼ 0.31, regardless of the mode of action.
We believe there is one parameter with the potential to affect our estimate of
IPV efficacy, and that is the immigration rate of infection. The immigration rate
was a parameter that accounted for introduction of WPV from regions outside the
US. Since the majority of WPV infections are silent or subclinical, the immigration
rate was included in the model to account for WPV introduction into the population
by the movement of people with subclinical infections. Given the large amount of
international travel into the US in the post-World War II era, we decided to include
immigration into the force of infection. The immigration rate was estimated along
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with the other epidemiological parameters in the pre-vaccine era. By profiling the
immigration rate (see Appendix), we found that the MLE was at the lower range
of our profile. Although immigration had a large impact on local polio epidemics
[10], it did not seem to have a substantial impact on the national-level epidemics
in the US. If we set immigration to zero, the pre-vaccine trajectories changed very
little. However, as WPV circulation decreased after years of vaccination with IPV,
we believe the immigration rate had a large effect on infection dynamics. This is
because, as the number of locally-derived WPV infections decreased, the relative
effect of the immigration rate on the force of infection increased. The immigration
rate is important because, if we had estimated a lower immigration rate, we would
have a lower baseline transmission rate, and therefore would require less efficacious
IPV to see the same reduction in cases. A very important follow up will be to more
precisely estimate the immigration rate in the US and then refit IPV efficacy. The
confidence intervals for IPV efficacy could also be calculated to account for uncertainty
in the immigration rate.
Other improvements to the US model include better estimates of IPV uptake.
The model currently captures vaccine coverage well, but the decline in IPV coverage
during the transition to the OPV era could be improved. With improved estimates
of IPV uptake and efficacy in the US, we believe we will be capable of fitting the
full observation model with the PSU data. As previously mentioned, the fitted IPV
model underestimated the number of cases in MMWR and NOVS (Fig 5.13). We
believe this was due to overestimating the reduction in the IPV paralytic probability
and the non-paralytic probability. Simulations from the fitted model had too few
IPV paralytic and non-paralytic cases reported to PSU. We suspect that this is why
we hit the limits of floating-point number representation when trying to calculate the
joint likelihood of the MMWR, NOVS, and PSU data.
As for OPV efficacy, the fitted OPV efficacy in the RSFSR and independent val-
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idation in Lithuania, Estonia, and Ukraine make a strong case for the accuracy of
our estimate. Although the estimate of OPV efficacy may be accurate, finer scale
profiling is warranted. The fitted models over-predicted the cases in the USSR, sug-
gesting that the true MLE has either a higher OPV efficacy (i.e., a greater reduction
in infectiousness or susceptibility) or a reduction in the OPV paralytic probability. It
was unexpected that the relative OPV susceptibility was 1, meaning OPV does not
reduce susceptibility. However, we assume further profiling in the neighborhood of
the OPV efficacy MLE will result in a lower estimate of this value and a better fit to
the data. An exciting extension to the independent validation of OPV efficacy will be
to deploy the MLE OPV efficacy to predict the OPV era data from the US. Similarly,
the IPV efficacy estimated in the US could be independently validated using data
from another country that relied on IPV, such as the Netherlands.
In conclusion, we found that OPV reduces WPV transmission on the popula-
tion level by reducing the infectiousness of vaccinated individuals by 96%. More
importantly, we demonstrated that IPV acts either by reducing the susceptibility to
infection or infectiousness by 69%. Although the MLE indicates IPV efficacy is 69%,
the efficacy may be higher because we used data from the 1950s and 1960s. The
regulations for vaccine licensure changed in 1968 and required higher potency IPV
[23]. Thus, IPV licensed and used today may have higher efficacy than the original
rolled-out in the US.
Clinical IPV efficacy studies— that simulated WPV challenge using OPV—suggested
that IPV does not protect from the establishment of infection, but reduces the quan-
tity of WPV shed in stool and the duration of shedding [3]. Our results indicate that
this individual-level estimate scales up to the population-level and IPV does in fact
reduce transmission. This is a hopeful indication that, if maintained at high levels
of vaccine coverage, IPV could significantly reduce polio transmission and result in
herd immunity. Given an IPV efficacy of > 69%, a “back of the envelope calculation”
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suggests that IPV could be used to lower the reproductive number of WPV < 1 in
regions with an off-season WPV reproductive number ≤ 3. If this is the case, WPV
could be driven to local extinction with high IPV coverage. Based on studies of im-
perfect vaccines [24], we estimate that with an off-season reproductive number ≤ 3,
96% vaccine coverage with IPV alone, or 69% vaccine coverage with OPV alone, could
eradicate polio. Given, that much of the world has OPV-derived immunity, and some
older individuals have naturally-acquired immunity, eradication might potentially be
achieved with a switch to IPV and coverage < 96%.
Our results eliminate much of the uncertainty that surrounded IPV efficacy, and
give a hopeful outlook for the successful withdrawal of OPV and reliance on IPV.
However, aside from questions regarding efficacy, another reason that IPV has limited
use is due to the difficulty of administering the 3 dose injection of IPV in mass
immunization campaigns. Fortunately, this year a new microneedle technology was
developed for administering IPV, which can be done cheaply, with limited training,
and simple transport [25]. In light of our results, new technology for administering
IPV, and the drawbacks of OPV, we suggest that the cautious withdrawal of OPV be
fully considered under (1) the explicit knowledge of an IPV efficacy of ∼ 69% and (2)
the dramatic seasonal fluctuations in WPV’s reproductive number and the limited
seasonal “window” for eradication.
Epilogue
Before publication of this work there are several extensions that must be com-
pleted. The list below contains some of the primary extensions.
• We will profile the IPV uptake rate to improve the fit to IPV coverage data in
the US
• We will test whether infection immigration is necessary in the US transmission
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model and we will refit IPV efficacy parameters under a “no immigration”
assumption.
• Using the US data, we will profile IPV efficacy along the IPV-efficacy-ridge
shown in Fig 5.12. The profiling will be along 3 parameter dimensions: IPV
efficacy, IPV relative paralytic probability, and IPV relative non-paralytic prob-
ability.
• For the USSR, we will be expanding the data both in the pre-vaccine era and
the vaccine era. With the expanded data, we will refit the WPV transmission
parameters in each region in the USSR
• Using expanded data from the USSR, we will once again simultaneously pro-
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An open challenge in disease ecology is to reveal the mechanisms and implications
of infectious disease seasonality [1, 2, 3, 4, 5]. My dissertation research was a starting
point for addressing disease seasonality in what will likely be a career-long endeavor.
I will now generally discuss disease seasonality and present ideas for extending my
dissertation research. Seasonal drivers of disease can be separated into four intercon-
nected categories: (1) environmental drivers, (2) host behavior, (3) host phenology,
and (4) exogenous biotic drivers. I will briefly discuss each of these four categories
and frame research approaches for studying seasonal cycles.
6.1 Environmental Drivers
Environmental drivers are abiotic conditions that influence transmission via their
effects on hosts and/or parasites. Such drivers include quantitative features of the en-
vironment; classical examples are temperature and rainfall, which influence a variety
of infectious diseases [2]. Environmental drivers can impact pathogen survival dur-
ing transitions between hosts. Transitions can take place during short time windows
(e.g., for droplet transmitted infections) or long time windows (e.g., for parasites with
environmental life stages). In addition to their impact on pathogens, environmental
drivers can also influence host susceptibility to infection. For example, environmental
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conditions can moderate the host immune response and increase the susceptibility
of cells to infection [6] or pose seasonal challenges (such as food limitations) that
leave hosts vulnerable to infection or pathology [7]. Environmental drivers, along
with host behavior, are the seasonal drivers that have received the most attention
from the scientific community. Presumably, environmental drivers have been a main
focus because they strongly covary with seasonal disease incidence. Associations be-
tween environmental conditions and disease incidence are causal in some cases, with
influenza transmission being the most notable example [8]. However, covariation is
expected between seasonal phenomena and we should also consider seasonal features
of the biotic environment in addition to the abiotic.
6.2 Host Behavior
Transmission seasonality is sometimes due to seasonal host behavior, most com-
monly fluctuations in host contact rates throughout the year. School-term trans-
mission of measles is an excellent example of seasonal contact rates [9]. Studies of
human diseases have been enlightening in this area; however, I would argue that wild
animal systems offer a richer arena for studying seasonal host behavior and disease
transmission. In the case of measles, children contact other children year-around, and
school-terms increase this rate; whereas, in non-human systems, risky contacts could
be seasonally isolated in time.
Let us consider sexually transmitted diseases in seasonally breeding mammals.
Seasonal transmission would not simply modulate a pre-existing non-zero contact
rate, but there is a complete absence of sexual contacts (and thus transmission)
outside of the breeding season. I propose that isolation in time is the most extreme
form of seasonal transmission, and it is an important area for future research. I predict
seasonally isolated transmission exists for STDs in wildlife, but may also occur for
parasites with other transmission modes. Discrete windows of transmission are likely
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to have evolutionary consequences for parasite life history. Cattadori et al. [10]
pointed out that, when transmission is restricted to a short seasonal window, natural
selection will favor parasites with “long-lived infective stages”. I further speculate
that transmission isolated in time will have dynamical consequences that make these
disease systems unique from those with year-around transmission.
Sexual contacts are not the only seasonal “risky” behavior. Seasonal engagement
in risky behavior may also occur in other disease contexts, including for infections
transmitted during bouts of fighting. For example, the Tasmanian devil contact net-
work varies between the mating and non-mating season and could influence transmis-
sion of devil face tumor disease, the transmission of which is facilitated by aggressive
behavior [11, 12]. Mating and aggression can elevate disease risk, but it is impor-
tant to acknowledge that some behaviors mitigate disease risk. Disease mitigation
behaviors include grooming to remove ectoparasites [13] and self-medicating [14], but
to my knowledge there are few studies of seasonality in risky behavior and disease
mitigation behavior. In the very least, disease ecology would benefit from a compre-
hensive review of the ways in which animal behaviors affect disease transmission and
how influential behaviors are structured in space (i.e., across populations), through
time (i.e., seasonally), and how they vary with age. By bringing a disease ecology
focus to analyzing observational studies of animal behavior and the growing amount
of telemetry data collected from wild animals we could form hypotheses regarding
how the ecology of infection and behavior overlap.
6.3 Host Phenology
Host behavior can also seasonally structure disease risk via the geographical local-
ization of hosts. Hosts seasonally engage with different aspects of their environment.
For hosts that migrate or hibernate, contact with risky environments can be seasonal
[15]. Migration and hibernation are part of host phenology, which includes host life
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history, annual cycles, and endogenous circannual rhythms. As discussed in Chapter
III, in disease ecology, relevant host phenology includes, but is not limited to, birth
seasonality, seasonal re-structuring of immunity, cycles of nutrition and body condi-
tion, hibernation, and migration. Unlike environmental drivers and host behavior,
host phenology can affect diseases dynamics by means other than transmission. In
SIR-type models of disease transmission, host phenology can generate seasonality in
(1) susceptible recruitment, (2) host susceptibility to infection, (3) host infectious-
ness, (4) the recovery rate, (5) the mortality rate (both natural and disease-induced),
and (6) symptomatology. An import extension to my dissertation research is to
test whether is it possible to determine which of these six seasonal mechanisms is
acting in specific infectious disease systems. The six mechanisms presumably have
different dynamical effects and would therefore leave imprints in long-term incidence
data. Extensive simulation studies are required to identify the dynamical effects of
these seasonal mechanisms acting in isolation and in combination. Simulation studies
will provide a foundation for determining the types of data required for distinguish-
ing among seasonal mechanisms. This challenge becomes greater when considering
chronic infection with parasites that have complex life histories and phenology of their
own.
6.4 Exogenous Biotic Drivers
In addition to abiotic, behavioral, and phenological features of host-parasite sys-
tems, hosts and their parasites are embedded in ecological networks that have addi-
tional seasonal aspects. I refer to interactions within ecological networks as exogenous
biotic drivers because they are exogenous to the host-parasite dyad. Exogenous biotic
drivers include parasite-parasite interactions and host community ecology. I did not
include exogenous biotic drivers in my dissertation research. In recent years, how-
ever, studies highlighting the importance of immune mediated parasite interactions
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and host heterogeneity in multi-host systems have demonstrated the need to con-
sider community ecology of hosts and their parasites [16, 17]. Interactions between
hosts/parasites and members outside of the dyad undoubtedly display seasonality, as
do nearly all aspects of ecology. Since seasonality is an inherent feature of ecologi-
cal systems, and seasonal incidence is a feature of infectious diseases, I propose that
progress can be made if we (the scientific community) embrace the assumption that
“everything is seasonal”. Working under this assumption would prevent us from fu-
tilely establishing correlative relationships among seasonal phenomena ad nauseam.
Instead, we can focus our attention on building theory that will provide a deeper
understanding of seasonal mechanisms, and we can learn how to identify imprints
of seasonal drivers in disease data. My general conclusion is, since “everything is
seasonal”, then everything will covary (usually with some phase shifts). Therefore,
seasonal covariance alone is not useful for establishing seasonal drivers. Long-term
parallel data of potential seasonal drivers and disease incidence could be used to es-
tablish causality or suggest causal mechanisms if we look beyond seasonal covariance.
I predict that the information contained in interannual variation and anomalous years
holds the key to establishing causality.
6.5 Understanding Seasonality
Let us do a thought experiment to illustrate how anomalous years and interannual
variation could be used establish the causal mechanism of disease seasonality. Con-
sider a human disease with seasonal peak incidence in the summer, since incidence
peaks in summer, it would have a strong positive relationship with temperature,
photoperiod, and many other summer-related features of the environment and host
population. To highlight how strongly non-causal seasonal factors correlate with dis-
ease incidence, we could quantify the positive relationship between disease incidence
and the sales of bathing suits or the frequency of back-yard barbecues, both of which
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presumably go up in summer. Now imagine we build transmission models for this
infection and test the four potential seasonal drivers (i.e., temperature, photoperiod,
swim suite sales, and barbecues) as modulators of host susceptibility to infection. If
the disease displays either interannual variation in epidemic size or anomalous years
with differences in epidemic timing, then only the data from the causal driver would
aid us in predicting the variation observed across years, assuming the causal driver is
responsible for some of the variation.
In this thought experiment, photoperiod might be ruled out as the causal driver
because there is no interannual variation in photoperiod for any given latitude. There-
fore, we need to consider a better metric of light conditions, such as sunlight hours
calculated using data on photoperiod and cloud cover. After correcting the sunlight
metric, we find that all four models capture the seasonal structure of epidemics, be-
cause they all covary with disease incidence. However, only the model with sunlight
hours accurately predicts the between-year variation in epidemic size and the anoma-
lous years. This suggests that sunlight is the primary (causal) seasonal driver, and
the model indicates that sunlight acts by modulating host susceptibility. As is the
case with any scientific endeavor, we would be left with a new problem: to identify
the mechanism of action on a biological level. We would need to address whether sun-
light is modulating host susceptibility by modifying host immunity, or if it is instead
influencing the transmission rate by affecting the pathogen or some other feature of
the host-pathogen system. The effects of seasonal drivers are multi-layered. Thus, in
order to better understand seasonality we must work at multiple organizational levels
of science. Geophysical factors, host population ecology, and within-host biology will
need to be integrated in the practice of studying seasonality. In my own work, I have
identified several new avenues for exploration that would require interdisciplinary
research.
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6.6 Expanding on Birth Seasonality
My work on birth seasonality had one major downfall, the lack of an empirical
example demonstrating the effect of birth seasonality in real-world epidemics. In
Chapter II, I studied the effect of birth seasonality on New York City measles epi-
demics. In hindsight, the data from New York were unlikely to prove insightful.
Based on my simulation studies, the birth amplitude needed to be fairly high in a
population (i.e., > 20%) in order to have an observable effect on measles incidence.
However, New York City had a birth amplitude well below 20% during the time pe-
riod I studied. I did not observe an effect of birth seasonality on estimates of measles
transmission in New York City, and I attributed this to the low amplitude of birth
seasonality.
I chose to investigate measles for two reasons. First, measles was the focus of foun-
dational studies in disease ecology [9, 18, 19, 20, 21, 22] making it familiar to many
disease ecologists. Second, the data were readily available for New York City. How-
ever, I recognize that my study of birth seasonality and disease needs to be repeated
using data from populations with higher amplitude birth seasonality. Furthermore, it
is likely that birth seasonality plays a larger role in disease systems with an infant age
of first infection, such as rotavirus or hand foot and mouth disease, but this remains
to be tested.
The difficulty of studying the impact of birth seasonality on childhood diseases—
which I will now refer to as early-life infections to include wildlife diseases—is that
births do not directly enter the susceptible pool. My work on measles and polio re-
quired me to grapple with the presence of maternal immunity in infants. In mammals,
maternal immunity is transferred from mothers to their offspring during pregnancy
and lactation. Females transfer maternal antibodies and leukocytes (i.e., immune
cells) that help fight early-life infections in their infants [23, 24]. The exciting next
step in the study of birth seasonality is to determine how it interfaces with the evo-
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lutionary ecology of maternal immunity.
Maternal immunity is short-lived, usually lasting weeks to several months [23].
In seasonally breeding mammals, maternal immunity is present in the population at
the same time as the birth pulse. Since birth pulses replenish the susceptible pool,
and can fuel outbreaks, I hypothesize that maternal immunity is an evolutionary
response for mitigating the dynamical consequences of birth seasonality. Furthermore,
there is evidence that the interaction between maternal immunity and infection is
not a one-way effect, but a feedback. A study of leukocytes in breastmilk found
that the abundance of leukocytes increased if either the mother or the infant was
infected [24]. This suggests there are dynamical feedbacks between infection and
maternal immunity. Transmission models that bridge the population-level and the
individual-level could be used to study the interaction between, and evolution of, birth
seasonality, maternal immunity, and disease seasonality. This work would require an
interdisciplinary group of disease ecologists, immunologists, and clinicians. The study
of maternal immunity and seasonal cycles of reproduction should not be studied
in isolation; additional seasonal features of host life history, including rhythms in
immunity and nutrition, would also require consideration.
6.7 Exploring Biological Rhythms
My work on biological rhythms and infection raised more questions than it an-
swered. Seasonal cycles of gene expression in the human immune system, which I
discussed in the introduction, are suggestive that the human immune system has
endogenous circannual cycles. In order for rhythms to be endogenous, they must
persist under constant environmental conditions. The test of this requires long-term
experiments where subjects are kept in an environment absent of seasonality, which
is one of the reasons laboratory studies of circannual rhythms are rare. In my view,
though unconventional, if desired it would be possible to test if seasonal rhythms in
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immunity are endogenous by studying crews working on the international space sta-
tion. NASA is currently conducting its first 1-year mission, which would encompass
a full circannual cycle. Astronauts are particularly promising for studies of immunity
rhythms because (a) they live in a relatively constant environment, and (b) they are
not exposed to pathogens that would stimulate an immune response and bias results.
The study of biological rhythms in space is promising, NASA is currently conduct-
ing studies on circadian rhythms; therefore, the opportunities space flight present for
chronobiology have been acknowledged [25].
Switching to the parasite perspective, F. Hawking extensively documented the
circadian and seasonal cycles of parasites in the 1970s [26], but the field has progressed
little since. Endoparasites pose a difficult problem for studying rhythms because
they live within other organisms. It is unclear how parasite rhythms are entrained.
Are parasite rhythms entrained to the rhythms of their host? If parasites rhythms
entrain to host rhythms, then parasites can be placed in a “constant” environment
by infecting hosts lacking functioning biological clocks. Fortunately, knockouts of
circadian clock genes (e.g., Per2 and Bmal1 ) exist in mouse models and are often
used in circadian clock studies. Regardless of whether parasite rhythms or seasonal
host immunity rhythms are endogenous, it is important to determine whether they
have consequences for disease.
The next step for studying biological rhythms and infection will be to expand
upon the pre-existing work on circadian rhythms. Circadian studies are data rich be-
cause they are short in period, and the circadian clock is well understood. Whereas,
the mechanistic underpinnings of the circannual clock remain a mystery. There are
several research groups studying circadian rhythms in malaria parasites. Over the
next several years, the rodent malaria system will undoubtedly progress the study of
rhythms and infection. As a complement to experimental studies, an open research
area is to develop dynamic models of the multi-oscillator system that includes host
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rhythms, parasite rhythms, and the environmental cycles to which these rhythms
entrain. Models of adaptive dynamics could be used to investigate the evolution-
ary trajectories of interacting host-parasite rhythms; whereas, within host models of
infection dynamics could be used to explore the effect of rhythms on parasite popula-
tions and pathology. Theory could also be developed to study circannual rhythms in
hosts and parasites. However, since data are limited for circannual rhythms, it would
be difficult to ground the theory with data.
6.8 Polio’s Temporal Niche
Polio’s temporal niche is the summer and autumn. Poliovirus transmission is lim-
ited during the wintertime low season but the mechanism responsible for this remains
unknown. Together with previous studies of polio seasonality [27, 28, 29, 4], my re-
sults narrowed the list of potential mechanisms to an environmental or host factor
that displayed latitudinal variation in its amplitude and phase. I propose temper-
ature, relative humidity, sunlight hours, and seasonal immunity as viable seasonal
drivers. Temperature, humidity, and sunlight hours (i.e., photoperiod taken together
with cloud cover) vary seasonally and latitudinally. Temperature and humidity have
been shown to have a strong relationship with polio cases, with the rise in temper-
ature and humidity preceding the rise in cases by 2–3 months [29, 28]. My fitted
transmission models from the US estimated the peak in poliovirus transmission to
precede the incidence peak by ∼ 2 months. Since temperature and humidity have
strong seasonal covariance with poliovirus transmission, they meet the minimum cri-
teria for potential seasonal drivers. Temperature and humidity also have an effect on
poliovirus survival in aerosol, with poliovirus surviving best in conditions reflective
of northern hemisphere summers, conditions opposite those that favor influenza virus
survival [30].
As shown in the introduction, human immunity is seasonally structured with
168
distinct summertime and wintertime gene expression profiles [31]. If the seasonal
structure of immunity varies with latitude, it could account for polio’s spatiotemporal
transmission structure. Polio transmission models could be used to test whether
temperature, humidity, sunlight, or immunity affect transmission. The models I used
in Chapter IV could be extended to include seasonal drivers as covariates. Based
on my one-step ahead-predictions, which moderately over- or under-predicted peak
cases each year, the model-data fit could be improved for polio in the US. If the model
contained the correct seasonal driver, it could better fit the data by predicting the
size of the epidemic peak, which varies significantly from year to year. As previously
discussed, I anticipate that the information contained in interannual variation in
epidemic size and anomalous years holds the key to establishing seasonal causality.
It is important to identify polio’s seasonal driver because knowledge of the driver
would allow transmission models to be extended to contemporary studies of polio
in endemic countries. By using historical data with recurrent epidemics, I had data
sufficient to estimate the seasonal transmission rate. Today, due to widespread vac-
cination, polio cases are rare and contemporary data are depauperate of information
needed to estimate transmission seasonality. If historical data were used to estab-
lish the relationship between environmental conditions and polio transmission, then
environmental conditions from polio endemic countries could be used in models of cur-
rent outbreaks. Polio’s environmental driver is the biggest knowledge gap in polio’s
ecology. Non-polio enteroviruses, such as coxsackievirus and echovirus, also display
elevated incidence in the summer [32]. I am therefore optimistic that uncovering the
mechanisms of poliovirus seasonality will result in a better understanding of the en-
teroviruses in general. This sentiment was shared in 1949 by the epidemiologist H.
Gear, who wrote: “It must be admitted that the reasons for the seasonal incidence of
poliomyelitis remain obscure. When they have been elucidated perhaps much of the
epidemiology of this disease will be solved” [33].
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Human Birth Seasonality: Latitudinal Gradient
and Interplay with Childhood Disease Dynamics
A.1 Human Birth Seasonality: Materials & Methods
A.1.1 Birth Timing and Amplitude
In our analyses we followed the work of Rosenberg, who stated that adjusting for
the differing number of days in each month had little effect on analyses of birth
seasonality [1] . Thus, we did not make any adjustments of our time series to account
for the different number of days in each month.
In the wavelet spectral analysis we tested for birth periodicity with periods ranging
from 2 months to one-third the length of each data series. Since a significant 1 year
period was observed, we constructed monthly phase angle time series for each data
series using an 11-13 month period. The phase angle time series were subsequently
used to determine the timing of the annual birth peak for each location. Peak-
birth months were then averaged for each individual data series, with the U.S. states
mapped to visualize the geographical variation in the timing of the annual birth
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peak. When biannual peak-births occurred in the U.S., they were separated into two
6 month periods: summer (May-Oct) and winter (Nov-April) (Supp. Figs. A.1 &
A.2).
The analysis of seasonal birth amplitude, or percent deviation from the annual
mean, was done using seasonally decomposed time series. The stl function in the
stats package in R was used to decompose the data into seasonal (S), trend (T ), and
noise (N ) components for each data series. The noise free time series were constructed
as:
F = S + T (A.1)
The deviation from the mean during the birth peak was calcualted for each year,
i, as:
x = max(Fi)−mean(Ti) (A.2)
The deviation from the mean during the birth trough was calculated for each year,
i, as:
y = min(Fi)−mean(Ti) (A.3)













For the simulation study we used a daily discrete-time SEIR model of measles
adopted from Earn et al. 2000 [2]. The model has a daily time step and uses school-
term forcing of seasonal transmission based on the school terms of England & Wales.
The models assume transition probabilities follow a Poisson process. The difference
equations are as follows:






































((1 + b1)273 + (1− b1)92)
(1 + b1Termt) (A.13)
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Termt is based off the the school term schedule. When school is in session Termt =
1 and when students are on holiday Termt = −1. See Table A.1 for the school term
schedule. The parameter values used for the simulation study can be found in Table
A.2. All simulations were run for 100 - 150 yrs. to ensure that the trajectories were
past the transient phase.
Holiday Model Days Calendar Days
Christmas 356 - 6 Dec 21 - Jan 6
Easter 100 - 115 Apr 10 - 25
Summer 200 - 251 Jul 19 - Sept 8
Autumn Half Term 300 - 307 Oct 27 - Nov 3
Table A.1: School term schedule. When students are on holiday Termt = −1 other-
wise 1.
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Parameter Value Parameter Value
R0 16 (basic reproductive no.) b1 0.25






















month−1 (balances δ) I0 0.001
A 0 - 0.0009208 month−1















Table A.2: Parameters used in simulation study, main text Figures 2.4A & 2.4B.
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A.1.3 Inference study using simulated data
For the inference study we coupled our SEIR model (Eqs. A.6 - A.13) with a
stochastic measurement model. The measurement model is as follows:
casest ∼ normal(ρIncidencet, ρτ) (A.14)
In order to test whether the seasonality in births influences parameter estimation,
we simulated case data using three parameterizations of our model, each differing in
the timing of the birth peak. The parameters used to generate the data are given in
Table A.3. Simulations were run to year 50 to ensure the transient phase had passed.
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Parameter Value Parameter Value
R0 6250365 (basic reproductive no.) b1 0.25
























month−1 (balances δ) I0 0.001
A 0.000456 month−1















Table A.3: Parameters used to generate data for study, main text Figure 2.4C.
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The three time series generated using the stochastic SEIR model were then fit to
the SEIR model with a 0% birth amplitude, i.e. A = 0. The mean transmission
rate, B0, was the only free parameter. All other parameters, aside from A and B0,
were fixed at the values used to generate the data. Only the last 6 years of the time
series were used for fitting, thus, the initial conditions were set to match those at the
beginning of data used for inference.
For each time series B0 was profiled and the likelihoods of the parameter sets with
varying values of B0 were calculated using a particle filtering in the R package pomp
[3]. A particle filter (a.k.a. Sequential Monte Carlo) is a method of integrating state
variables of a stochastic system and estimating the likelihood of the model for a fixed
parameter set, given the data. However, since our model lacked process noise, we
were able to obtain the exact likelihood for each parameter set.
A.1.4 Inference study using New York City measles data
For the New York inference study we utilized a Partially Observed Markov Process
(POMP) model which are suited for dealing with epidemiological data where the state
variables (susceptible, infected, recovered individuals) are not observed in the data,
rather the infected individuals are partially observed through case reports [3]. For
our process model we used a stochastic biweekly discrete-time SIR model. Similar to
the model used for the simulation study, transitions were modeled using a Poisson












St+1 = dtBt + %tSt (A.17)




The transmission rate βt was modeled using a periodic B-spline with 6 bases, a
degree of 2, and a period of 1 year. The process noise εt was modeled as εt ∼
normal(1, βsd). The covariates Bt, monthly number of individuals entering the sus-
ceptible class, and Nt, population size, were taken from data. All parameters were
estimated using iterated particle filtering [3] (discussed later), with the exception
of the death rate which was fixed at δ = 1
600
month−1, i.e. 50 yr. life span, and
dt = 1
2
fixing the time step to biweekly. In order to couple our model with measles
case data we overlaid the process model with a stochastic measurement model. The
measurement model is as follows:
casest ∼ normal(ρIt, τIt) (A.19)
The case data, gathered from [2], consisted of monthly measles cases for New York
City from January 1949 - December 1962. Although we did not have birth data for
New York City we did have per capita monthly births for the state of New York.
Thus, we assumed the per capita monthly birth rate for New York City was equal to
the per capita monthly birth rate for New York state. The population size of New
York City was taken from the decadal census and the population size was interpolated
for non-census years. Taking the New York City population size together with the
time series of per capita monthly births we constructed a time series of the number
of monthly births, Bt, in New York City (not to be confused with Bt in Eqn. A.17,
which will be explained in the next section).
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In order to test whether the seasonality in births influences model parameterization,
we used four variants of our model (Eqn. A.15-A.18), each differing in the susceptible
recruitment covariate, Bt. The first three models contain birth seasonality and ac-
count for the existence of maternal antibodies for 3-9 months. Whereas, in the fourth
model we removed the birth seasonality. The first model variant lags the births by 3
months to account for a scenario where maternal antibodies confer protection from
measles for the first 3 months of life:
Bt = Bt−3 (A.20)
In the second model variant we lag births by 6 months.
Bt = Bt−6 (A.21)
In the third model variant we lag births by 9 months.
Bt = Bt−9 (A.22)
In the fourth model variant we removed the seasonality of births by making the
monthly births constant within each year by setting them equal to the mean monthly





; j ∈ [1948 : 1962], (A.23)
where i is the month and j is the year.
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Each of the four model variants were independently fit to the data using Maxi-
mization by Iterated particle Filtering (MIF) using the R package POMP. MIF is
a state-of-the-art simulation based method for parameter estimation that uses likeli-
hood as the objective function. The basis of MIF is particle filtering (a.k.a. Sequential
Monte Carlo), which is a method of integrating state variables of a stochastic system
and estimating the likelihood of the model for a fixed parameter set, given the data.
Unlike particle filtering, which uses fixed parameter values, MIF varies parameter
values throughout the filtering process and selectively propagates particles (in the
simplest sense, parameter sets) that have the highest likelihood. Thus, by initializ-
ing MIF throughout parameter space one can get a picture of the likelihood surface
and identify the maximum likelihood parameter combinations within that space. For
each of our models, MIF was initialized with 80000 parameter sets generated using a
Sobol design, which pseudo-randomly samples parameters across parameter space in
order to evenly sample the space. After this initial phase of MIF, parameter sets were
passed through 15 successive stages of MIF, which included profiling. In total, for each
model MIF was initialized at over 424000+ locations in parameter space to estimate
the shape of the likelihood surface and identify the maximum likelihood parameter
set(s). Table A.4 provides the maximum likelihood estimate (MLE) parameter set
for each model.
A.2 Human Birth Seasonality: Results.
A.2.1 Detailed Results
Biannual birth pulses. During the pre-baby boom and baby boom eras, we found
that some states had two birth pulses per year, i.e. they had a significant biannual
period. All states significant for the biannual period were clustered together in the
lower-midwest, deep south, and southeast (Figs. A.1 & A.2). In the baby boom era,
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some of the states lost their significant biannual period and transitioned to having
only a single seasonal birth pulse (Figs. A.1, & A.2). In the modern era, Arkansas
remained the only state with a biannual period. The clustering of the states with
a significant 6 month period in the southeastern U.S. may have been due to now







Figure A.1: Bi-annual winter (November-April) birth peak timing by period. (a)
pre-baby boom (1931-1945), (b) baby boom (1946-1965), and (c) present








Figure A.2: Bi-annual summer (May-October) birth peak timing by period. (a) pre-
baby boom (1931-1945), (b) baby boom (1946-1965), and (c) present
period (1965-2008). States shown in white were not significant.
Birth rates. Raw birth rates in the pre-baby boom era ranged from 0.89/1000/month
in Nevada (February, 1936) to 2.80/1000/month in New Mexico (May, 1932), with
the mean and median both approximately 1.60/1000/month; while in the baby boom
era Maryland had the lowest birth rate at 1.13/1000/month (April, 1950), New Mex-
ico with the highest birth rates at 3.36/1000/month (October, 1946), and the mean
and median both approximately 2.04/1000/month. In the present period Vermont
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had the lowest birth rate at 0.67/1000/month (July, 2005), and Utah had the high-
est at 2.61/1000/month (July, 1977) with the mean and median falling in around
1.27/1000/month. Worldwide birth rates were not calculated, because we did not
have population size data for our 200+ countries, rather raw birth values per month
were used for wavelet spectral analysis. See Figure A.3 for maps of the mean birth
rates in each state and each era.
The seasonal birth pulse. Examining the phase angle time series at a period
ranging from 11-13 months, the U.S. data had twenty four states significant in the
pre-baby boom era, whereas all were significant in the baby boom and present eras.
Of the 210 worldwide data series analyzed, 132 (63%) were significant at an 11-13
month period. Many of those found insignificant were shorter time series (5-7 years)
or countries with extremely low birth values (<100 individuals/month). Those states
and countries found to be significant were then analyzed for the timing of the peak
birth month using a wavelet spectral analysis.
U.S. timing of the seasonal birth peak. During the pre-baby boom era, of the
states with a significant 1 year period, Oregon (June 12th) and Maine (June 10th) had
the earliest peak birth timing —excluding New Mexico, which is an outlier because
it has an early peak in all eras yet is located in the southern U.S. Florida (Nov 10th)
had the latest peak birth timing in early November. The median peak birth timing
was July 3rd, and the mean was July 26th. The range of peak birth timing was
at a maximum in the pre-baby boom era with a length of 156 days, approximately
5 months. In this era there was a subtle pattern in the birth peak timing, with
the northeast and northwest having earlier peaks than that of the deep south, the
southeast and California.
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Average birth rate: Pre−Baby Boom Era (1931−1945)














Average birth rate: Present Period Era (1965−2008)
Figure A.3: Maps of mean birth rates for each state, in each era. Top to bottom: pre-
baby boom, baby boom, and present era. No geographic pattern could
be easily discerned.
In the baby boom era, when all states were significant at the 1 year period, there
was a clear latitudinal gradient in birth amplitude and peak birth timing. Northern
















































































































































































































































































Figure A.4: Seasonal amplitude of births in U.S. states during each era. Note the
high amplitude in the southern states (far right in all panels).
mid-July (July 13th), followed by Washington with a peak birth timing a few days
later (July 18th) with no other peak birth timing occurring for at least another week
after that. Again, Florida had the latest peak birth timing 3 months later in mid-
October (Oct 21st). The mean (Sept 4th) and median (Sept 8th) both occurred in
early September. In the baby boom era, other than Maine and those states already
mentioned, the only states to have a peak prior to August 1st were also located in
the northwestern U.S. (Idaho, Montana, North Dakota, and Oregon).
In the modern era, the spatial pattern of peak births was further elucidated with
the mid-latitude states acting as a gradient for the northern and southern states.
Utah again had the earliest peak birth timing in late June (June 26th), while Florida
had the latest peak birth timing in early October (Oct 5th). The mean (Aug 11th)
and median (Aug 7th) in this era both occurred in early August. Maine and Vermont
also had peak birth timing prior to July 15th, which were the earliest peaks east of the
Rocky Mountains. As with the baby boom era, many of the northwest states (Utah,
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Idaho, Montana, Oregon, Washington, and Wyoming) had peaks prior to July 15th
in the present era. Over all eras, Florida consistently had the latest peak ranging
from early October in the present period, to early-November in the pre-baby boom
era.
Worldwide timing of the seasonal birth peak. The worldwide birth peak tim-
ing followed a similar pattern as observed in the U.S., with countries at higher lati-
tudes having an earlier birth peak than those closer to the equator. The earliest peak
was in Italy during the period 1970-1985 (March 22nd) followed closely by Tajikstan
in the period 1989-1994 (April 15th). The latest birth peak occurred in Saint Vincent
and the Grenadines during the period 1992-2005 (November 17th). The mean world-
wide peak (U.S. states not included) was mid-August (August 17th). The overall
pattern is clear, with Europe (high latitude) having an earlier birth peak, and the
Caribbean having a later peak. Both the Asian/Middle Eastern and Non-U.S. data
are difficult to categorize as they span broad geographical ranges.
Seasonal birth amplitude. In the U.S., the largest seasonal amplitude in the
pre-baby boom era was 20% from the mean (Louisiana, 1945), and the minimum
was 4.2% from the mean in 1931 South Dakota (Fig. A.4 top panel). These values
increased during the baby boom era with a maximum 21.3% variation from the mean
(Louisiana, 1954), and a minimum of 5.5% (Connecticut, 1957) (Fig. A.4 middle). In
the modern era, the maximum variation from the mean dropped to 17.4% (Louisiana,
1965) with the minimum staying relatively similar 5.4% (Delaware, 2004) (Fig. A.4
bottom). The mean percent deviation from the mean in all states during the pre-baby
boom era was 9.0%, 9.8% during the baby boom, and 8.5% in the modern era.
As shown in the main text Figure 2.2, we observed a latitudinal gradient in the
seasonal birth amplitude in each era in the U.S. However, the latitudinal gradient in
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Figure A.5: Seasonal (intra-annual) amplitude of northern hemispheric data plotted
vs latitude.
birth amplitude was not observed outside of the U.S. (Fig. A.5). European seasonal
amplitudes tended to be low, with a mean of 10.3%. Non-U.S. Americas had an
approx. 9.8% amplitude, Asian/Middle Eastern countries having approx. 12.6%, and
Caribbean countries approx. 17.2% (Fig. A.5). However, due to the high variation









































Intra−annual Vs Inter−annual amplitude

















Post Baby Boom (1965−2008)
































































Figure A.6: The seasonal (intra-annual) amplitude vs the annual (inter-annual) am-
plitude. In both the pre-baby boom and baby boom most states had
a stronger seasonal component, whereas in the present period all states
have a stronger seasonal component.
Intra- vs. inter-annual variation in birth rates. We examined the seasonal
(intra-annual) variation in births and compare that to the inter-annual variation (per-
cent change from one year to the next) for each state in every era. We found that the
seasonal (intra-annual) variation is generally larger (Fig. A.6), with the intra-annual
variation in the modern era 2-3 times larger than the inter-annual value.
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A.2.2 Simulation study
Fig. A.7 shows the effect of increasing birth amplitude on measles incidence with
the birth peak occurring at various times of the year. The difference in incidence
resulting from measles models with either constant births or seasonal births increases
with birth amplitude. However, depending on the phase relationship between peak
susceptible recruitment (i.e. the birth peak) and the peak in seasonal transmission,
birth seasonality can have the effect of either enhancing or dampening the epidemic
year incidence.
Fig. A.8 shows the effect of birth seasonality for various values of R0. Birth
seasonality in this range of amplitude, < 28%, has a pronounced effect on incidence



































































Figure A.7: Effect of increasing seasonal birth amplitude on measles incidence. The
main graph show the change in epidemic and skip year incidence as a
function of birth amplitude for 5 different phases of births seasonality.
Phases were set such that the birth peak occurred in either Jan, Jun,
Aug, Oct, or Dec. The turquoise and the fuschia points in the main
graph correspond to the turquoise and fuchsia time series in the inset.
HereR0 = 17 and the birth amplitude ranged from 0-28%, all parameters
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Figure A.8: The effect of birth seasonality on diseases with varying basic reproduc-
tive numbers (R0). This is a bifurcation diagram our SEIR model with
varying R0 and varying seasonal birth amplitude. The black lines are the
incidence for the model with no birth seasonality (i.e. birth amplitude =
0%). The solid shaded intervals indicate the regions containing the inci-
dence of the model with seasonal births, where the birth peak is in early
June and the amplitude ranges from 1.4 - 27.7%. Birth seasonality in this
range of amplitude has a pronounced effect on incidence when epidemics
are biennial or triennial, as opposed to annual. Here R0 ∈ [2 : 20], and
S0 = 1/R0, otherwise all other parameters are those in Table A.2.
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A.2.3 Inference study using New York City measles data
Maximum likelihood parameter estimates were obtained for each of our four
measles models: seasonal births with a lag of 3 months from birth to susceptible
to account for maternal antibodies, seasonal births with a lag of 6 months, seasonal

















R0 19.3 19.5 20.3 19.7
βcoef1 55.4 55.6 58.9 56.5
βcoef2 45.8 47.2 48.6 46.8
βcoef3 45.6 45.5 48.5 47.8
βcoef4 44.0 44.2 46.8 45.3
βcoef5 17.5 18.5 18.7 18.3
βcoef6 28.7 27.6 28.3 27.7
ψ 3.4× 10−4 3.8× 10−4 4.2× 10−4 4.1× 10−4
βsd 0.121 0.118 0.121 0.124
dt 1/2 1/2 1/2 1/2
δ 1/600 1/600 1/600 1/600
ρ 0.238 0.236 0.239 0.238
τ 3.8× 10−2 3.8× 10−2 3.9× 10−2 3.8× 10−2
S0 819214 947306 937014 1719583
I0 16602 22758 17265 27629
R0 6238289 6104041 6119826 5326893
Table A.4: Maximum likelihood parameter estimates for each model. Rates are given
in units of month−1. All parameters were estimated using MIF with the
exception of δ and dt, which were fixed. Note, R0 is the basic reproductive
number and R0 is the initial number of recovered individuals.
197
Country Years No. Years Latitude Mean peak month Significant Group Amplitude
Albania 1981-2007 27 41.17 6.15 Yes Europe 19.37%
Algeria 1998-2002 5 33.10 8.80 No Africa 10.11%
American Samoa 1984-1988 5 -14.30 5.20 Yes Asia 14.77%
American Samoa 1996-2006 11 -14.30 4.45 Yes Asia 14.81%
Antigua and Barbuda 1979-1986 8 17.05 10.50 Yes Caribbean 16.62%
Armenia 1987-1999 13 40.29 7.31 No Europe 15.81%
Aruba 2002-2007 6 12.52 9.17 Yes Caribbean 14.60%
Australia 1973-2008 36 -32.35 6.56 No Asia 6.06%
Austria 1973-2011 38 47.77 6.50 Yes Europe 6.33%
Azerbaijan 1992-2004 13 40.18 2.31 No Asia 13.81%
Bahamas 1972-1979 8 24.32 10.50 Yes Caribbean 13.95%
Bahrain 1975-1985 11 26.03 6.09 No Asia 15.33%
Bahrain 1986-2002 17 26.03 10.35 Yes Asia 13.26%
Barbados 1969-1976 7 13.16 7.86 No Caribbean 23.73%
Barbados 1982-1991 10 13.16 11.00 Yes Caribbean 19.78%
Belarus 1987-1999 13 53.33 5.31 Yes Europe 11.52%
Belgium 1971-1995 25 50.84 6.08 Yes Europe 7.18%
Belgium 1998-2008 11 50.84 7.64 No Europe 6.54%
Belgium-Bruxelles 1998-2008 11 50.84 8.09 No Europe 7.35%
Belgium-Flamande 1998-2008 11 50.84 6.73 No Europe 6.54%
Belgium-Anvers 1998-2008 11 50.84 6.64 No Europe 7.33%
Belgium-Limbourg 1998-2008 11 50.84 6.45 No Europe 7.96%
Belgium-Flandreorientale 1998-2008 11 50.84 7.18 No Europe 6.25%
Belgium-Brabantflamand 1998-2008 11 50.84 6.91 Yes Europe 7.47%
Belgium-Flandreoccidentale 1998-2008 11 50.84 5.64 No Europe 7.17%
Belgium-Wallonne 1998-2008 11 50.84 8.55 Yes Europe 6.73%
Belgium-Germanophone 1998-2008 11 50.84 5.18 No Europe 15.34%
Belgium-Brabantwallon 1998-2008 11 50.84 6.91 Yes Europe 7.86%
Belgium-Hainaut 1998-2008 11 50.84 9.09 Yes Europe 6.20%
Belgium-Liege 1998-2008 11 50.84 8.27 No Europe 7.08%
Belgium-Luxembourg 1998-2008 11 50.84 8.55 Yes Europe 8.38%
Belgium-Namur 1998-2008 11 50.84 8.91 Yes Europe 7.27%
Bermuda 1984-1991 8 32.30 9.38 Yes Caribbean 17.48%
Bermuda 1995-2001 7 32.30 9.00 Yes Caribbean 16.45%
BVI 1980-1986 7 18.43 10.43 Yes Caribbean 23.23%
Brunei Darussalam 1972-1976 5 4.82 8.00 No Asia 12.46%
Brunei Darussalam 1980-1992 13 4.82 9.31 No Asia 10.75%
Brunei Darussalam 1996-2002 7 4.82 9.71 Yes Asia 8.26%
Bulgaria 1973-1978 6 42.75 4.83 No Europe 8.01%
Bulgaria 1980-1990 11 42.75 6.18 Yes Europe 8.87%
Canada 1973-1990 18 56.76 6.06 Yes Americas 7.49%
Canada 1992-1997 6 56.76 6.00 Yes Americas 8.82%
Canada 1999-2008 10 56.76 6.80 Yes Americas 8.03%
Cape Verde 1968-1975 8 15.11 3.63 No Africa 12.94%
Cape Verde 1980-1985 6 15.11 11.50 No Africa 17.40%
Caymen Islands 1986-1995 10 5.36 10.20 Yes Caribbean 24.20%
Chile 1967-2008 42 -35.12 9.29 Yes Americas 7.83%
China-Hong Kong 1973-1977 5 22.30 10.00 Yes Asia 14.66%
China-Hong Kong 1979-2009 31 22.30 10.00 Yes Asia 14.85%
China-Macao 1971-1975 5 22.17 9.60 Yes Asia 16.52%
China-Macao 1984-1989 6 22.17 9.83 Yes Asia 17.67%
China-Macao 1991-2010 20 22.17 9.70 Yes Asia 16.06%
Cook Islands 1983-1988 6 -21.20 6.50 No Asia 19.36%
Costa Rica 1987-1991 5 9.92 10.40 Yes Americas 9.59%
Costa Rica 2003-2010 8 9.92 9.88 Yes Americas 10.90%
Croatia 1988-2004 17 45.32 8.18 No Europe 7.36%
Cuba 1976-1988 13 22.03 10.00 Yes Caribbean 16.68%
Cuba 1990-2009 20 22.03 10.20 Yes Caribbean 19.93%
Cyprus 1973-2009 37 34.97 8.49 Yes Asia 11.88%
Czech Republic 1991-2010 14 49.82 5.36 Yes Europe 10.15%
Denmark 1972-2005 34 55.85 6.03 Yes Europe 9.57%
Egypt 1972-1982 11 28.80 7.00 Yes Africa 30.08%
Egypt 1987-1999 13 28.80 10.85 No Africa 35.30%
Egypt 2003-2009 7 28.80 9.29 No Africa 12.60%
El Salvador 1973-2007 35 13.72 10.46 Yes Americas 12.48%
Estonia 1989-1997 9 58.96 4.89 Yes Europe 12.05%
Estonia 1999-2005 6 58.96 5.67 Yes Europe 8.67%
Estonia 2007-2011 5 58.96 6.40 Yes Europe 9.82%
Faeroe Islands 1972-1987 16 62.09 7.25 No Europe 11.90%
Table A.5: Data used in national-level analyses of birth seasonality. Significance
refers to the annual period. Mean birth peak timing and amplitude were
estimated from the data.
198
Country Years No. Years Latitude Mean peak month Significant Group Amplitude
Finland 1972-1988 17 61.76 4.94 Yes Europe 10.55%
Finland 1994-2004 14 61.76 5.93 Yes Europe 7.86%
France 1974-1989 16 47.14 5.75 Yes Europe 10.02%
France 1991-1997 7 47.14 7.00 Yes Europe 8.69%
France 1999-2004 6 47.14 7.83 Yes Europe 8.06%
French Guiana 1977-1986 10 5.09 10.10 No Americas 13.00%
French Guiana 1997-2003 7 5.09 10.71 No Americas 12.35%
French Polynesia 1985-1992 8 -17.53 4.63 Yes Asia 9.81%
Germany 1991-1997 7 50.86 7.14 Yes Europe 7.72%
Germany 2004-2010 7 50.86 8.00 Yes Europe 9.30%
Gibraltar 1973-1988 16 36.14 7.50 No Europe 14.75%
Gibraltar 2002-2008 7 36.14 10.00 No Europe 18.51%
Greece 1974-1985 12 38.69 6.00 Yes Europe 10.53%
Greece 1990-2001 12 38.69 7.67 Yes Europe 11.05%
Greenland 1972-1987 16 67.10 7.63 No Europe 12.57%
Greenland 1992-2010 19 67.10 6.95 No Europe 11.90%
Guadeloupe 1975-1980 6 16.27 9.33 No Caribbean 10.58%
Guadeloupe 1982-1986 5 16.27 11.00 Yes Caribbean 13.27%
Guadeloupe 1997-2003 7 16.27 10.57 Yes Caribbean 16.23%
Guam 1973-1982 10 13.45 10.10 No Asia 8.43%
Guam 1988-1992 5 13.45 9.80 No Asia 9.40%
Guatemala 1972-1979 8 14.72 7.38 No Americas 7.12%
Guatemala 1981-1999 19 14.72 10.79 No Americas 9.54%
Guernsey 1973-1979 7 49.48 2.71 No Europe 12.37%
Guernsey 1992-2000 9 49.48 8.22 No Europe 11.49%
Guyana 1967-1971 5 6.35 9.60 Yes Americas 10.04%
Hungary 1973-1992 20 47.29 6.40 Yes Europe 8.74%
Hungary 1994-2004 11 47.29 7.73 No Europe 7.90%
Iceland 1972-1980 9 64.37 5.67 Yes Europe 10.39%
Iceland 1982-2004 22 64.37 6.77 Yes Europe 10.23%
Iran 1999-2004 6 33.68 2.83 No Asia 7.95%
Ireland 1972-2004 33 53.11 5.94 Yes Europe 8.33%
Isle of Man 1973-1988 16 54.19 7.38 No Europe 12.52%
Israel 1973-1981 9 31.78 9.33 Yes Asia 9.58%
Israel 1983-1988 6 31.78 9.00 Yes Asia 9.60%
Israel 1990-2009 20 31.78 9.60 Yes Asia 8.97%
Italy 1970-1985 15 42.87 3.20 Yes Europe 10.01%
Italy 1988-2009 22 42.87 8.14 Yes Europe 11.01%
Jamaica 1999-2007 9 18.13 10.78 Yes Caribbean 18.60%
Japan 1972-1992 21 35.41 7.48 Yes Asia 7.59%
Japan 1994-2010 17 35.41 8.24 Yes Asia 7.01%
Jersey 1973-1989 17 49.22 6.59 No Europe 11.64%
Kazakhstan 1987-2008 22 43.35 6.27 No Asia 10.11%
Korea Republic 1996-2009 24 36.47 4.83 No Asia 7.75%
Kuwait 1975-1987 13 29.33 10.23 No Asia 9.06%
Kuwait 1991-2008 18 29.33 9.44 No Asia 10.68%
Kyrgyzstan 1985-2004 20 41.76 4.85 No Asia 11.06%
Kyrgyzstan 2005-2009 5 41.76 7.40 Yes Asia 12.02%
Latvia 1989-2005 17 56.83 5.12 Yes Europe 11.12%
Lebanon 2003-2010 8 33.93 8.88 No Asia 11.44%
Libya 1972-1981 10 29.96 1.00 Yes Africa 12.01%
Libya 1989-1996 8 29.96 7.00 No Africa 10.04%
Liechtenstein 1978-1987 10 47.15 6.80 No Europe 13.16%
Liechtenstein 2000-2005 6 47.15 5.83 No Europe 18.31%
Lithuania 1987-2011 25 55.22 5.72 Yes Europe 13.11%
Luxembourg 1973-1989 17 49.64 6.47 No Europe 9.22%
Luxembourg 1998-2010 13 49.64 6.23 Yes Europe 10.08%
Malaysia 1994-2008 15 4.19 7.67 No Asia 8.71%
Maldives 1978-2009 32 4.17 7.31 No Europe 13.36%
Moldova Republic 1987-1992 6 47.17 5.67 No Europe 7.60%
Moldova Republic 1998-2010 13 47.17 8.62 No Europe 8.86%
Malta 1973-1988 16 35.90 9.06 Yes Europe 11.41%
Malta 1992-2004 13 35.90 9.85 No Europe 9.17%
Martinique 1975-1992 18 14.67 10.94 Yes Caribbean 15.60%
Martinique 1998-2003 6 14.67 11.00 Yes Caribbean 18.29%
Mauritius 1994-2010 17 -20.16 5.76 Yes Africa 11.34%
Mongolia 1994-2003 10 47.77 5.10 No Asia 8.24%
Netherlands 1973-1988 16 52.07 6.06 Yes Europe 7.46%
Netherlands 1990-2010 21 52.07 7.62 Yes Europe 6.63%
New Caledonia 1970-1977 8 -21.50 5.63 Yes Asia 11.36%
New Caledonia 1982-2007 26 -21.50 5.54 Yes Asia 12.12%
New Zealand 1972-2009 39 -41.44 7.46 Yes Asia 23.52%
Niue 1982-1987 6 -19.06 7.83 No Asia 45.89%
Norway 1976-1987 12 61.13 5.00 Yes Europe 11.51%
Norway 1995-2004 10 61.13 5.50 Yes Europe 9.64%
Occ. Palestinian Territory 1997-2007 11 31.88 10.64 Yes Asia 10.81%
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Country Years No. Years Latitude Mean birth month Significant Group Amplitude
Palau 1997-2003 7 7.35 7.29 No Asia 16.08%
Panama 1973-1999 27 8.75 10.78 Yes Americas 8.35%
Panama 2005-2009 5 8.75 10.00 Yes Americas 10.60%
Phillipines 1997-2007 11 11.87 10.00 Yes Asia 13.93%
Poland 1978-2005 28 51.71 5.43 Yes Europe 9.95%
Portugal 1973-1993 21 39.75 6.67 No Europe 8.42%
Portugal 1999-2009 11 39.75 8.64 Yes Europe 9.11%
Puerto Rico 1967-1985 19 18.26 10.05 Yes Caribbean 11.33%
Puerto Rico 1987-1992 6 18.26 10.00 Yes Caribbean 12.49%
Puerto Rico 1996-2000 5 18.26 10.00 Yes Caribbean 11.71%
Puerto Rico 2002-2008 7 18.26 10.00 Yes Caribbean 11.12%
Qatar 1985-1990 6 25.30 9.50 No Asia 11.93%
Qatar 1999-2009 11 25.30 10.18 No Asia 9.78%
Reunion 1977-1986 10 -21.11 6.40 Yes Africa 7.53%
Reunion 1998-2003 6 -21.11 4.33 No Africa 6.77%
Romania 1986-1992 7 45.69 6.29 Yes Europe 9.60%
Romania 1994-2010 16 45.69 6.25 Yes Europe 10.66%
Saint Helena ex dep 1981-1986 6 -15.93 6.83 No Africa 31.44%
Saint Lucia 1976-1986 11 13.90 10.82 Yes Caribbean 15.27%
Saint Lucia 1994-2002 9 13.90 11.00 Yes Caribbean 20.24%
Saint Vincent and the Grenadines 1992-2005 14 13.20 11.07 Yes Caribbean 23.24%
San Marino 1973-1978 6 43.94 7.33 No Europe 21.85%
San Marino 1984-1989 6 43.94 9.50 No Europe 29.63%
San Marino 2000-2004 5 43.94 7.60 No Europe 21.12%
Sao Tome and Princepe 1967-1971 5 0.32 4.20 No Africa 13.27%
Seychelles 1973-1993 21 -4.63 6.24 Yes Africa 14.81%
Seychelles 1995-2010 16 -4.63 5.94 Yes Africa 18.63%
Singapore 1973-2009 36 1.37 9.36 Yes Asia 12.77%
Slovakia 1988-1995 8 48.66 5.75 Yes Europe 10.10%
Slovakia 1998-2002 5 48.66 6.20 Yes Europe 10.16%
Slovenia 1988-1996 9 46.17 6.67 No Europe 7.17%
Slovenia 1998-2005 8 46.17 7.38 Yes Europe 7.97%
Spain 1970-1985 16 39.72 6.38 Yes Europe 8.40%
Spain 1991-2005 15 39.72 7.87 No Europe 6.53%
Sri Lanka 1973-1986 14 7.57 9.14 No Asia 7.64%
Sri Lanka 2005-2010 6 7.57 10.00 Yes Asia 8.98%
Suriname 1989-2009 21 5.06 11.05 Yes Americas 15.05%
Sweden 1973-1990 18 58.91 4.56 Yes Europe 15.25%
Sweden 1992-2002 11 58.91 4.91 Yes Europe 13.90%
Sweden 2004-2010 7 58.91 5.71 Yes Europe 11.19%
Switzerland 1973-1982 10 47.03 5.00 Yes Europe 10.33%
Switzerland 1984-1990 7 47.03 5.86 Yes Europe 6.26%
Switzerland 1998-2002 5 47.03 6.80 No Europe 5.78%
Tajikstan 1989-1994 6 38.70 4.00 Yes Asia 23.24%
Macedonia 1989-1993 5 41.74 8.20 No Europe 9.54%
Macedonia 1999-2010 12 41.74 7.83 Yes Europe 10.20%
Tonga 1993-2000 8 -19.70 4.25 Yes Asia 16.00%
Trinidad and Tobago 1972-1995 24 10.55 10.83 Yes Caribbean 14.04%
Tunisia 1971-1976 6 35.42 2.83 Yes Africa 16.04%
Tunisia 1978-1982 5 35.42 4.00 Yes Africa 13.83%
Tunisia 1985-1995 11 35.42 5.18 No Africa 13.40%
Tunisia 2001-2007 7 35.42 7.00 Yes Africa 16.75%
Turks and Caicos Islands 1997-2005 9 21.51 9.56 No Caribbean 25.43%
Ukraine 1980-1986 7 48.81 6.00 Yes Europe 9.52%
Ukraine 1989-1996 8 48.81 5.75 Yes Europe 9.77%
Ukraine 2003-2010 8 48.81 8.25 Yes Europe 10.28%
UK + NI 1982-1988 7 52.75 6.71 Yes Europe 6.85%
UK + NI 1990-2006 15 52.75 7.47 Yes Europe 6.61%
USA 1969-1975 7 40.42 8.86 Yes Americas 7.21%
USA 1978-2006 29 40.42 8.07 Yes Americas 7.95%
USVI 1969-1973 5 18.33 10.80 Yes Caribbean 19.68%
USVI 1980-1997 18 18.33 10.61 Yes Caribbean 16.64%
Uruguay 1980-1988 9 -33.00 8.33 No Americas 5.55%
Uzbekistan 1993-1997 5 40.68 5.80 No Asia 8.36%
Venezuela 1972-2001 30 9.39 9.40 Yes Americas 9.41%
Wallis and Futuna Islands 1973-1978 6 -13.30 4.00 No Asia 10.72%
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APPENDIX B
Unraveling the Transmission Ecology of Polio
B.1 Polio Transmission Ecology: Materials & Methods
B.1.1 Data
Our data consisted of monthly cases reported in the weekly US Public Health
Reports and the CDC Morbidity and Mortality Weekly Report from January 1931–
December 1954 for each US state and the District of Columbia. The data were first
published in [1], which includes discussion of data quality during this period. Data
are included in CSV files as Supporting Information. Estimates of paralytic polio
reporting during this time period are 60–80%, while the reporting of non-paralytic
cases varied city-to-city. Monthly state–level time series of live births from 1931–1954
were downloaded from the Vital Statistics of the United States [2]. Annual state–level
population size data were collected from the Population Distribution Branch of the
US Census Bureau [3].
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B.1.2 Data Analysis
An epidemic fadeout was defined as three consecutive months without reported
cases. The portion of fadeout months was calculated for each state and each year as
the number of months that were part of a fadeout, divided by the total months in the
era. The relationship between the portion of fadeout months and state population
size (taken as the mean population size for the era) was fit using a negative exponen-
tial to the fadeout data. A negative exponential was fit to each era independently
using Nonlinear Least Squares, nls, in R. The following is the equation used to relate
fadeouts to population size:
portion of fadeout months = be−aN , (B.1)
where N is log10(population size). The pairwise epidemic synchrony between states
was measured using the spatial nonparametric covariance function in the R package
ncf [4]. The distance between states was measured as the distance between the pop-
ulation center of each state. Population centers were gathered from the US Census
Bureau from the 2000 US Census. Data from https://www.census.gov. Population
centers were used from the year 2000 because, at the time of this project, mid-20th
century estimates of population centers were not available. However, the US Census
has now made historical population centers available.
In order to test for periodicity in epidemics, a wavelet spectral analysis was con-
ducted for each state using the R package biwavelet [5]. Significance of the 1 year
period was tested using the lag-1 autocorrelation, with state-specific lag-1 autocor-
relation calculated for each time series. Since the 1 year period was significant for
each state, phase angle time series were constructed for the 1 year period in order to
measure the seasonal timing of epidemics. For each year, the states were ranked 1 –
49, with 1 being the state for which the epidemic peaked earliest in the year, and 49
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being the state with the latest epidemic peak. The states were ranked according to
their phase angle in the month of August. The phase angle is zero at the epidemic
peak, negative before the peak, and positive after the peak. Thus, the state with the
largest positive phase angle was ranked 1. The epidemic timing was regressed with
latitude and mapped in order to test for spatial patterns.
B.1.3 Model
To mechanistically model polio epidemiology we utilized a Partially Observed Markov
Process (POMP) model which is suited for dealing with epidemiological data where
the state variables (susceptible, infected, recovered individuals) are not observed in
the data; rather the infected individuals are partially observed through case reports.
For our process model we used a seasonally-forced stochastic monthly discrete-time
SIR model where transitions followed a Poisson process. The model has a single re-
covered class that accounts for life-long immunity. The model contains 6 classes (SBi )
of infants susceptible to infection but protected from clinical illness by maternally
antibodies. The 6 susceptible infant classes contain 0–1 month olds, 1–2 month olds,
etc., up to 6 month olds. The model had a single infected class for infants (IB).
The older age class contains individuals > 6 months of age, and these individuals
have their own susceptible (SO) and infected class (IO). The measurement model
translated infections to clinical reported cases. We assume that infections in indi-
viduals under 6 months of age are asymptomatic, and only individuals over 6 month
of age can be symptomatic and reported as a clinical case. Refer to the main text















with the following condition imposed,
λt =

λt, if λt ≥ 0
0, otherwise
. (B.3)
The first term of the force of infection represents transmission that occurs locally by
individuals infected in the state at time t. Whereas, the second term, ψ, encompasses
WPV that arises in the population in a way that is divorced from the local infection
dynamics. These infections can include immigration of infected individuals from
other geographic locations, environmental sources of WPV, and individuals shedding
with an infectious period longer than a month. The transmission parameter βt was
parameterized using a B-spline, giving it the flexibility to have either a constant





where each ξit is a periodic B-spline basis with a 1 year period. The periodic.bspline.basis()
function in the pomp package was used to construct the B-spline bases. The process









where the scale parameter, Θ, of the gamma distribution accounts for both environ-













The first term of Θ represents demographic stochasticity that is modulated by the
force of infection, λt. Whereas, the second term represents environmental stochastic-
ity. Formulating the process noise in this way gives us some useful properties,
E [εt] = 1 (B.7)
Var [εt] = Θ. (B.8)
Thus, the variance can capture purely environmental stochasticity, under the following
parameterization:
Var [εt] = β
2
sd2
, if βsd1 = 0 (B.9)










, if βsd2 = 0 (B.10)
Due to the computational intensity of this project, we used a discrete time model
with a 1 month time step to speed-up simulation. We implemented the model as a
poisson process. There is one probability governing the movement of individuals out





One minus the probability of remaining susceptible is the probability of either being
infected or dying. The parameter δ is the natural death rate. The superscripts B and
O will indicate infants (i.e., babies) and older individuals, respectively. The equations
for the first infant class is:
SB1t+1 = Bt+1, (B.12)
where Bt+1 are the births in month t + 1. Similarly, the other five infant classes are
tracked using the following equations:
SBjt+1 = S
B
j−1tpSt ; for j ∈ 2 : 6. (B.13)
The equation above describes that infants in the j−1 susceptible infant class at time
t move into infant class j at time t+ 1 if they are not infected or die of natural death.








The first term of the SO equation represents the movement of infants from the oldest
infant class SB6 to the susceptible non-infant class. Whereas, the second term repre-
sents susceptible non-infants from time t remaining susceptible at time t + 1. The








Infants from each of the six susceptible infant classes have a probability of being
infected or dying, 1− pSt . The probability that an individual is infected, rather than
death is λt
δ+λt








Note, infected individuals are infected for exactly 1 month, which is the typical dura-
tion of shedding [7]. There was one rounding condition imposed on infections in the
process model. If IBt or I
O
t were values between 0 and 1, they were rounded to 0 or
1. This was in order to prevent fractions of infected individuals.
B.1.3.2 Measurement Model
In order to model the stochastic process of infected individuals becoming symp-
tomatic and subsequently being reported as a case, we drew cases from a normal
distribution.
casest ∼ normal(ρtIOt , τIOt ), (B.17)
with the following condition imposed,
casest =

round(casest), if casest ≥ 0
0, otherwise
(B.18)
For calculating likelihood we used a binned-normal probability density.
If casest > 0,




t )−pnormal(casest−0.5, ρtIOt , τIOt )+1e−18.
(B.19)
If casest = 0,




t ) + 1e
−18. (B.20)
The report rate, ρt, was estimated for the Pre-Baby Boom era and the Baby Boom
era, with the change in report rate occurring in January 1946, the start of the Baby
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Boom. The parameter τ captures the variation in the process of observing infections
via reported cases. The scaler 1e−18 was used for practical purposes to put a lower
bound on the likelihood in order to ensure finite log-likelihood values. Initially we
tried using a continuous normal measurement model, however, we discovered that a
continuous normal model over-inflated the likelihood of parameter sets that produced
zero cases in trough months, making it difficult to identify parameter regimes that
could capture both the epidemic cases and the trough cases. Thus, we used the
binned-normal distribution.
B.1.4 Statistical Inference
We fit our SIR model to the data from each state independently using Maximiza-
tion by Iterated particle Filtering (MIF) in the R package pomp [8, 9]. pomp tu-
torials and vignettes may be found at http://pomp.r-forge.r-project.org/. MIF is a
simulation-based likelihood method for parameter estimation. The basis of MIF is
particle filtering, which integrates state variables of a stochastic system and estimates
the likelihood for fixed parameters. Instead of fixing parameters, MIF varies them
throughout the filtering process and selectively propagates particles (parameter sets)
that have the highest likelihood. By initializing MIF throughout parameter space we
estimated the shape of the likelihood surface for each US state and identified the Max-
imum Likelihood parameter Estimates (MLEs). MIF was initialized from 1 million
parameter sets for a global search, followed by additional phases of increasingly local-
ized searches, which included profiling. In total, for each US state, MIF was initialized
from tens-of-thousands of locations in parameter space to estimate the shape of the
likelihood surface and identify the MLEs. We characterized seasonal transmission
using a B-spline with six bases. Although the transmission rate fluctuated seasonally,
there was no inter–annual variation in transmission in our model. In order to account
for improved reporting brought about by the Foundation for Infantile Paralysis, we
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estimated two report rates, one for the Pre-Baby Boom Era and another for the Baby
Boom Era. Inference was done using the data from May 1932 to January 1953, with
the exception of South Dakota and Texas, whose inference started in May 1933 and
1934, respectively.
For each state inference was initiated in May of the year following the first full year
of available data on polio cases and births. This was done in order to construct the
infant initial conditions directly from the birth data. The month of May is the tail-end
of the polio off-season. Thus, the 0-6 month old infants in May were born between
November and April, when polio transmission was low and they were unlikely to be
infected. Based on this, we assumed that the initial number of susceptible infants in
the 6th infant class was the number of individuals born in November of the previous
year, individuals born in December were in the 5th infant class, January births were
in the the 4th infant class, February births in the 3rd infant class, March births in the
2nd infant class, and April births in the the 1st infant class. We set the initial number
of infected infants to zero. Constructing the infant initial conditions prevented us from
having to estimate an addition seven parameters.
B.1.4.1 Phase I: Global Search
To initialize a global search of parameter space, 1 million parameter combinations,
with initial conditions reflecting a low incidence month, were generated to cover the
range of parameter values given in Table B.1. For each parameter set, ten replicate
particle filters were run, each with 2000 particles, to estimate the likelihood of the data
from the state of Illinois. Illinois was chosen because of the high incidence of polio
in Illinois and because Illinois had an increase in incidence following the World War
II baby boom, which was a characteristic feature of most US states. The reporting
transition was fixed to January 1946, the start of the Baby Boom era and about the
time when non-paralytic polio cases started being reported. Each parameter set was
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placed in combination with an increase in report rate of 0% and 1%. The 1 million
likelihoods were used to provide a rough estimate of the global shape of the likelihood
surface and identify regions of parameter space with high likelihood. Of the 1 million
parameter sets, the 50000 with the highest likelihoods were used to initialize Phase
II. It is important to note that the particle filter gives an unbiased estimate of the
likelihood, but some extra algebra needs to be done to get the estimates of the log-
likelihood from replicate particle filters. We calculated the unbiased estimate of the
log-likelihood using the following equations,
log ~L(Θ) = ~x. (B.21)
Given the vector of log-likelihoods, ~x, produced from n replicate particle filters under
the parameter set Θ (not to be confused with Θ in earlier equations), we find the
mean:
y = mean(~x) (B.22)
then we use the mean to estimate of the log-likelihood:
logL = y + log(mean(e~x−y)) (B.23)







where sd is the standard deviation.
B.1.4.2 Phase II: Initial Condition Improvement
Each of the 50000 parameter sets obtained from Phase I was taken in pairwise
combination with the data from each of the 49 continental US states. For each
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parameter interpretation lower bound upper bound search scale
ρ report rate 0.0001074816 0.9999401 logit
∆ρ increase in report rate 0 0.01 logit
τ measurement stochasticity 1.024683e-06 2390.506 log
ψ external source of infection 1.843172e-07 114.648 log
δ natural death rate 0.001388889 NA NA
βsd1 demographic stochasticity 1.835635e-07 21.59023 log
βsd2 environmental stochasticity 1.217956e-07 15.25643 log
βi B-spline basis coefficients 9.152956e-12 770910.8 log
Table B.1: Parameter Bounds used in Global Search. Values in the table are on
the natural scale, rates are given in months. ρ is the report rate for
the Pre-Baby Boom era, and ∆ρ is the increase in report rate during
the Baby Boom. The natural death rate δ was fixed. The search scale
indicates whether parameters were transformed into the log or logit scale
for searching parameter space. The transformation ensured the breadth
of the search. Note, that parameter searches were not restricted to these
bounds, rather these bounds were used to initialize searches for parameter
space.
parameter set and US state combination, maximization by iterated particle filtering
(MIF) was used to improve the estimates of the initial conditions using the first 12
months of data. Each initial condition had a random walk standard deviation of
0.02. Each MIF had 45 iterations, 2000 particles, hyperbolic cooling with a variance
factor of 2, and a cooling fraction of 0.5. This resulted in 50000 parameter sets for
each state, each with unique initial conditions. For each parameter set, ten replicate
particle filters were run, each with 2000 particles, to estimate the likelihood of the
full time series (i.e., the fitted region of the data) from the state. All searches of
parameter space were done on the log or logit scale. The log scale was used to enforce
parameter values > 0 and the logit scale was used to bound parameters, such as the












B.1.4.3 Phase III–V: Local Searches of Parameter Space
In Phase III, for each US state, the top 25000 likelihood parameter sets from Phase
II were carried forward into Phase III. Therefore, in Phase III, MIF was initiated
from a total of 1225000 parameter sets. Each initial condition and all other estimated
parameter were allowed to vary in MIF with a random walk standard deviation of
0.02, with the exception of ∆ρ which was given a random walk standard deviation
of 0.03. It is important to note that the random walk standard deviations for ρ and
∆ρ were time-varying. ρ was estimated using the data up through December 1945,
and ∆ρ was estimated using the data beginning in January 1946. Thus, the random
walk standard deviation for ρ was zero from Jan 1946 onward. Likewise, the random
walk standard deviation for ∆ρ was zero up until January 1946. In order to define
time-varying random walk standard deviations, the MIF2 method was used in the
developer version of pomp, version 0.44-1. Refer to Table B.1 for a list of estimated
parameters. Each MIF run had 45 iterations, 2000 particles, hyperbolic cooling with
a variance factor of 2, and a cooling fraction of 0.5. Here the reporting transition
remained fixed at January 1946, although ∆ρ was allowed to vary. Once again, for
each parameter set, ten replicate particle filters were run, each with 2000 particles,
to estimate the likelihood of the data from the state.
In Phase IV, the 1225000 parameter sets from Phase III were culled to remove
all parameter combinations that had a likelihood 20 log-likelihood units below the
maximum for that state. Using the culled parameter sets, MIF was run with 45
iterations, 2000 particles, hyperbolic cooling with a variance factor of 2, and a cooling
fraction of 0.5. Random walk standard deviations were the same as Phase III. To
estimate the likelihood, ten replicate particle filters were run, each with 2000 particles.
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In Phase V, 49000 parameter sets were chosen using the 1000 top likelihood pa-
rameter sets for each US state from Phase IV. In Phase V, MIF was run with 45
iterations for each parameter set using the same MIF settings as Phase IV, with the
exception of the ∆ρ random walk standard deviation, which was 0.02.
B.1.4.4 Phase VI & VII: Profiling Report Rate and Immigration
In Phase VI, we found the range of ρ and ψ in the top parameter sets for each
state. For profiling, ρ and ψ values were generated to span the range. The ranges
were [0.001, 0.1] and [6e-6, 2.5e-3], for ρ and ψ, respectively. There were 37 values of
ρ, (ρ1, ρ2, ..., ρ37), with 0.001 interval sampling in the range of [0.001,0.03] and 0.01
interval sampling in the range of [0.04,0.1]. There were 50 values of ψ, (ψ1, ψ2, ..., ψ50)
evenly sampled across the range. In order to make the profiles two dimensional, we
took every pairwise combination of ρ and ψ, which resulted in 1850 profile points,
each being a unique combination of ρ and ψ. Next, we needed to identify the other
parameters to join with our 1850 combinations of ρ and ψ. At each of the 1850 profile
points we used four parameter set variants for each US state. The first variant was
the ρi and ψj combination substituted into the maximum likelihood parameter set
from Phase V (US state-specific maximum). The second variant was the ρi and ψj
combination substituted into the highest likelihood parameter set for which ρi−1 ≤
ρ ≤ ρi+1. The third was the ρi and ψj combination substituted into the highest
likelihood parameter set for which ψj−1 ≤ ψ ≤ ψj+1. The fourth was the ρi and ψj
combination substituted into the parameter set with the minimum Euclidean distance
from ρi and ψj.
With four parameter set variants at each of the 1850 profile values, there were a total
of 7400 parameter sets used to initialize the 2-D profile for each state. ρ and ψ were
fixed at the given profile values, and MIF was used to maximize the likelihood along
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the other parameter and initial condition dimensions. Starting at each of the 7400
parameter set variants, two replicates of MIF were run. Each estimated parameter
and initial condition had a random walk standard deviation of 0.02. Once again,
the random walk standard deviations for ρ and ∆ρ were time-varying. There were
45 iterations of MIF per replicate, with 2000 particles, hyperbolic cooling with a
variance factor of 2, and a cooling fraction of 0.5. The reporting transition remained
fixed at January 1946. This resulted in 14800 parameter sets for each state, and
725200 parameter sets across all US states. For each state, the likelihood of the
14800 parameter sets was estimated by running 10 replicate particle filters, each with
2000 particles.
In Phase VII, we found the highest likelihood parameter set at each state’s 1850
profile points. The ρ and ψ values remained fixed at each profile point and two repli-
cate MIF runs were preformed. Now each estimated parameter and initial condition
had a random walk standard deviation of 0.01.There were 60 iterations of MIF per
replicate, with 4000 particles, hyperbolic cooling with a variance factor of 2, and
a cooling fraction of 0.5. This resulted in 3700 parameter sets for each state, and
181300 parameter sets across all US states. For each state, the likelihood of the 3700
parameter sets was estimated by running 10 replicate particle filters, each with 4000
particles.
B.1.4.5 Phase VIII: Profiling Report Rate and Immigration with Con-
stant Reporting Assumption
In order to test whether the increased report rate during the Baby Boom Era,
represented by ∆ρ, is necessary to account for the increased incidence during the
Baby Boom Era, we repeated the profiling in Phase VII, with ∆ρ = 0. For each US
state we then used AIC to determine which model best fit the data, the model with
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∆ρ = 0 or the model with ∆ρ > 0. For each state, the MLE was taken from the
model with the lower AIC.
B.2 Polio Transmission Ecology: Results
B.2.1 Patterns in the Data
The negative exponential functions representing the relationship between fadeouts
and population size for the Pre-Baby Boom and Baby Boom are given as,
portion of fadeout months Pre-Baby Boom = 9195e
−1.8N | N is log10(population size),
(B.27)
portion of fadeout months Baby Boom = 10230e
−2N . (B.28)
B.2.2 Inference Results
Model Validation. In order to test the fit of the model for each state we first
used the MLE for each state to calculate the expected number of infected non-infants
for each month of the fitted data, May 1932–January 1953 for all states except South
Dakota and Texas whose inference started in May 1933 and 1934, respectively. The
expected number of infections was obtained by running a particle filter with 2000
particles and taking the prediction mean of the particles at each time point. The
prediction mean is the expected state value at time t, given the data and the state
values up to time t− 1.
E(Xt | Xt−1, casest−1) (B.29)
In order to get the expected number of cases, we took the expected number of non-
infant infections and multiplied it by the state- and time-specific report rate.
E(casest) = ρtE(IOt | Xt−1, casest−1) (B.30)
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For model validation, the r-squared was quantified for the model as the reduction
in the sum-of-squared deviations obtained when using the expected cases from the







The generalized r-squared was quantified for the model as the reduction in the sum-
of-squared deviations across all US states obtained when using the expected cases












The out-of-fit predictions were done using the same procedure as was used for the
fitted data region. The out-of-fit predictions were done using the data from the last
two epidemic years, January 1953–December 1954.
Predicated Latitudinal Gradient. In order to determine whether or not the
model reproduces the latitudinal gradient in the timing of polio epidemics, 10 stochas-
tic simulations were run using the MLE for each state. For these 10 simulations, we
used the inference time period inclusive to all states, May 1934–January 1953. The
simulations were taken together to test for a gradient in the simulated data. A wavelet
analysis was run on the simulated time series and the phase angles associated with
the 1 year period were used to rank the states 1-49, 1 being the earliest epidemic
peak and 49 being the latest epidemic peak. We found that the model reproduces
the latitudinal gradient in the timing of polio epidemics (main text Fig 4.3) with
epidemics peaking earlier in the southern US and later in the northern US (observed
gradient shown in Fig B.1). In order to determine whether the latitudinal gradient in
the timing of polio epidemics is driven by the latitudinal gradient in birth peak tim-
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ing, and/or seasonal birth amplitude, we simulated the model with birth seasonality
removed. We did this by decomposing the birth time series using the stl function in R
and using the trend in births as a model covariate, rather than using the actual births.
We found that the model without birth seasonality (Fig B.4) also displays a latitu-
dinal gradient (Fig B.5). The latitudinal gradient in the timing of polio epidemics is
largely driven by the latitudinal variation in the timing of peak polio transmission.
Fig B.7 shows that the peak transmission rate for polio occurs between May and July
in the US. The peak transmission rate in southern states typically occurs in May and
the peak transmission rate in northern states occurs in July, a couple months earlier
than their respective peak in incidence. In order to test whether the predicted timing
of peak polio incidence matches the observed timing, we compared the mean rank
calculated from the data and the mean rank based off simulation. See main text Fig
4.3D, showing the correlation between the observed and predicted mean rank. You
will also see in Fig B.5C–D that the simulated slope and R2 values of latitude vs.
mean rank reflect a latitudinal gradient.
While geographical variation in birth seasonality was insufficient to explain the lat-
itudinal gradient seen in epidemic timing, birth seasonality played a role in shaping
seasonal incidence of polio. Epidemiological theory indicates that birth seasonality
can have important dynamical consequences for childhood diseases [10, 11, 12]. To
quantify the influence of birth seasonality (Fig B.4) on infant infections, we com-
pared simulations of the fitted models to simulations for which seasonal fluctuations
in births were removed. In the presence of birth seasonality, infant infection incidence
was generally higher during the epidemic peak (Fig B.6); however, since infant infec-
tions were assumed to be asymptomatic, this did not affect the incidence of disease
directly, and no indirect effect was observed. We attribute the negligible effect of
birth seasonality on disease incidence to the low amplitude of birth seasonality, which
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was ∼ 10% in the US at this time[11].
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Figure B.1: Probability densities of the timing of the epidemic peak for each state
during the pre-baby boom and baby boom eras. For each state, the
timing of the epidemic peak was determined for each year with 20+ polio
cases. The probability was measured as the portion of years (in each era)
for which the peak occurred between July/Aug, Aug/Sept, Sept/Oct,
and Oct/Nov. Peak timing was measured using the 1 yr wavelet band
phase angle.
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Figure B.2: One-step-ahead predictions based on the MLE model for each of four
states. Observed and expected cases are shown on the natural scale, in
contrast to Fig 4.3B in the main text, which is on the log10 scale.
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Figure B.3: Out-of-fit predictions based on the MLE model for each of four states.
Observed and expected cases are shown on the natural scale, in contrast
to Fig 4.3C in the main text, which is on the log10 scale. A negative R
2
value indicates that the null model had a lower sum of squared deviations
than the fitted model for the out-of-fit predictions, which was the case
for 3 of the 49 states (Alabama, Connecticut, and Delaware). Alabama
























































































Figure B.4: Monthly births (black time series) are seasonal. Monthly births were
used as covariates for the fitted models. Th trend in births is shown by
the dashed line (fuchsia). Four states from different geographic regions
are shown.
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R2  = 0.51
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Model with birth seasonality (1935−1952)A
Model without birth seasonalityB
C D
Figure B.5: Latitudinal gradient predicted from model simulations using maximum
likelihood parameter estimates for each state. (A) Latitudinal gradient
in simulations of the fitted models with seasonal births. (B) Latitudi-
nal gradient in simulations with birth seasonality removed (i.e., trend in
births was used). (C) The distribution of the latitudinal gradient slopes
for 10 simulations for each US state for the model with birth seasonal-
ity (i.e. using the raw birth data) and the model with birth seasonality
removed (i.e. using the trend in births). (D) The R2 for the latitudinal















































































































































































































































Figure B.6: Mean monthly incidence of infant-infections per 1000 infants, with and
without birth seasonality. Model with birth seasonality is shown in black,
model without birth seasonality in fuchsia. 500 simulation were run for
each state and model combination. Points indicate annual peak incidence.
The model with birth seasonality generally displayed higher peak infant-





































































































Figure B.8: MLE report rates. The report rate is a composite parameter that encom-
passes the probability of an infected individual becoming symptomatic,
and the subsequent probability that symptomatic infections are reported.
(top-left) The distribution of mean report rates for infants and non-
infants across states. Non-infant report rates during the pre-baby boom
era (top-right) were lower than that of the baby boom era (bottom-left),
due to the increase shown in (bottom-right).
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Likelihood profiles for the pre-baby boom non-infant report rate (ρt) and
the immigration rate (ψ). MLE indicated by pink asterisk. Profile color
indicates whether the report rate was increased during the baby boom








































































































































































































































































































































































































































































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the














































































































































































































































































































































































































































































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the























































































































































































































































































































































































































































































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the






















































































































































































































































































































































































































































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the





































































































































































































































































































































































































































































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the








































































































































































































































































































































































































































































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the

















































































































































































































































































































































































































































































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the
































































































Likelihood profiles for the pre-baby boom non-infant report rate (ρt)
and the immigration rate (ψ). MLE indicated by pink asterisk. Profile
color indicates the whether the report rate was increased during the
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Both Salk and Sabin Vaccines Effectively Reduce
Polio Transmission in Epidemic Settings
C.1 Salk and Sabin Vaccines: Data from the US
Polio case data from the US were separated among 3 data sets, (1) the US Mor-
bidity and Mortality Weekly Report (MMWR) monthly polio case data, (2) the US
National Office of Vital Statistics (NOVS) annual polio case data, and (3) the Cen-
ters for Disease Control and Prevention Poliomyelitis Surveillance Unit (PSU) annual
polio case data. There were 2 demographic data sets, (1) monthly births from the US
National Office of Vital Statistics, and (2) annual population sizes from the US Census
Bureau. There were 6 sets of data regarding the vaccines: the Inactive polio vaccine
(IPV), also known as the Salk Vaccine, and the Oral polio vaccine (OPV), also known
as the Sabin Vaccine. The 6 vaccine data sets were (1) annual age-structured IPV
coverage in the US, by dose of IPV, (2) quarterly or annual shipments of IPV in the
US, (3) annual age-structured OPV coverage in the US, by dose of OPV, (4) annual
shipments of OPV in the US, (5) annual-age structured coverage of dual vaccination
with IPV and OPV, and (6) annual age-structured percent of the population unvac-
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cinated or under-vaccinated with both IPV and OPV. The data sets are discussed in
more detail in the following sections.
C.1.1 MMWR Polio Data.
The MMWR data consisted of monthly polio cases reported in the weekly US
Public Health Reports and the CDC Morbidity and Mortality Weekly Report from
1931–1968 for each US state and the District of Columbia. The data were first
published in [1], which includes discussion of data quality during this period. The
data for the contiguous US states and the District of Columbia were aggregated to
construct a single time series of “national” data, which is used for the entirety of this
project. For details on the state-level data please refer to our previous study [2]. The
MMWR case data were aggregated on the national-level because our vaccine data
were national-level data.
C.1.2 NOVS Polio Data.
The NOVS data contained the number of reported polio cases in the US each year
from 1951–1965. These annual cases were broken down by symptomatology (i.e.,
paralytic, non-paralytic, and unspecified). These data were digitized from the Com-
municable Disease Center Poliomyelitis Surveillance Report Number 268, September
21, 1962, Supplement: The Association of Cases of Poliomyelitis with the use of Type
III Oral Poliomyelitis Vaccines: A Technical Report by Luther L. Terry, Surgeon
General, Public Health Service, US Department of Health, Education, and Welfare,
September 20 1962. The data from 1951–1954 and 1962–1965 came from Public
Health Reports volume 82, Number 5, May 1967 titled “Surveillance of Poliomyelitis
in the United States, 1962–1965” by Morris, Witte, Gardner, Miller, and Henderson.
The data in the aforementioned reports were compiled by the Poliomyelitis Surveil-
lance Unit, Communicable Disease Center, Public Health Service, US Department of
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Health, Education, and Welfare. The NOVS polio case data and the MMWR polio
case data are not completely independent. It is the National Office of Vital Statistics
that provided the polio case data reported in the MMWR. The NOVS data are an
annual breakdown of the MMWR data by symptomatology.
C.1.3 PSU Polio Data.
The PSU data were digitized from the US Centers for Disease Control and Preven-
tion Poliomyelitis Surveillance Unit Reports, these reports were bound as periodicals
and are housed at the Centers for Disease Control and Prevention Library in the
Clifton Landmark Collection, with the call number WC 555 C397p. Each table from
the PSU reports from 1955 onward was evaluated for data. The earliest reports from
which we digitized data were from 1959. The latest reports from which we digitized
data were from the late 1970s. The PSU polio case data contained an annual break-
down of polio cases by age, symptomatology, and vaccine status. The Poliomyelitis
Surveillance Unit was tasked with gathering the details on every polio case in the US
and ensuring vaccine safety following the Cutter incident. Therefore, the Poliomyelitis
Surveillance Unit collected their own case data, independent of the National Office
of Vital Statistics, and the number of cases reported differed among the PSU and
NOVS data.
C.1.4 Demography Data.
Monthly state–level time series of live births from 1931–1954 were downloaded
from the Vital Statistics of the United States [3]. Annual state–level population
size data were collected from the Population Distribution Branch of the U.S. Census
Bureau [4]. The state-level population size and birth data for the contiguous US were
aggregated to form national-level demography time series.
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C.1.5 Vaccine Data.
Vaccination data were also gathered from the Poliomyelitis Surveillance Unit Re-
ports housed at the CDC Library, Clifton Landmark Collection. The main text shows
the raw vaccine coverage data, which are age-stratified vaccine coverage for the age
classes: under 1 year old, 1–4 years old, 5–9, 10–14 years old. Data for these age
classes were used to construct the vaccine coverage for the 1–14 year old age group
as a whole (Figure S1). The under 1 year old age class was excluded due to the lack
of data for this age class from 1962 onward, and because vaccination efforts were
concentrated on the school-aged children. Age-structured population size and vac-
cine coverage data for the 1–14 year old age group constructed from the population
size and coverage data for the 1–4, 5–9, and 10–14 year old age classes. The annual
vaccine coverage data for the 1–14 year old age group was used for statistical infer-
ence. Interpolations are shown for visualization. We lacked IPV coverage data from
1955-1958; however, the cumulative distribution of IPV suggests a linear increase in
vaccine coverage from this time period. Therefore, we fit a single IPV per capita
vaccine uptake rate for the US from April 1955–December 1959.
C.2 Data from the USSR
In order to track the success of the massive polio immunization campaign, the
USSR’s Poliomyelitis Research Laboratory tracked vaccine coverage and clinical cases.
Polio case data and OPV data from the USSR were digitized from Some Results on
the Work on Mass Immunization in the Soviet Union with Live Poliovirus Vaccine
prepared from Sabin Strains in Bulletin of the World Health Organization,
1961, 25, 79-91. Demography data for the USSR was obtained from the United
Nations Demography database. We downloaded crude birth rates (per 1000 people)




































































































































































































































Figure C.1: Age-structured population size and vaccine coverage data for the 1–14
year old age group constructed from the population size and coverage
data for the 1–4, 5–9, and 10–14 year old age classes. The annual vaccine
coverage data for the 1–14 year old age group was used for statistical
inference. Interpolations are shown for visualization.
number of live births occurring during the year, per 1000 population estimated at
midyear. Data available online at https://data.un.org. Population data were also
























































































































Figure C.2: IPV coverage and distribution in the US. We lacked IPV coverage data
from 1955-1958; however, the cumulative distribution of IPV suggests a
linear increase in vaccine coverage from this time period. Therefore, we
fit a single IPV per capita vaccine uptake rate for the US from April
1955–December 1959.
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C.3 Modeling Vaccine Uptake Rate
In order to capture the vaccine coverage in the population of each country/region,
we estimated the per capita monthly vaccine uptake rates using the vaccine coverage
data. In the pre-vaccine era, the vaccine uptake rate was set to zero and it was
estimated beginning with the introduction of IPV/OPV in the US and USSR.
C.3.1 US
In the US, the vaccine uptake rates were tracked as state variable in our process
model. The IPV uptake rate was










where the first term represents the IPV uptake rate from 1955–1959, the second
term represents the IPV uptake rate from 1960–1962, and the last term represents
the gradual decline of the IPV uptake rate during the OPV era, 1963 onward. The
covariates, IPV icover, are time-varying and take on the value of either 0 or 1, allowing
us to shut off or turn on each component of the uptake rate. Similarly, for the OPV
uptake rate in the US, we used the equation:




covar)− (OPV 2uptakeOPV 2covart). (C.2)
However, since individuals with 3+ doses of IPV were also vaccinated with OPV, we
had an IPV to OPV uptake rate of:
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IPV to OPV uptake ratet = (IPV to OPVuptakeOPV
1
covar)− (OPV 2uptakeOPV 2covart).
(C.3)
Once again, the covariates OPV icovar allow us to shut off or turn on each term in the
equation. OPV 1covar was turned on at the onset of licensing of all monovalent OPVs,
and OPV 2covar allowed us to account for the decline in the OPV uptake rate toward
the end of the OPV era. We constrained the uptake rates such that they had a value
≥ 0.
C.3.2 USSR
Modeling vaccine uptake in the USSR was much more simple than the US, because
only OPV was in use. The uptake rate for OPV in the USSR was either zero (before
OPV was launched) or it was a fixed value estimated form the data. For each region
in the USSR, OPV uptake was modeled as:
OPV uptake ratet = OPVuptakeOPVcovar, (C.4)
where, OPVuptake was estimated from the data and OPVcovar was zero before the use
of OPV in the USSR, and was 1 after the launch of OPV.
C.4 Transmission Models
To mechanistically model polio epidemiology we utilized Partially Observed Markov
Process (POMP) models which are suited for dealing with epidemiological data where
the state variables (susceptible, infected, recovered individuals) are not observed in
the data; rather the symptomatic infected individuals are partially observed through
case reports. For our process models we used seasonally-forced stochastic monthly
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discrete-time SIR models where transitions followed a Poisson process. The models
had a single recovered class that accounts for life-long immunity. The models con-
tained 6 classes (SBi ) of infants susceptible to infection but protected from clinical
illness by maternally antibodies. The 6 susceptible infant classes contained 0–1 month
olds, 1–2 month olds, etc. up to 6 month olds. The models had a single infected class
for unvaccinated or under-vaccinated infants (IB). The older age class contained indi-
viduals > 6 months of age, and these individuals had their own unvaccinated/under-
vaccinated susceptible (SO) and infected class (IO). Infected individuals > 6 months
of age, that were no longer protected from disease by maternal antibodies, had a
probability of having paralytic polio or non-paralytic polio. Each process model had
a measurement model that translated symptomatic (i.e., paralytic and non-paralytic)
infections to clinical reported cases. Based on clinical data, we assumed that infec-
tions in individuals under 6 months of age are asymptomatic, and only individuals
over 6 month of age can be symptomatic and reported as a case.
C.5 Epidemiological Process Model
A similar version of this model was originally validated in our previous study to
understand the state-level transmission dynamics of polio [2]. The difference between
this model and our previous model is now we explicitly accounted for symptoms in
the process model (i.e., paralytic and non-paralytic polio), and we now included IPV
and OPV vaccination in the population. In our model, the force of infection, also











The first term of the force of infection represents transmission that occurs locally
by individuals infected in the country/regions at time t. Whereas, the second term,
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ψ, encompasses WPV that arises in the population in a way that is divorced from
the local infection dynamics. These infections can include immigration of infected
individuals from other geographic locations, environmental sources of WPV, and in-
dividuals shedding with an infectious period longer than a month. The parameters
ζ1 and ζ2 are the relative infectiousness of individuals vaccinated with IPV or OPV,
respectively. Therefore, if ζ = 1 the vaccine does not reduce infectiousness. The
parameter α was used in the model of the US to account for deviations from homoge-
nous mixing due to the board geographic scale. A value of α ≤ 1 saturates the force
of infection as the number of infected individuals in the population increases. For
the USSR, we fixed α = 1. The transmission parameter βt was parameterized using






where each ξit is a periodic B-spline basis with a 1 year period. Although the trans-
mission rate was able to fluctuate seasonally, there was no inter–annual variation in








where the scale parameter, Θ, of the gamma distribution accounts for both environ-
















The first term of Θ represents demographic stochasticity that is modulated by the
force of infection, λt. Whereas, the second term represents environmental stochastic-
ity. Formulating the process noise in this way gives us some useful properties:
E [εt] = 1, (C.9)
Var [εt] = Θ. (C.10)
Thus, the variance can capture purely environmental stochasticity, under the following
parameterization:
Var [εt] = β
2
sd2
, if βsd1 = 0, (C.11)










, if βsd2 = 0. (C.12)
Due to the computational intensity of this project, we used a discrete time model
with a 1 month time step to speed-up simulation. We implemented the model as a
poisson process. There is one probability governing the movement of individuals out




The parameter δ is the natural death rate. One minus the probability of remaining
susceptible is the probability of either being infected or dying. The equations for the
first infant class is:
SB1t+1 = Bt+1, (C.14)
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where Bt+1 are the births in month t + 1. Similarly, the other five infant classes are
tracked using the following equations:
SBjt+1 = SBj−1tpBt ; for j ∈ 2 : 6 (C.15)
The equation for SBjt+1 states that infants in the j−1 susceptible infant class at time
t move into infant class j at time t+ 1 if they are not infected or die of natural death.
Similarly, there is one probability governing the movement of individuals out of the
susceptible non-infant class, pOt , which is the probability that a susceptible remains
susceptible. One minus the probability of remaining susceptible is the probability of
either being infected, vaccinated, or dying.
pOt = e
−(δ+λt+IPV uptake ratet+OPV uptake ratet), (C.16)
where “IPV uptake ratet” and “OPV uptake ratet” are monthly per capita vaccine
uptake rates that account for vaccine roll-out. See earlier section for calculation of
vaccine uptake rates. The equation for the susceptible non-infant age group is:
SOt+1 = SB6tpBt + pOtSOt (C.17)
The first term of the SO equation represents the movement of infants from the oldest
infant class SB6 to the susceptible non-infant class. Whereas, the second term repre-
sents susceptible non-infants from time t remaining susceptible for time t+1. For the
vaccinated classes, the probability that an individual remains in the IPV class, pIPVt ,
is dependent on the force of infection and the OPV uptake rate of IPV-vaccinated
individuals, i.e., the “IPV to OPV uptake ratet”. Thus,
pIPVt = e
−(δ+ζ3λt+IPV to OPV uptake ratet). (C.18)
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Here, ζ3 is the susceptibility to infection of IPV-vaccinated individuals, relative to
unvaccinated individuals. The equation for the IPV class is:
IPVt+1 = SOt(1− pOt)
IPV uptake ratet
δ + λt + IPV uptake ratet + OPV uptake ratet
+ pIPVtIPVt.
(C.19)
Similarly, the probability that an individual remains in the OPV class is dependent
on the force of infection,
pOPVt = e
−(δ+ζ4λt) (C.20)
The equation for the OPV class is,
OPVt+1 = SOt(1− pOt)
OPV uptake ratet
δ + λt + IPV uptake ratet + OPV uptake ratet
+IPVt(1− pIPVt)
IPV to OPV uptake ratet
δ + ζ3λt + IPV to OPV uptake ratet
+ pOPVtOPVt;
(C.21)








Infants from each of the six susceptible infant classes have a probability of being
infected or dying, 1 − pBt . The probability that an infant is infected, rather than
death is λt
δ+λt
. The equation for infected non-infants is similar in structure,
IOt+1 = SOt(1− pOt)
λt
δ + λt + IPV uptake ratet + OPV uptake ratet
. (C.23)
Vaccinated individuals are also able to be infected, according to the reports of par-
alytic and non-paralytic polio in IPV and OPV vaccinated individuals in the PSU
data. The infected IPV class was modeled as:
IIPVt+1 = IPVt(1− pIPVt)
ζ3λt
δ + ζ3λt + IPV to OPV uptake ratet
. (C.24)
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Similarly, the infected OPV class is:




Note, infected individuals are infected for exactly 1 month, which is the typical dura-
tion of shedding [5]. The infections were then broken down based on symptomatology.
The majority of polio infections are asymptomatic, but some will manifest as para-
lytic or non-paralytic polio. We modeled paralytic polio for the unvaccinated/under-
vaccinated individuals as,
ParalyticUt = ppIOt ; (C.26)
and for non-paralytic polio as,
NParalyticUt = pnpIOt , (C.27)
where pp and pnp are the probability of paralytic and non-paralytic polio, respectively,
in an unvaccinated infected individual. Paralytic and non-paralytic infections were
also tracked for IPV individuals. Paralytic IPV infections are:
ParalyticIPVt = ζ5ppIIPVt , (C.28)
while, non-paralytic IPV was,
NParalyticIPVt = ζ6pnpIIPVt , (C.29)
where ζ5 and ζ6 are the reduction in the paralytic and non-paralytic probability
provided by IPV. Since the PSU reports no cases of non-paralytic polio in OPV
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individuals, we only tracked paralytic polio in OPV individuals,
ParalyticOPVt = ζ7ppIOPVt . (C.30)
There was one rounding condition imposed in the model of infections. If the number
of individuals in IBt , IOt , IIPVt , IOPVt , paralytic, or non-paralytic infection classes were
values between 0 and 1, they were rounded to 0 or 1. This was in order to prevent
fractions of infected individuals. Since the MMWR data reports both paralytic and
non-paralytic infections, we also had a symptomatic class,
Symptomatict = ParalyticUt+NParalyticUt+ParalyticIPVt+NParalyticIPVt+ParalyticOPVt .
(C.31)
The NOVS data had the breakdown of cases by paralytic and non-paralytic symptoms,
so we also tracked those classes for NOVS,
Paralytict = ParalyticUt + ParalyticIPVt + ParalyticOPVt , (C.32)
and,
NParalytict = NParalyticUt + NParalyticIPVt . (C.33)
For data sets where cases were reported annually (i.e., NOVS and PSU), in the model
the cases were accumulated from January–December and reported in December.
C.6 Vaccine Tracker Model
Since the majority of polio infections are asymptomatic, when the vaccines were
rolled-out, naturally-immune individuals (i.e., individuals in the recovered class) were
undoubtedly vaccinated and counted in the vaccine coverage data. Therefore, in order
to estimate the vaccine uptake rates from the vaccine coverage data, we needed to
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track vaccine coverage in the population, not just the susceptible individuals. To do
so we constructed what we refer to as vaccine tracker classes, these classes tracked
the demography of each country/region and are similar to the epidemiological process
model states, with the exception that they do not include the infection process. For
the US, the vaccine tracker classes tracked the individuals >6 months old and <15
years old; this is because our vaccine data for the US were based on the 1–14 year age
group. In contrast, in the USSR, the vaccine tracker classes tracked all individuals >6
months old, because vaccine coverage data in the USSR were for the entire population.
In the vaccine tracker model, the probability that an individual remained in the
unvaccinated class, pU , was:
pUt = e
−(Λ+δ+IPV uptake ratet+OPV uptake ratet); (C.34)
where, the new parameter Λ is the rate of aging out of the vaccine tracker class.
In the US the rate of aging out was 14 yrs−1, because we were tracking the vaccine
coverage in the population under 15. The unvaccinated/under-vaccinated class was
tracked as:
Ut+1 = SB6tpBt + UtpUt . (C.35)
The first term represents 6 month olds entering the unvaccinated class after their
material antibodies have waned, and the second term represents individuals from
time t remaining in the class at time t+ 1. For individuals vaccinated with IPV, the
probability of them remaining in the vaccine tracker IPV class was,
pSalkt = e
−(Λ+δ+IPV to OPV uptake ratet); (C.36)
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and the probability of individuals remaining in the OPV or the dual-vaccine IPV &
OPV vaccine tracker class was,
pSabint = e
−(Λ+δ). (C.37)
The IPV vaccine tracker class was,
Salkt+1 = Ut(1− pUt)
IPV uptake ratet
Λ + δ + IPV uptake ratet + OPV uptake ratet
+ pSalktSalkt.
(C.38)
The OPV vaccine tracker class was,
Sabint+1 = Ut(1− pUt)
OPV uptake ratet
Λ + δ + IPV uptake ratet + OPV uptake ratet
+ pSabintSabint.
(C.39)
The final vaccine tracker class contained individuals with dual vaccine coverage with
both IPV & OPV,
IPVOPVt+1 = Salkt(1− pSalkt)
IPV to OPV uptake ratet
Λ + δ + IPV to OPV uptake ratet
+ pSabintIPVOPVt;
(C.40)
For measuring vaccine coverage, we were interested in the fraction of individuals
vaccinated with IPV, OPV, or dual vaccinated. Therefore, we tracked the fraction of




Ut + Salkt + Sabint + IPVOPVt
. (C.41)
The OPV fraction was,
OPVfract =
Sabint + IPVOPVt
Ut + Salkt + Sabint + IPVOPVt
; (C.42)
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the dual vaccine fraction was,
IPVOPVfract =
IPVOPVt
Ut + Salkt + Sabint + IPVOPVt
; (C.43)
and the unvaccinated/under-vaccinated fraction was,
Ufract =
Ut
Ut + Salkt + Sabint + IPVOPVt
. (C.44)
C.6.1 Observation Models
In order to model the stochastic process of symptomatic infected individuals being
reported as a case, we drew cases from a normal distribution. In the US, Lithuania,
and Estonia symptomatic cases were reported monthly. In the RSFSR and Ukraine
paralytic cases were reported monthly. In addition to the monthly cases reported
in the US in the MMWR, non-paralytic and paralytic cases were reported annually
in NOVS and PSU. To represent observations in each data set, the reporting of the
appropriate state variable X it was drawn from a normal distribution with a report
rate ρit and dispersion parameter τ
i,
casest ∼ normal(ρitX it , τ iX it), (C.45)
with the following condition imposed,
casest =

round(casest), if casest ≥ 0
0, otherwise
(C.46)
For calculating the likelihood for each case data set, we used a binned-normal proba-
bility density and used the lower tail of the cumulative density function to discretize
the density.
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If casest > 0,





iX it)− pnormal(casest − 0.5, ρitX it , τ iX it)
(C.47)
If casest = 0,






For all data sets, with the exception of the US MMWR data, the report rate, ρit, was
constant. For the MMWR data, there was a report rate for the pre-baby boom era in
the US (May 1934–Dec 1945), when mostly paralytic polio was reported; and there
was a higher report rate in the baby boom era (1946 onward), with the increase in
report rate occurring in January 1946. The elevated report rate accounted for the
reporting of non-paralytic polio cases that began sometime in 1945. The parameter
τ i captures the variation in the process of observing infections via reported cases. In
addition to the observation models for disease, we also had observation models for
vaccine coverage.
To represent vaccine coverage in each country/region, the reporting of the appro-
priate vaccine tracker state variable V it was drawn from a normal distribution with a
dispersion parameter τ i,
coveraget ∼ normal(100V it , τ iV it ). (C.49)
The vaccine tracker state variables, V it , are fractions, but we were fitting to vaccine
coverage as the percent of the population; therefore we multiplied by 100. We also
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imposed the following condition,
coveraget =

round(coveraget), if 0 ≤ coveraget ≤ 100
0, if coveraget < 0
100, if coveraget > 100
(C.50)
For calculating the likelihood for each vaccine coverage data set, we used a binned-
normal probability density.
If 0 < coveraget < 100, we used the lower tail of the cumulative density function
to discretize the density,





iV it )−pnormal(coveraget−0.5, ρitV it , τ iV it )
(C.51)
If coveraget = 0, we once again used the lower tail of the cumulative density function
to discretize the density,





iV it ). (C.52)
In contrast, if coveraget = 100, we used the upper tail of the cumulative density
function to discretize the density,
Likelihoodit = pnormal(coveraget − 0.5, ρitV it , τ iV it ). (C.53)
Because we were fitting the data to multiple data sets, the likelihood was taken as the










where n is the appropriate number of data sets for that country/region. The scaler
1e−18 was used for practical purposes to put a lower bound on the likelihood in order
to prevent arithmetic underflow. In the US, we fit the vaccine uptake rates to the four
time series of vaccine coverage (IPV, OPV, dual vaccinated, and unvaccinated/under-
vaccinated). In the US we also fit to the two NOVS time series and the MMWR time
series. The state variables used to report to NOVS were the paralytic and non-
paralytic infections. Whereas, the symptomatic infections were reported in the US
MMWR, and in Lithuania, and Estonia. The paralytic infections were reported in
the RSFSR and Ukraine.
C.7 Pre-Vaccine Era Statistical Inference
We fit our SIR models to the data using maximization by iterated particle filtering
(mif) in the R package pomp [6]. mif is a simulation-based likelihood method for
parameter estimation. The basis of mif is particle filtering, also known as Sequential
Monte Carlo, which integrates state variables of a stochastic system and estimates
the likelihood for a fixed parameter set. Instead of fixing parameters, mif varies
the parameters throughout the filtering process using a random walk and selectively
propagates particles (parameter sets) that have high likelihood. By initializing mif
throughout parameter space, we identified regions of high likelihood and identified the
maximum likelihood parameter estimates. We estimated parameters independently
for the US and the four regions of the USSR. The inference conducted in this study was
an extension to model fitting that was done in a previous study of WPV transmission
in the US [2]. In our baseline study, in order to get a handle on WPV epidemiological
parameters in the pre-vaccine era, mif was initialized from 1 million parameter sets
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for a global search, followed by additional phases of increasingly localized searches,
which included profiling.
To estimate WPV epidemiological parameters for the US, inference was done
using the data from May 1934 to December 1954, the pre-vaccine era. Inference was
initiated in May of the year following the first full year of available data on polio cases
and births. This was done in order to construct the infant initial conditions directly
from the birth data. The month of May is the tail-end of the polio off-season. Thus,
the 0–6 month old infants in May were born between November and April, when
polio transmission was low and they were unlikely to be infected. Based on this,
we assumed that the initial number of susceptible infants in the 6th infant class was
the number of individuals born in November of the previous year, individuals born in
December were in the 5th infant class, January births were in the the 4th infant class,
February births in the 3rd infant class, March births in the 2nd infant class, and April
births in the the 1st infant class. We set the initial number of infected infants to zero.
Constructing the infant initial conditions prevented us from having to estimate an
addition seven parameters. We used a similar procedure for the USSR. We initialized
inference in January of the first year of available data. Once again, we assumed all
infants were susceptible. Unlike the US where we had monthly birth data, for the
USSR we had birth data on the annual basis. Therefore, we had to assume births
were distributed evenly throughout the year in the USSR. We know that births are
in fact seasonal, as shown in the US birth data in the main text. However, without
monthly birth data for the USSR we had no way to constructing the birth seasonality
in the USSR.
C.7.1 WPV Global Search
In our original study of WPV transmission [2], to initialize a global search of
parameter space, 1 million parameter combinations, with initial conditions reflecting
259
a low incidence month, were generated to cover a broad range of parameter values.
For each parameter set, ten replicate particle filters were run, each with 2000 parti-
cles, to estimate the likelihood of the data from the state of Illinois. Although the
state of Illinois was used to initially search the global space for WPV epidemiolog-
ical parameters, the US national-level data and the USSR regional-level data were
used to find the country/region specific MLEs. Illinois was chosen in our previous
study because of the high incidence of polio in Illinois and because Illinois had an
increase in incidence following the World War II baby boom, which was a charac-
teristic feature of many US states. The 1 million likelihoods were used to provide a
rough estimate of the global shape of the WPV likelihood surface and identify regions
of parameter space with high likelihood. Of the 1 million parameter sets, the 50000
with the highest likelihoods were used to initialize local searches of parameter space
using mif. It is important to note that the particle filter gives an unbiased estimate
of the likelihood, but some extra algebra needs to be done to get the estimates of the
log-likelihood from replicate particle filters. We calculated the unbiased estimate of
the log-likelihood using the following equations,
log ~L(Θ) = ~x. (C.55)
Given the vector of log-likelihoods, ~x, produced from n replicate particle filters using
the parameter set Θ, we find the mean:
y = mean(~x), (C.56)
then we use the mean to estimate of the log-likelihood:
logL = y + log(mean(e~x−y)); (C.57)
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where sd is the standard deviation.
C.7.2 Local Searches of Parameter Space
Each of the 50000 “best” likelihood parameter sets obtained from the Global
search were used to initiate local searches of WPV transmission parameter space. mif
was used for local searches of parameter space. In general, for each run of mif, we
used a random walk standard deviation of 0.02, 45+ iterations of mif, 2000+ particles,
hyperbolic cooling with a variance factor of 2, and a cooling fraction of 0.5. Monte
Carlo replicate mif runs were also used in local searches. All searches of parameter
space were done on the log or logit scale. The log scale was used to enforce parameter
values >0 and the logit scale was used to bound parameters, such as the report rate











It is important to note that the random walk standard deviations for some parameters
were time-varying, such as for the pre-baby boom report rate for the US MMWR data.
This is because, if the parameter was only relevant to a particular time period (e.g.,
the pre-baby boom), then that parameter was only allowed to vary via the random
walk during the time points for which the parameter was relevant. This was done
in order to align the inference procedure with the data containing information to
guide the estimation of each parameter. In order to define time-varying random walk
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standard deviations, the mif2 method was used in the developer version of the package
pomp. As parameters passed through our multiphase inference pipeline, the number
of parameter sets expanded and contracted. This is because the use of Monte Carol
mif replicates expanded the parameter sets, but we would also cull parameter sets to
remove all parameter combinations that had a likelihood >> 20 log-likelihood units
below the current maximum.
C.7.3 US Profiling Report Rate and Immigration
In the US, we identified that the MMWR report rate of infections (i.e., not broken
down by symptoms, IOt), in the pre-baby boom era, ρ
mmwr, to be important; along
with the immigration into the force of infection, ψ. Therefore, we decided to profile
ρmmwr and ψ. The profile values spanned the ranges [0.001, 0.1] and [6e-6, 2.5e-3], for
ρmmwr and ψ, respectively. There were 37 values of ρmmwr, (ρ1, ρ2, ..., ρ37), with 0.001
interval sampling in the range of [0.001,0.03] and 0.01 interval sampling in the range of
[0.04, 0.1]. There were 50 values of ψ, (ψ1, ψ2, ..., ψ50) evenly sampled across the range.
In order to make the profiles two dimensional, we took every pairwise combination,
which resulted in 1850 profile points, each being a unique combination. Monte Carlo
replicate mif runs were used to maximize the likelihood along the other parameter
and initial condition dimensions. We found the highest likelihood parameter set at
each of the 1850 profile points and profiling was repeated to refine the parameter
estimates. Fig C.3 shows the resulting likelihood profile for the MMWR report rate
during the pre-baby boom and the the immigration term. The MLE from this profile
was used as the MLE for the WPV epidemiological parameters in the US. Therefore,
these MLEs remained fixed from here out in order to do inference on symptomatology
and vaccine efficacy in the US.
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US national MMWR data likelihood profile. Profile contains the
pre-baby boom non-infant report rate (ρmmwr) and the immigration rate
(ψ). MLE indicated by pink asterisk.
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C.7.4 US Profiling Paralytic and Non-paralytic Probabilities.
Using the monthly MMWR data from May 1934–December 1954 and the NOVS
data from 1951–1954, we conducted 2-dimensional profiling of the probability of par-
alytic symptoms, pp, and the probability of non-paralytic symptoms, pnp, in infected
unvaccinated individuals. The profile values ranged from 0.001–0.04 for the para-
lytic probability and 0.008–0.15 for the non-paralytic probability. For pairwise profile
combinations, we used the constraint that the the combined probability of paralytic
or non-paralytic polio upon infection was ≥ ρmmwr. This is because ρmmwr was the
combined probability of symptoms and reporting. Therefore, the probability of ei-
ther a paralytic or non-paralytic infection (i.e., the probability of symptoms) must be
greater than or equal to the joint probability of symptoms and subsequent reporting.
Since we fixed all epidemiological parameters based on the profile of ρmmwr and ψ,
we estimated 7 parameters while profiling pp and pnp. The new parameters estimated
were the report rate of symptomatic infections (now infections are being distinguished
by symptoms) in the MMWR data (during the pre-baby boom and baby boom eras),
the associated dispersion parameter, the report rate of paralytic polio in NOVS, the
reporting of non-paralytic polio in NOVS, and the associated dispersion parameters
for NOVS reports. The NOVS parameters had non-zero random walks from January
1951 onward, and zero otherwise. mif2 was initiated from each of the 22451 profile
points for the paralytic probability versus the non-paralytic probability. We used
Monte Carlo replicate runs for each profile point. Each mif2 run had 60 iterations,
8000 particles, a variance factor of 2, hyperbolic cooling, and a cooling fraction of 0.5.
We took the highest likelihood parameter set from each profile point and initiated
the profiles multiple times.
The profiles of the paralytic and non-paralytic probability were fairly flat across
a large region of parameter space. We discovered that this was due to a tradeoff
between the probability of symptoms and the probability of reporting to MMWR and
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NOVS. The combined probability of symptoms and reporting was well identified (see
Fig C.4). This tradeoff results in a “ridge” in the likelihood surface (see Fig C.5) along
6 dimensions of parameter space (i.e., paralytic probability, non-paralytic probability,
pre-baby boom reporting to the MMWR, the increase in MMWR reporting in the
baby boom, reporting of paralytic cases to NOVS, and reporting of non-paralytic
polio to NOVS). In order to deal with this tradeoff, we assumed that the report rate
of paralytic polio was 60–80% as taken from the literature [1], and we then profiled
intensely within the region of parameter space that fit this assumption. We specifically
profiled along the likelihood ridges because we knew they were areas of high likelihood.
We then drew the MLE from this final profile. The profile shown in Fig C.6 is the
combination of the top parameter sets from all of the profiles done on the paralytic
and non-paralytic probability. The densely profiled area in the forward left corner is



















































































































































































































































































































































































































































































































Figure C.4: Symptoms and Subsequent Reporting. In the US pre-vaccine
era, the combined probability of symptoms and subsequent reporting to
MMWR and NOVS were well identified, but the individual probabilities
of symptoms versus reporting traded off with one another. Shown here
are quasi-profiles.
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Figure C.5: In the US pre-vaccine era, the combined probability of symptoms and re-
porting to MMWR and NOVS were well identified. However, there are 6
parameters that combined to results in the 4 well-identified symptomatic
and reporting probabilities in the previous figure. The tradeoffs between
these parameters result in a “ridge” along 6 dimensions of the likelihood
surface. Components of this ridge are shown here. The parameters sets
from the quasi-profiles in the previous figure are plotted and fall along
the ridges.
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Figure C.6: Multi-phase profiles of the unvaccinated paralytic probability and non-
paralytic probability. The blue asterisk indicates the MLE, the yellow
dots indicate parameter sets within 2 log-likelihood units of the MLE,
demonstrating that a broad range of parameter combinations could ex-
plain these dynamics due to the tradeoffs between the probability of
symptoms and the probability of reporting. Therefore, we did high res-
olution profiling in the region with the reporting of paralytic polio to
MMWR between 60–80% and the MLE was drawn from there. The high
resolution profiling can be seen in the forward left corner of the profile.
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C.7.5 USSR Pre-Vaccine Era Statistical Inference
Using MLEs from each US state provided in [2], we initialized mif2 for the pre-
vaccine era in each of the USSR regions. The data from Estonia and Lithuania from
January 1955–December 1958 were used to estimate the epidemiological parameters.
The data from the RSFSR and Ukraine did not begin until January 1957. Due to
the similarity in the epidemiological dynamics in the US and the USSR, and the
limited size of the USSR data sets, we were quickly able to identify parameter sets
that captured the USSR pre-vaccine dynamics. We did not do any pre-vaccine era
profiling in the USSR or convergence diagnostics. However, no tradeoffs in the pre-
vaccine parameters were observed when fitting this model to US states. Therefore,
we assumed our pre-vaccine MLEs for the USSR are in the neighborhood of the true
MLEs. We decided to wait to do pre-vaccine profiling in USSR until we have extended
our pre-vaccine data for the USSR.
C.8 Vaccine Efficacy Statistical Inference
C.8.1 US Vaccine Phase 1: Sobol Design
Importantly, all epidemiological parameters (i.e., transmission parameters, MMWR
and NOVS report rates, symptomatic probabilities, noise terms, etc.) were fixed based
on the pre-vaccine era MLEs. In order to get a broad overview of the shape of the
likelihood surface under various parameter combinations of vaccine efficacy, a Sobol
design with > 4 million parameter sets was generated. The Sobol design included
both IPV and OPV efficacy parameters. The likelihood of the full vaccine era model
was estimated for each parameter set. The full likelihood was a joint likelihood based
on the MMWR, NOVS, PSU, IPV coverage, and OPV coverage data. The parameter
sets within 100 log likelihood units of the top parameter set, were carried forward into
Phase 2 (there were 2914 parameter sets carried forward). The parameters used in
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the Sobol design were: the IPV and OPV parameters measuring efficacy and effects
on pathology, ζ1−7, as well as the two reporting (i.e., paralytic and non-paralytic) and
two dispersion parameters for PSU. We used rough estimates of the vaccine uptake
rates for calculating the likelihoods in the Sobol design.
C.8.2 US Vaccine Phase 2: MIF
We were unable to reliably run mif using the full vaccine era likelihood model
because the joint likelihood calculation for all 12 time series resulted in numerics below
that computationally possible. Therefore we ran what we will refer to as a mif cascade,
which involved using the same process model but fitting non-overlapping parameters
to various data set combinations sequentially. We (1) improved the fit of the vaccine
uptake rates using the vaccine coverage data, (2) fit the IPV efficacy parameters
using the MMWR and NOVS data, and (3) fit the report rate and the reporting
standard deviation of the paralytic cases to PSU using the paralytic cases in the PSU
data. We continued to hit the limits of floating point number representation when
incorporating the PSU data. When hitting the floating point number representation
limit, the likelihood returned was the tolerance level, 1e-18, in C.54. Without a way to
calculate the PSU likelihoods reliably, we decided not to particle filter using the PSU
data. Therefore, we did all subsequent fitting using the MMWR and NOVS data and
we focused our attention on the estimation of IPV efficacy in the US. By exploring the
results from our Sobol design and running mif to estimate IPV efficacy parameters,
we identified a tradeoff between estimates of IPV’s reduction in susceptibility to
infection, ζ3, and IPV’s reduction in infectiousness, ζ1. Fig C.7 shows high likelihood
parameter sets resulting from the Sobol design and the tradeoff between susceptibility
and infectiousness. This tradeoff persisted after running mif using the MMWR and
NOVS data, as shown in the main text.
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Figure C.7: Tradeoff observed between IPV efficacy parameters. The relative
infectiousness of IPV-vaccinated individuals, relative to unvaccinated in-
dividuals, and the relative susceptibility to infection of IPV individuals,
as compared to fully susceptible individuals.
C.8.3 US Vaccine Phase 3: Profiling IPV Efficacy
Due to the tradeoff between IPV efficacy parameters, we decided to fix the suscep-
tibility to infection in IPV individuals. We assumed that IPV individuals are equally
susceptible to infection as unvaccinated individuals, an assumption supported by clin-
ical data [7]. Under this assumption, we profiled the reduction in infectiousness in
IPV individuals, ζ1. The profile results are shown in the main text. We profiled ζ1
in the range [0.1,0.7] by units of 0.01. For all parameters with the exception of ζ1,
we used the highest likelihood parameter combination from Phase 2 at each profile
point, as well as the highest likelihood parameter sets from Phase 2 that fell within
each profile slice, to initialize the profiling. Each profile parameter set was run with
25 Monte Carlo replicates, each with 60 mif2 iterations, and 2000 particles.
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C.8.4 USSR Vaccine Efficacy Statistical Inference
We fit parameters relating OPV efficacy and the reduction in the paralytic prob-
ability to the data from the RSFSR. We did 2-dimensional profiling of the reduction
in infectiousness, ζ2, and the reduction in the paralytic probability, ζ7. Both ζ2 and
ζ7 were profiled in the range of [0.001,0.999] in a 50x50 profile. All epidemiological
and reporting parameters were fixed at the MLEs estimated using the pre-vaccine
data. The parameters maximized during profiling were the OPV uptake rate and
the dispersion parameter for reporting the OPV coverage. We also did 2-dimensional
profiling of the reduction in susceptibility, ζ4, and the reduction in the paralytic prob-
ability, ζ7. ζ4 was profiled in the range of [0.001,0.5] and ζ7 was profiled in the range
of [0.001,0.999] in a 50x50 profile. All epidemiological and reporting parameters were
fixed at the MLEs estimated using the pre-vaccine data. Once again, the parameters
maximized during profiling were the OPV uptake rate and the dispersion parame-
ter for reporting the OPV coverage. We used the MLE OPV uptake rate from the
2-dimensional profiles and constructed a 3-dimensional 50x50x50 profile of reduction
in infectiousness, reduction in susceptibility, and reduction in paralytic probability.
Particle filters were run to calculate the likelihood at each of the 125000 profile points
and the MLE was taken from the 3-dimensional profile. For independent validation of
the OPV parameters, we then took the MLEs of ζ2, ζ4, and ζ7 from the RSFSR and
used them to predict the vaccine era cases in Ukraine, Lithuania, and Estonia. Be-
fore doing independent validation, we fit the OPV uptake rate and the OPV coverage
dispersion parameter for Ukraine, Lithuania, and Estonia.
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